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ABSTRACT 
 
Porcine reproductive and respiratory syndrome (PRRS) is the most economically 
important disease in the swine industry. The effects of PRRS are two fold in that it causes 
reproductive problems in breeding females and respiratory problems in growing animals. 
Vaccination has generally not been effective in the prevention of PRRS, partially due to the 
rapid mutation rate and evolution of the virus. The overall objective of this thesis was to 
discover the genetic basis of host response to PRRS virus (PRRSV) using data from the 
PRRS Host Genetics Consortium PRRS-CAP project by conducting genome-wide 
association analyses and estimating genetic parameters. Eight groups of ~200 commercial 
crossbred pigs from 5 breeding companies and 6 unrelated populations were infected 
between 25 and 35 days of age. Blood samples and body weights were collected up to 42 
days post infection (dpi). Pigs were genotyped with the Illumina Porcine 60k Beadchip. 
Whole genome analyses focused on serum viremia and weight gain from 0 to 42 dpi (WG). 
Virus load (VL) was quantified as area under the curve of log viremia from 0 to 21 dpi. VL 
and WG were found to be moderately heritable at 0.44 and 0.39, respectively. A quantitative 
trait loci (QTL) was identified on Sus scrofa chromosome (SSC) 4 for VL and WG using 
data from the first 3 trials and validated in trials 4 through 8. The SSC4 QTL explained 13% 
of genetic variance for VL and 9% for WG. The favorable allele at the QTL had a dominance 
mode of action and resulted in reduced VL (0.50 phenotypic SD) and increased WG (0.49 
phenotypic SD). The favorable allele was identified in all breeds represented in the trials but 
at a low frequency. Additional genomic regions were identified on SSCX and SSC1 for VL 
and SSC5 and 7 for WG, each explaining less than 3% of the genetic variance. The QTL on 
SSC1 was also associated with mortality in one trial where death loss was ~50% due to 
 xiv
secondary infections. In conclusion, host response to PRRSV infection has a sizable genetic 
component. Estimates of heritability were moderate and, with a frequency of 0.17 for the 
favorable allele for the SSC4 QTL across trials, there is opportunity for genetic improvement 
of pigs for response to PRRS infection. 
 
 
 1 
CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
 
Porcine reproductive and respiratory syndrome (PRRS) is a relatively new disease 
caused by the PRRS virus (PRRSV). The virus is an enveloped, positive sense, single-
stranded RNA virus with two genotypes, the European (Type 1) and the North American 
(Type 2) isolates. Interestingly, these two isolates were identified at roughly the same time, 
with Type 1 in the Netherlands in 1991 (Wensvoort et al., 1991) and Type 2 in North 
America in 1992 (Benfield et al., 1992). These two isolates share approximately 67% 
homology at the nucleotide level (Rowland and Morrison, 2012). 
The PRRSV is particularly devastating because it can affect all phases of swine 
production. The effects of PRRS include reproductive problems in breeding animals and 
respiratory problems in growing animals (Neumann et al., 2005; Doeschl-Wilson et al., 
2009). Specifically, PRRS results in an increase in the number of abortions, early farrowings, 
stillbirths, mummified piglets, and weak piglets on the reproductive side, and decreased 
production and respiratory problems in growing animals. Secondary infection is common in 
the field, which ultimately results in an increase in death loss. As a result, PRRS is the 
economically most important disease to the swine industry, with estimated annual costs in the 
US alone of $660 million (Holtkamp et al., 2013). Over 50% of the annual costs are 
contributed to the growing pig herd.  
Herd health is a key component to the success and profitability of swine production. 
Improved herd health can be achieved through many different methods, including the use of 
vaccines, antibiotics, and strict biosecurity. With respect to PRRSV, antibiotics are not 
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effective because it is a virus. Biosecurity can be an effective method to maintain a PRRSV-
free health status if farm personnel are disciplined and follow all aspects of the biosecurity 
protocol put in place for that farm. Examples of biosecurity include air filtration systems, 
boot baths, shower-in and changing into clothes kept at the farm, limiting access to the farm, 
intensive rodent and other animal control, and no returning of pigs to the farm once pigs 
leave the farm (Lambert and D’Allaire, 2009; Pitkin et al., 2009). Some aspects of 
biosecurity are difficult to control due to the many routes of transmission of PRRSV. For 
example, a farm may not have control of where feed and rendering trucks have been prior to 
arrival at that farm. 
Vaccination has also had limited success with respect to the PRRSV. Vaccination 
may have some effectiveness when a homologous strain is used for infection, but 
effectiveness is absent with a heterologous strain (Cano et al., 2007ab; Kimman et al., 2009). 
Others have reported that modified-live PRRSV used in vaccines can become virulent in the 
field (Bøtner et al., 1997; Storgaard et al., 1999; Nielsen et al., 2001). Therefore, additional 
methods to control and reduce the impact of PRRS must be investigated. One of these 
methods is improvement of host genetics. 
Breed differences in response to PRRSV infection have been identified, indicating a 
genetic component (Halbur et al., 1998; Petry et al., 2005; Ait-Ali et al., 2007; Doeschl-
Wilson et al., 2009). Others have identified that PRRS related traits such as survival, viremia, 
and reproductive performance are heritable (Lewis et al., 2009; Biffani et al., 2010; 
Vukasinovic and Clutter, 2010). However, little is known about the mechanisms at the 
genetic level that drive these differences. To this end, the PRRS Host Genetics Consortium 
(PHGC) was established with 3 main objectives: 1) determine if there are host genes that 
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control resistance/susceptibility to PRRSV infection, 2) verify genetic variation in response 
to PRRSV, and 3) identify relevant phenotypic traits and estimate genetic parameters of those 
traits (Lunney et al., 2011).  
The hypotheses behind the research presented in this thesis are: 1) traits associated 
with host response to PRRSV infection are heritable and 2) genomic regions or QTL 
associated with host response to experimental PRRSV infection are present and can be used 
to improve herd health in response to PRRS. To test these hypotheses, the objectives of this 
thesis were to utilize the data generated by the PHGC to: 
1) Estimate genetic parameters of traits related to PRRSV infection. 
2) Identify genes or genomic regions associated with piglet response to PRRSV 
infection through a genome-wide association analysis. 
3) Characterize genes or genomic regions associated with piglet response to PRRSV 
infection identified in the genome-wide association analysis. 
4) Investigate whether marker effects estimated from one population can predict the 
response to PRRSV infection of animals in unrelated populations. 
 
Thesis Organization 
Based on the work to achieve the objectives of this thesis, four manuscripts for 
publication in scientific journals were written and are included as chapters in the thesis. 
Chapter 2 includes a review of literature as background for this research. Estimates of genetic 
parameters and results of a genome-wide association analysis of the first three trials are 
described in Chapter 3. Further characterization and validation of the effects of a quantitative 
trait locus (QTL) that was identified in Chapter 3 in unrelated populations are described in 
Chapter 4. Validation of the QTL identified in Chapter 3 in additional unrelated populations, 
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along with phylogenetic analyses of the haplotypes associated with the QTL, are described in 
Chapter 5. Investigation of different models for QTL detection, characterization of additional 
QTL, and predictive ability of PRRS response across unrelated populations using genome-
wide SNPs are described in Chapter 6. Finally, Chapter 7 includes general conclusions, 
discussion, and a quantification of the potential economic benefit that could be achieved by 
selecting for the QTL identified in Chapter 3. 
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CHAPTER 2. LITERATURE REVIEW
 
Porcine reproductive and respiratory syndrome virus
The porcine reproductive and respiratory syndrome virus (PRRSV) was first isolated 
in the Netherlands in 1991 (Wensvoort et al., 1991)
al., 1992). The virus is an enveloped, positive sense, sin
the family Arteriviridae, order 
American (Type 2) isolates are approximately 67% homologous at the nucleotide level 
(Rowland and Morrison, 2012)
 
The PRRSV genome is approximately 15kb and consists of a 5’ cap structure, a non
translated leader, at least 9 open reading frames (ORF), a 3’ non
poly(A) tail (Meulenberg et al., 1993; Wootton et al., 2000; Johnson et al., 2011)
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1.1). The first 2 ORFs (1a and 1b) contain the non-structural proteins (i.e. proteins involved 
in virus replication) and encompass 75% of the entire genome. The remaining 7 ORFs 
contain structural proteins, which are involved in virion structure and organization. The 
major structural proteins of PRRSV are glycoprotein (GP) 5, matrix, and nucleocapsid, 
which are encoded in ORFs 5, 6, and 7, respectively (Dea et al., 2000). Minor structural 
proteins include GP2, GP3, and GP4, and are encoded in ORFs 2, 3, and 4, respectively 
(Rowland and Morrison, 2012). Additional minor structural proteins have recently been 
identified and include GP2b and GP5a, which are encoded in ORFs 2 and 5, respectively 
(Wu et al., 2005; Johnson et al., 2011). 
 The genome is encased by an icosahedral structure formed by the major structural 
nucleocapsid protein. The outermost layer of the virus is a lipid bilayer envelope (Benfield et 
al., 1992; Meulenberg et al., 1993). The major structural proteins GP5 and matrix form a 
disulfide-linked heterodimers in the envelope (Van Breedam et al., 2010), while minor 
structural proteins GP2a, GP3, and GP4 form heterotrimers. 
 
Effects and economic impact of the PRRS virus 
Porcine reproductive and respiratory syndrome (PRRS) is a relatively new disease 
caused by the PRRS virus. PRRS results in devastating losses for swine operations globally. 
The effects of PRRS are two fold, in the sense that it causes reproductive problems in 
breeding animals and respiratory problems in growing animals (Doeschl-Wilson et al., 2009; 
Neumann et al., 2005). These effects include abortions, early farrowing, stillbirths, 
mummified piglets, weak piglets, and delayed return to estrus in breeding animals and 
increased mortality, decreased production, and respiratory problems in growing animals. In a 
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commercial setting, secondary infections are also common in pigs that have PRRS. 
Secondary infections, which include Streptococcus suis, bacterial pneumonia, Esherichia 
coli, Actinobacillus suis, Arcanobacterium pyogenes, and Salmonella choleraesuis, can 
increase the likelihood of death compared to infection with the PRRS virus (PRRSV) alone 
(Chung et al., 1997; Johnson et al., 2004). Collectively, PRRS is the economically most 
important disease to the swine industry, with estimated annual costs of $664 million in the 
US alone (Holtkamp et al., 2011). 
The growing pig herd accounts for over 50% of the total economic loss due to PRRS 
in the US (Holtkamp et al., 2011). Understanding the effects of PRRS on the growing animal 
provides a basis for improving resistance to PRRS, and these effects have been well 
documented. Two different lines of pigs that were artificially infected with PRRSV had 
significantly reduced weight gain (WG) compared to their uninfected littermate controls, 
suggesting a negative phenotypic correlation (Petry et al., 2005). Doeschl-Wilson et al. 
(2009) also reported a significant correlation of -0.4 between average daily gain (ADG) and 
serum PRRSV titer at 21 days post experimental infection. Correlations of PRRSV titer 
levels with clinical signs, encompassing respiratory signs, behavior, and coughing, were 
reported to be positive (r=0.80) (Johnson et al., 2004). Fever and respiratory problems were 
positively correlated with each other (r=0.29) across 2 genetically diverse lines of pigs that 
were experimentally infected with PRRSV (Doeschl-Wilson et al., 2009). Rectal 
temperatures were elevated by 24 hours post infection and remained elevated for at least 10 
days post experimental infection (dpi) (Halbur et al., 1996; Doeschl-Wilson et al., 2009). 
Lethargy and anorexia have also been associated with PRRSV infection in cesarean-derived, 
colostrum-deprived (CDCD) pigs (Halbur et al., 1996). Presence and severity of clinical 
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signs partially depend on the virulence of the PRRSV strain. Halbur et al. (1996) compared 
clinical signs when different groups of CDCD pigs were infected with 1 of 9 different US 
strains of PRRSV. In general, pigs inoculated with a more virulent strain suffered more 
severe respiratory problems and the duration of clinical signs was longer, compared to pigs 
infected with a less virulent strain. Internally, PRRSV infection causes lung lesions and 
macroscopic and microscopic pneumonia, which are both correlated (0.33 < r < 0.46) with 
PRRSV titers in bronchoalveolar lavage (Doeschl-Wilson et al., 2009). Although clinical 
signs were mild to absent in some pigs, all infected animals had lesions in the lung and 
lymph nodes (Halbur et al., 1996). Collectively, these effects result in great economic losses 
to the swine industry. 
 
Life cycle of the PRRS virus 
The PRRSV infects primarily macrophages in lungs, lymphoid tissues, and placenta 
(Van Breedam et al., 2010). The stages of the PRRSV life cycle include entry into the host 
cell, translation of its genetic material, replication and transcription, assembly, and release.  
Entry. The process of entry of the virus into the porcine macrophage was reviewed by 
Van Breedam et al. (2010). The virus first attaches to heparan sulphate glycosaminoglycans 
located on the cell surface of macrophages. Secondary attachment is to sialoadhesin, also on 
the cell surface, via the viral M/GP5 heterodimer. This secondary attachment strengthens the 
bond between the virus and the cell. Once attached, the virus is taken into the cell through 
receptor-mediated endocytosis, which is initiated as the result of secondary attachment of the 
virus to the cell. Cellular pH must be reduced before the viral genome is released into the cell 
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(Kreutz and Ackermann, 1996).  Entry is complete once the viral genome is released into the 
cytoplasm. 
 Translation. The PRRSV is a positive-strand RNA virus; therefore, once it has 
entered the cell, it is ready to be translated by the host cell translation machinery. Translation 
of ORF 1a and 1b results in polyproteins 1a and 1b, which are then cleaved into 14 non-
structural proteins, including the important RNA-dependent RNA polymerase (Bautista et al., 
2002; Ziebuhr et al., 2000). The polymerase is critical for replication of PRRSV. 
 Replication and Transcription. The virus is replicated in the cytoplasm of the host 
cell (Dea et al., 2000). RNA-dependent RNA polymerase initiates replication by generating a 
full-length negative-strand RNA genome (Pasternak et al., 2006). The negative strand in turn 
is a template to synthesize more positive strand RNA. The new genome is used for synthesis 
of genome-length negative-strand RNA and sub-genomic minus strand RNA (Snijder and 
Meulenberg, 1998). More positive strand RNA is synthesized than negative strand RNA 
during replication because positive strand RNA is used as the genomic template during 
replication. The non-structural proteins are synthesized from positive strand RNA, and 
positive strand RNA is packaged into new virions for release from the cell (Sawicki et al., 
2001). 
 Assembly. Assembly of PRRSV is not fully understood at this time. However, this 
process occurs via the budding of preformed nucleocapsids into the lumen of the 
endoplasmic reticulum and the Golgi apparatus (Dea et al., 2000). 
Release. The PRRSV is released through exocytosis, whereby the virus is released to 
the exterior of the cell (Dea et al., 1995). This process lyses the cell, ultimately killing it. 
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Host defense to PRRS virus infection 
 The PRRSV can enter the host through an array of routes including inhalation, 
physical contact with a carrier pig or human, or insemination. Irrespective of the point of 
entry, PRRSV thrives in the alveolar macrophages of the lung and can persist in the host for 
months (Murtaugh et al., 2002). Host responses discussed here include innate and adaptive 
immune responses.  
 Innate immune response. Most cells, including macrophages, are able to trigger the 
innate immune system when a foreign pathogen invades the cell. Interferons (IFN) are the 
first line of defense. Once the virus attaches to a cell, pattern recognition receptors (PRRs), 
such as Toll-like receptors (TLR) and RIG-I-like receptors (RLR), recognize pathogen-
associated molecular patterns (PAMPs) (Luo et al., 2008). Following PAMP binding, TLRs 
and RLRs communicate through specific adaptor proteins that activate transcription factors 
IFN regulatory factor 3 (IRF3), IRF7, and NF-κB, which in turn induces Type 1 IFNs and 
proinflammatory  cytokines. Interferons attach to IFN receptors located on neighboring cells, 
which induces the Jak-Stat pathway, and signals IFN stimulated genes (Acheson, 2007). 
These genes encode the proteins that ultimately block virus transcription, translation, or 
replication. 
 A weak innate immune response to a virus results in the inability of the host to 
rapidly control virus replication. It has been well established that PRRSV elicits a weak IFN 
response (Albina et al., 1998; Beura et al., 2010; Luo et al., 2008; Miller et al., 2004; 
Thanawongnuwech et al., 2001; Van Reeth et al., 1999), which allows the virus to replicate 
quickly, invade neighboring cells, and remain in the host for a prolonged period of time (3+ 
months). Albina et al. (1998) found that IFN-alpha titers in serum were in low concentration 
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on days 2 through 5 following experimental infection with PRRSV, compared to IFN-alpha 
concentration when pigs were infected with transmissible gastroenteritis virus, which is a 
known inducer of IFN. Furthermore, no IFN-alpha was found in lung secretions following 
PRRSV infection (Albina et al., 1998). In vitro, Miller et al. (2004) found that abundance of 
INF-alpha or –beta in PRRSV infected MARC-145 cells was not significantly different from 
mock-infected MARC-145 at 16 or 24 hours post infection. Luo et al. (2008) investigated the 
pathway for the inhibition of cellular IFN-beta and concluded that PRRSV interferes with the 
RIG-I pathway. Briefly, PRRSV inactivates INF-beta promoter stimulator 1, which prevents 
the nuclear translocation of IFR3, resulting in a weak or lack of IFN-beta response. 
Furthermore, the non-structural virus protein 1-beta has an important inhibitory role on IRF3 
(Beura et al., 2010) 
 Adaptive immune response. The adaptive immune response partially depends on a 
strong innate immune response to a pathogen. Because PRRSV induces suboptimal innate 
immune response, specifically the induction of type 1 IFNs, the adaptive immune response is 
weak and does not provide full immunity (Beura et al., 2010). A protective level of immunity 
can take at least 3 months to develop and this allows the virus to persist in the host for long 
periods of time (Kimman et al., 2009). Under experimental conditions, protective immunity 
to a homologous strain of PRRSV develops but not against a heterologous strain. In one 
study, gilts were inoculated with an American strain of PRRSV at breeding and re-infected 
between 90 and 205 d post breeding with either the same American strain or the heterologous 
European strain (Lager et al., 1999). Gilts challenged with the homologous strain had 
complete protection, whereas gilts inoculated with the heterologous strain had incomplete 
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protection. The lack of protection against heterologous strains is a challenge for development 
of effective vaccines. 
 Antibodies are generated within 5 days after inoculation; however, most of these are 
non-neutralizing antibodies (Kimman et al., 2009). The role of neutralizing antibodies (NA) 
against PRRSV is debatable. Using the European Lelystad strain of the PRRSV, NA were 
detected at 25 days post infection and remained at low levels (<4 titers on a log 2 basis) in 
serum (Labarque et al., 2000). Furthermore, NA in bronchoalveolar lavage cells were 
detected in only 2 of 29 pigs and also remained at low levels. Similarly, Diaz et al. (2005) 
first detected serum NA in only 3 of the 5 Landrace pigs at 56 days following infection at 4 
weeks of age. Serum NA was never detected in the remaining 2 pigs by the end of the 70 day 
experiment. Conversely, as reviewed by Lopez and Osorio (2004), NA to PRRSV have been 
associated with the prevention of viremia and NA levels correlate with clearance of viremia 
from circulation and tissue. Clearly, more research is needed to understand the molecular 
mechanisms driving the differences observed with respect to NA. 
 
Spread, control, and elimination of the PRRS virus 
Spread of the PRRV poses a problem because of the multiple methods by which it 
can be transmitted. Common methods include contaminated semen (Yaeger et al., 1993), 
contaminated equipment (Rowland and Morrison, 2012), pig-to-pig contact (Yoon et al., 
1993), and, although controversial, through the air (Kristensen et al., 2004). For example, in 
a study by Kristensen et al. (2004), PRRSV seropositive and negative pigs were placed in 1 
confinement and all PRRSV negative pigs were placed in another confinement building. The 
two buildings were 1 meter apart and connected via 4 valves that allowed airflow from 
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PRRSV positive confinement to PRRSV negative confinement at different rates (70, 10, and 
1% air transmission) for 3 different experiments. At the end of the ~ 1 month experimental 
period, all PRRSV negative pigs placed with PRRSV positive pigs were PRRSV positive, 
demonstrating pig-to-pig transfer, and 94, 100, and 100% of pigs in the PRRSV negative 
confinement were PRRSV positive, demonstrating airborne transmission. Conversely, 
Torremorell et al. (1997) stated that airborne transmission may be strain specific, as 
transmission was observed for only 1 of the two strains tested, and Otake et al. (2002) did not 
find evidence of airborne transmission in a field study, where pigs were housed 1 and 30 m 
from the infected barn. 
Irrespective of the route of transmission, once PRRSV seropositive pigs are in a herd, 
~95% of the pigs will become seropositive within 2 to 3 months (Terpstra et al., 1992). Once 
a herd is PRRSV positive, the virus can persist for more than 3 months (Chung et al., 1997; 
Christopher-Hennings et al., 2001; Wills et al., 2003). Transmission and persistency of the 
virus is partially to blame for the inability to control PRRS. 
 The swine industry has been fighting PRRSV for roughly 25 years and much research 
has been dedicated to developing methods to control and eliminate the virus at the herd level. 
These methods have been reviewed by Corzo et al. (2010). Methods to control PRRSV 
include testing of semen for PRRSV before use, Management Changes to Reduce Exposure 
to Bacteria to Eliminate Losses (McRebel), gilt acclimation strategies during a PRRS 
outbreak, and vaccination. Methods to eliminate PRRSV include test and removal, whole 
herd depopulation and repopulation, herd closure and rollover, and regional elimination. 
Some methods have been relatively successful, but come with great monetary expense and 
are still not 100% effective. Other methods have been ineffective, strain specific, or labor 
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intensive. Select methods will be briefly discussed here based on popularity and 
effectiveness. 
Vaccination. Although controversial, vaccination against PRRS virus has been 
relatively unsuccessful. Dewey et al. (1999) observed a decrease in the number of pigs born 
alive and weaned, an increase in the number of stillborns, and an increase in the number of 
mummified pigs, after sows were vaccinated with PRRSV modified-live vaccine during the 
last 4 weeks of gestation. Furthermore, a number of studies have reported that modified-live 
PRRSV used in vaccines can become virulent in the field (Bøtner et al., 1997; Nielsen et al., 
2001; Storgaard et al., 1999). As reviewed by Kimman et al. (2009), PRRSV modified-live 
vaccines reduce the presence of clinical signs but do not prevent infection, which is a 
problem if naive pigs are introduced into the herd. In support of Kimman et al. (2009), one 
study showed that a vaccine containing a modified-live virus of 84% homology to the field 
PRRS virus provided only 72% effectiveness (Borghetti et al., 2011). Another study reported 
that vaccination did not remove the virus from the host but reduced the number of pigs that 
were persistently infected with the homologous strain but not with a heterologous strain 
(Cano et al., 2007ab) 
 Depopulate and repopulate. Depopulation and repopulation entails eradicating all 
breeding and/or growing swine from production, disinfecting the facilities, and restocking 
with PRRSV free pigs. This method is extremely effective, not only in eliminating PRRSV 
but other pathogens as well (Corzo et al., 2010). However, this method is also expensive 
since all animals must be eliminated, irrespective of age and weight, and new animals must 
be purchased. 
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 Herd closure and rollover. Introducing naive animals into a PRRS-positive herd 
enables the virus to persist for longer periods of times than in acclimated animals, as naïve 
pigs have no immunity to the virus. Even if clinical signs are absent in the herd, naïve pigs 
are extremely susceptible and can stimulate recirculation (Corzo et al., 2010). Herd closure 
and rollover includes stopping the introduction of new animals into the herd for at least 6 
months and eliminating seropositive animals over time (Torremorell et al., 2003). 
Replacement females should be negative when introduced into the sow farm.  Semen must 
also be PRRS negative. This method has become increasingly popular and is relatively 
inexpensive compared to depopulation and repopulation (Corzo et al., 2010). 
 Regional elimination. This method is a collaborative effort amongst producers and 
veterinarians in a designated region. Regional elimination utilizes elimination methods such 
as herd closure and rollover and whole herd depopulation and repopulation to eliminate the 
PRRSV from a designated region, e.g. a county. Once PRRSV is eliminated from the 
designated region, the region is expanded to eliminate PRRSV from neighboring regions 
with the goal of maintaining a PRRSV-free health status of the original region. In theory, the 
designated region would eventually span the whole United States, and then all of North 
America. One successful example of regional elimination is in Stevens County, Minnesota, 
which was initiated in 2004 (Corzo et al., 2010). These projects require voluntary 
participation, which has been a challenge for the Stevens County project. Producers that 
choose not to participate pose a threat to the overall goal of the project because the health 
status of farms owned by non-participants is unknown. 
Which method to choose depends the type of production system. Depopulation and 
repopulation is likely the best method when dealing with a finisher production system, 
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whereas herd closure and rollover is a good option for breeding herds. Clearly, biosecurity is 
of utmost importance in preventing PRRS outbreaks or when attempting to rid the virus once 
the herd is PRRS positive. Nonetheless, these methods are not perfect and reinfection is 
possible. Reinfection after depopulation and repopulation or herd closure and rollover can be 
devastating not only financially, but emotionally as well. Furthermore, these methods do not 
tackle the problem of decreased production during a PRRS outbreak. 
 
Host genetics and PRRS 
Between breed differences are typically of first order when determining the genetic 
basis of a trait and such differences, have been reported with regards to PRRS tolerance. 
When experimentally infected with a highly virulent PRRSV strain, purebred Hampshire pigs 
had significantly more PRRSV-induced gross lung lesions compared to purebred Duroc and 
Meishan pigs (Halbur et al., 1998). Petry et al. (2005) compared the effects of PRRSV in a 
Large White-Landrace composite line against an F1 Hampshire-Duroc cross. They found the 
Large White-Landrace composite line to have greater weight gain, lower rectal temperatures 
at 4, 7, and 11 dpi, and lower viral titer levels in serum compared to the F1 cross (Petry et al., 
2005). Doeschl-Wilson et al. (2009) compared the effects of PRRSV in Large White and 
Pietrain breeds and reported reduced incidence of interstitial pneumonia, viral concentration 
in the blood, and greater WG for Large White pigs. Using PRRSV infected isolated Swine 
Alveolar Macrophages from Large White, Pietrain, Landrace, and 2 synthetic line pigs, Ait-
Ali et al. (2007) found that Landrace animals had significantly reduced percent PRRSV 
positive cells, reduced viral titer levels, and significantly greater expression of tumor necrosis 
factor-α compared to the other breeds.  Collectively, maternal lines (Large White and 
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Landrace) appear to be less susceptible to the virus compared to breeds or lines selected for 
lean growth and efficiency (Pietrain, Duroc, and Hampshire). 
Clearly, breed differences are present with respect to the effects of PRRSV. However, 
heritability estimates of PRRS resistance/susceptibility are scarce. Using commercial sow 
performance data before and after a naturally occurring PRRS outbreak from a single farm, 
heritability estimates for number born alive, number of stillborn, and number of mummies 
ranged from 0.12 to 0.15 in sows infected with PRRS (Lewis et al., 2009a). Using data 
collected from herds naturally infected with PRRSV in northern Italy, heritability of viremia 
as a binary trait (positive or negative for PRRSV) was 0.096 in weanling pigs (Biffani et al., 
2010).  Heritability of survival in weanling pigs experimentally challenged with PRRSV was 
0.26 (Vukasinovic and Clutter, 2010). 
 
Methods to detect quantitative trait loci (QTL) 
 Detection of QTL depends on linkage disequilibrium (LD), or the non-random 
assortment of alleles, between a marker and the causative mutation. Types of markers include 
restriction fragment length polymorphisms (RFLPs), microsatellites, and single nucleotide 
polymorphisms (SNPs) (Vignal et al., 2002). There are two main types of analyses for 
detecting QTL, linkage analyses and association analyses. Linkage analyses use family 
information or strategic crosses (in plant and animal breeding) to follow markers through the 
pedigree. One linkage analysis method is to cross pure lines that have different marker allele 
frequencies to create an F1 population and then interbreed the F1 to produce an F2 
population (Zhou et al., 2006). In the F2 population, phenotypic differences are investigated 
and are related back to the marker information of the purebred lines to determine an 
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association. Association analyses do not rely on family information and can be performed 
using unrelated individuals. Association analyses rely on LD between markers and QTL 
across the population, which requires them to be in close proximity to each other; therefore, 
association analyses require a larger number of markers compared to linkage analyses. 
 Genome-wide association analyses have grown in popularity with the development of 
high-density SNP panels, which contain tens to hundreds of thousands of SNPs spread across 
the genome. Genome-wide association analyses have been successfully used to identify QTL 
for various traits in swine. Much emphasis has been placed on production traits. For example, 
using Large White and Large White X Landrace F1 gilts, Fan et al. (2011) identified QTL for 
10th-rib backfat, 10th-rib loin muscle area, and overall leg action. Fewer studies have used 
genome-wide association analyses for disease resistance, specifically viral diseases. Using a 
linkage analysis and microsatellite markers, one study identified several QTL related to 
humoral immune response of pigs after vaccination for Mycoplasma hyopneumoniae, 
Aujesky’s disease virus, and PRRSV (Wimmers et al., 2009). Specifically for PRRS, QTL 
related to antibody titers were identified on chromosomes 1 and 7 (Wimmers et al., 2009).  
Thus far, only one study has reported associations between SNP and response to 
PRRS using a genome-wide association analysis (Lewis et al., 2009b). Using data from a 
database that contained 5 years of production traits from a multi-line multiplication herd, the 
authors used performance records to distinguish between PRRS diseased and non-diseased 
states. A PRRS outbreak significantly affected number born alive, piglets mummified, piglets 
born dead, and pigs weaned per litter. In total, 1545 sows with phenotypic records were 
genotyped using a 7k SNP chip. Genome-wide association analysis revealed 6 significant 
SNP for number born alive, number born dead, and number mummified. The most significant 
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SNP explained 4.7% of the genetic variance for number born alive, 1.6% for number born 
dead, and 2.2% for number born mummified (Lewis et al., 2009b). The location of these SNP 
was not provided. To date, no papers have been published on SNP associations and PRRS 
resistance/susceptibility using a 60k SNP chip in breeding or growing animals. Compared to 
the 7k SNP chip, the 60k SNP chip has greater coverage across the genome, likely resulting 
in a greater number of SNPs in LD with PRRS related QTL. 
 
Conclusions 
 
 The PRRSV is a relatively recent virus that the swine industry has been fighting for 
approximately 25 years. The effects of the virus have been well documented in both breeding 
and growing animals. The disease is considered the economically most important in the 
swine industry worldwide. Strict biosecurity is important in preventing the virus from 
entering the farm. If a herd becomes infected with PRRSV, strategies to clear the virus have 
been developed, including depopulation and repopulation or herd closure and rollover. 
However, neither preventive measures nor clearing the virus from a herd tackles the problem 
of decreased production during a PRRS outbreak. For many viruses, vaccines successfully 
prevent the effects through adaptive immunity; however, vaccines have had little to no 
success in controlling PRRS. Host genetics has been shown to play a role in 
resistance/susceptibility to PRRSV but to what extent is not clear. Identifying QTL or genes 
associated with PRRS resistance/susceptibility to be used during selection could greatly 
reduce the economic impact of this devastating disease. 
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Abstract 
Porcine reproductive and respiratory syndrome (PRRS) causes decreased reproductive 
performance in breeding animals and increased respiratory problems and morbidity in 
growing animals, which results in significant economic losses in the swine industry. 
Vaccination has generally not been effective in the prevention of PRRS, partially due to the 
rapid mutation rate and evolution of the virus. The objective of the current study was to 
discover the genetic basis of host resistance or susceptibility to the PRRS virus through a 
genome wide association study using data from the PRRS Host Genetics Consortium 
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PRRS-CAP project. Three groups of ~190 commercial crossbred pigs from one breeding 
company were infected with PRRS virus between 18 and 28 days of age. Blood samples and 
body weights were collected up to 42 days post infection (dpi). Pigs were genotyped with the 
Illumina Porcine 60k Beadchip. Whole genome analysis focused on viremia at each day 
blood was collected, and weight gains from 0 to 21 dpi (WG21) or 42 dpi (WG42). Viral 
load (VL) was quantified as area under the curve from 0 to 21 dpi. Heritabilities for WG42 
and VL were moderate at 0.30 and litter accounted for an additional 14% of phenotypic 
variation. Genomic regions associated with VL were found on chromosomes 4 and X, and on 
1, 4, 7, and 17 for WG42. The 1 Mb region identified on chromosome 4 influenced both WG 
and VL, exhibited strong linkage disequilibrium, and explained 15.7% of the genetic 
variance for VL and 11.2% for WG42. Despite a genetic correlation of -0.46 between VL and 
WG42, genomic estimated breeding values (GEBV) for this region were favorably and 
nearly perfect correlated. The favorable allele for the most significant SNP in this region had 
a frequency of 0.16 and estimated allele substitution effects were significant (p < 0.01) for 
each group when the SNP was fitted as a fixed covariate in a model that included random 
polygenic effects using ASREML, with overall allele substitution estimates of -4.1 units for 
VL (phenotypic SD = 6.9), and 2.0 kg (phenotypic SD = 3 kg) for WG42. Candidate genes in 
this region on SSC4 include the interferon induced guanylate-binding protein gene family. In 
conclusion, host response to experimental PRRS virus challenge has a strong genetic 
component and a QTL on chromosome 4 explains a substantial proportion of the genetic 
variance in the studied population. These results could have a major impact in the swine 
industry by enabling marker-assisted selection to reduce the impact of PRRS but need to be 
validated in additional populations. 
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Introduction 
 Porcine reproductive and respiratory syndrome (PRRS) is caused by a single-stranded 
RNA virus of the genus Arterivirus (Wensvoort et al. 1991; Benfield et al., 1992) and is 
currently the most economically important disease for the United States swine industry 
(Neumann et al., 2005). PRRS causes reproductive problems in breeding animals and 
respiratory problems and reduced performance in growing animals. Vaccination for 
protection against PRRS virus (PRRSV) has generally been unsuccessful, primarily due to 
the high degree of antigenic and genetic drift in viral structural and non-structural viral 
proteins and the capacity of the virus to subvert early innate immune responses (Fang et al., 
2007; Kinman et al., 2009; Mateu and Diaz, 2008). Methods other than vaccination must be 
explored to aid in this pandemic; one possibility is genetic improvement of the host (Lewis et 
al., 2007). Early work investigating a host genetic component to resistance to PRRS revealed 
significantly more gross lung lesions in PRRS infected Hampshire pigs compared to Duroc 
and Meishan pigs (Halbur et al., 1998). Petry et al. (2005) found that a Large White/Landrace 
synthetic line had reduced rectal temperatures and decreased viremia when infected with 
PRRSV compared to a Hampshire/Duroc synthetic line. Petry et al. (2007) found that, pre-
infection, PRRS resistant pigs exhibited higher levels of serum interleukin-8.  
Estimates of heritability of PRRS resistance are scarce but estimates for number born 
alive, number stillborn, and number of mummies in sows infected with PRRSV ranged from 
0.12 to 0.15 (Lewis et al., 2009a). The PRRS Host Genetics Consortium was established to 
investigate the genetic basis of host response to PRRSV infection in experimentally infected 
commercial crossbred pigs (Lunney et al., 2011). The objective of the current study was to 
use data from the first 3 infection trials from this consortium to estimate genetic parameters 
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and to conduct a genome-wide association study to discover the genetic basis of host 
response to the PRRSV.  
 
Materials and Methods 
The Kansas State University Institutional Animal Care and Use Committee approved 
all experimental protocols for this study. 
 
Study Design 
 A detailed description of the design, data collection, and molecular techniques for the 
PRRS host genetic consortium trials is in Lunney et al. (2011) and Rowland et al. 
(Manuscript in preparation). Briefly, for the data used in this study, 3 groups of ~190 
commercial crossbred barrows from 1 genetic source were transported at weaning (11-21 
days of age) to Kansas State University and subjected to a PRRS challenge in 3 separate 
infection trials. The pigs were from 2 high health farms that were free of PRRSV, 
Mycoplasma hyopneumoniae, and swine influenza virus. Pigs from trials 1 and 2 came from 
1 farm and pigs from trial 3 came from the other farm. Upon arrival, pigs were randomly 
placed into pens of 10 to 15 pigs. After a 7-day acclimation period, pigs now between 18 and 
28 days of age (day 0) were experimentally infected intramuscularly and intranasally with 
105 tissue culture infectious dose50 (TCID50) of NVSL 97-7985, a highly virulent PRRSV 
isolate (Fang et al., 2007). Blood samples were collected at -6, 0, 4, 7, 11, 14, 21, 28, 35, and 
42 days post infection (dpi). Body weight was collected at 0, 7, 14, 21, 28, 35, and 42 dpi. 
Pigs were euthanized at 42 dpi.  
Viremia was measured using a semi-quantitative TaqMan PCR assay for PRRSV 
RNA. PCR was performed as a routine diagnostic test by personnel of the Kansas Veterinary 
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Diagnostic Laboratory (KSVDL). Briefly, total RNA was isolated from serum using a 
MagMAXTM-96 Viral RNA Isolation Kit (Applied Biosystems, Foster City, California) in 
accordance with the manufacturer’s instructions. PCR master mixes were obtained from the 
AgPath IDTM NA & EU PRRSV kit (Applied Biosystems) and assays were set up as a one-
step reverse transcriptase (RT-PCR reaction), according to kit instructions. The RT-PCR 
reactions were carried out on a QST 7500 Real-Time PCR System (Applied Biosystems, 
Foster City, California) in a 96-well format according to the manufacturer’s 
recommendations. For the construction of a standard curve, dilutions of a template RNA, 
supplied in the Applied Biosystems RT-PCR kit, were prepared and assayed along with the 
samples. The assay results were reported as the Log10 of PRRSV RNA copies per reaction 
relative to the standard curve. Note that resulting values do not directly quantify the absolute 
amount of virus in the sample but, by comparing to the standard curves based on template 
RNA run on the same plate, the values do reflect quantitative differences in viremia between 
samples, which was needed for the purposes of this study. Due to the sensitivity of PCR, 
values that were less than 10 units prior to log-transformation were assumed to have 
negligible amounts of virus in the serum relative to the standard and were given a value of 1, 
corresponding to a log-transformed value of 0. For DNA isolation, ear tissue was collected 
pre-infection or at sacrifice. Genomic DNA was prepared with Qiagen DNeasy Blood and 
Tissue Kit from 20 mg ear tissue after overnight digestion at 56oC with proteinase K. DNA 
quantity was evaluated by a NanoDrop Spectrophotometer and quality was assured by sizing 
on Agarose gels. Arrayed DNA samples were sent to GeneSeek Inc. (Lincoln, Nebraska) for 
genotyping with Illumina’s Porcine SNP60 BeadChip (San Diego, California). 
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In total, data for 570 pigs infected with PRRSV, primarily from Landrace by Large 
White crosses (n = 565) were evaluated; the 5 piglets from other crosses were excluded from 
analyses. The 565 pigs included in analyses came from 208 litters and 30 sires. Pigs per litter 
ranged from 1 to 6 and pigs per sire from 3 to 93. A total of 48 pigs died before 42 dpi. Dead 
pigs were necropsied and gross and microscopic pathology was performed by a board-
certified pathologist. The major reason for mortality was from PRRS associated disease.  
 
Phenotypic traits 
 Traits evaluated in this study included RT-PCR based serum viremia levels up to and 
including 21 dpi, and 3 measures of weight gain (WG). Viremia past 21 dpi was not analyzed 
because the viremia levels rebounded past 21 dpi in approximately 33% of the pigs (Figure 
3.1). The estimate of heritability for rebound, as a 0/1 trait, was low (0.03), suggesting that 
rebound was related to the virus or environment rather than genetics of the host. Viral load 
(VL) was quantified as area under the curve for log-transformed viremia for 0, 4, 7, 11, 14, 
and 21 dpi. Viral load was calculated for each animal that had viremia records on day 0 and 
at least 5 other days. The algorithm to compute VL fitted a smooth curve over the 21 days 
and summed the area in increments of 0.01 units (Rowland et al, manuscript in preparation). 
Edits removed 34 animals from the analysis, including 22 that died prior to 21 dpi, 8 with 
missing viremia records at 0 dpi, 1 that was not genotyped, and 3 that had missing dam parity 
information. Animals that died before 21 dpi were removed from the analyses, rather than 
relying on extrapolation to 21 dpi to estimate VL. Total WG was calculated as body weight 
(BW) at day 42 minus BW at day 0 (WG42), weight gain from 0 to 21 dpi (WG21) and 
weight gain from 21 to 42 dpi. For the WG21 analysis, 22 animals that died prior to 21 dpi 
 
were excluded and 44 animals that died prior to 42 dpi were excluded for WG42 and for WG 
from 21 to 42 dpi. All WG analyses exclude the 3 animals that had missing parity 
information and 1 that was no
after edits is in Table 3.1. 
 
Statistical analyses 
 Heritabilities and maternal effects were estimated based on 3 generation pedigree 
relationships, using a single-
interaction of trial and parity of dam
as random factors. Piglets were born from parities ranging from 1 to 6. Parities 3 through 6 
were combined into one parity class. Pair
estimated using bivariate animal models with the same fixed and random factors as used in 
the single-trait models.  
 
Genome-wide association analysis
 Associations of SNP genotypes with phenotypes were analyzed by fitting all SNPs 
simultaneously using Bayesian genomic se
implemented in the 3.04 version of  the software GenSel (Fernando and Garrick, 2009). After 
removal of monomorphic SNPs, 56,118 SNPs remained. Genotypes were coded 0/1/2. Any 
missing genotype at a locus was replace
The following mixed model was used to determine associations of SNPs with phenotypes:
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t genotyped. The number of individuals available for each trait 
trait animal model in ASREML (Gilmour et al., 2006)
 as a fixed factor and pen within trial, animal, and litter 
-wise genetic correlations between traits were 
 
lection methods (Habier et al., 2011), as 
d with the trial specific mean genotype for that SNP. 
, with the 
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where y = vector of phenotypic observations, X = incidence matrix relating fixed factors to 
phenotypes, b = vector of fixed factors of pen within trial and the interaction of trial and 
parity class, zi = vector of the genotype covariate for SNP i (coded 0, 1, 2, or average for 
missing genotypes), αi = allele substitution effect for SNP i, and δi = indicator for whether 
SNP i was included (δi=1) or excluded (δi=0) in the model for a given iteration of the Monte 
Carlo Markov Chain. The prior probability of δi=0 was set equal to  =0.99. The Bayesian 
model was implemented using methods Bayes-B and Bayes-C (Habier et al. 2011), which 
differ in the assumed distribution for the variance of non-zero allele substitution effects: 
Bayes-C assumes that non-zero SNP effects are from a single distribution, whereas Bayes-B 
assumes that each SNP has its own variance. Both methods combine prior information with 
the data, but Bayes-B is more dependent on the prior than Bayes-C because the variance for 
each locus must be estimated from the information for that locus alone, whereas Bayes-C 
estimates a single variance for all non-zero SNP effects from the joint analysis of all SNPs.  
Method Bayes-B is preferred if SNP with both large and small effects are present, although 
estimates from the two methods are expected to converge as the number of animals available 
for analysis increases. Total GEBV were computed by summing the product of the genotype 
covariate and the estimate of the SNP effect across all evaluated SNPs for each individual. 
Genomic regions associated with traits were identified using windows of 5 consecutive SNPs 
based on build 10 of the swine genome (http://www.ncbi.nlm.nih.gov/genome/guide/pig/, 
accessed December 13, 2011). For each individual animal and each 5-SNP window, the 
posterior means of the relevant SNP effects were multiplied by their corresponding genotype 
covariates and then summed to compute each individual’s window GEBV. The variance of 
these window GEBV across individuals, expressed as a proportion of the variance of the total 
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GEBV across individuals, was used to identify genomic regions that were most strongly 
associated with phenotype.  
Version 3.04 of the GenSel software does not allow additional independent random 
effects such as litter to be fitted. Thus, to evaluate the potential impact of litter effects on 
SNP associations, two additional analyses were conducted in which 1) phenotypes were 
preadjusted for estimates of litter effects obtained from the ASREML analyses described 
previously and 2) litter was included as an additional fixed factor.  
 
Further analysis of specific SNPs 
Specific SNPs identified in the genome-wide analyses as contributing the largest 
fraction of GEBV variance were further evaluated by including the SNP genotype as a fixed 
factor in the ASREML analyses described previously. SNP genotype was either included as a 
covariate to estimate allele substitution effects, or as a class variable, to separately estimate 
additive and dominance effects. To evaluate the consistency of SNP effects across trials, SNP 
genotype by trial was included as a fixed factor in these analyses. The associations of specific 
SNP identified in the Bayesian analyses were re-analyzed using several approaches for 
estimating the variance explained by the SNP: 1) the variance in whole-genome GEBV 
explained by the SNP, 2) 2pqα
^ 2, where α
^  is the posterior mean of the estimated allele 
substitution effect for the SNP, and 3) the reduction in genetic variance when including the 
most significant SNP as a fixed factor in the ASREML analysis of phenotypes. Haplotypes 
for all animals for a specific region were determined using PHASE (Stephens et al., 2001). 
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Results 
Phenotypic Data and Correlations 
Individual BW and log-transformed viremia over time are presented in Figure 3.1 for 
trial 2; results for trials 1 and 3 were similar. Raw means and standard deviations of traits are 
in Table 3.1. On average, BW and its variance increased with time (Figure 3.1A). The 
observed variation in BW after infection was greater than typically observed for uninfected 
pigs. The raw mean and SD of BW at 42 dpi across the three trials were 20.2 and 5.0 kg, 
giving a coefficient of variation of 25%, whereas uninfected littermates (n=551) raised at the 
breeding company that provided the pigs had a BW mean and SD at ~70 days of age of 29.2 
and 3.8 kg, resulting in a coefficient of variation of only 13%.  
Viremia had increased by 4 dpi for all pigs, with peak viremia by 11 dpi (Figure 
3.1B). After 11 dpi, viremia declined for most animals and by 21 dpi, some animals had 
cleared the circulating virus, some still had declining viremia levels, while others exhibited 
natural rebound of the PRRSV. Due to the large variation in viremia after 21 dpi, which was 
confounded by rebound, analyses focused on viremia up to 21 dpi. 
The interaction of trial and parity was significant for both traits (p < 0.01), so the 
effects of parity were significant but not consistent across trials. Specifically, pigs from 
parity 1 sows had higher WG and lower VL in trials 1 and 2, compared to pigs from parity 2 
and 3 sows, but WG and VL in trial 3. Pigs from parity 1 sows gained 13.3, 16.3, and 11.2 kg 
for trials 1, 2, and 3, while pigs from parity 3 sows gained 12.2, 14.3, and 13.8 kg to 42dpi. 
For VL, pigs from parity 1 sows had 96, 100, and 111 units for trials 1, 2, and 3 compared to 
99, 104, and 107 units for pigs from parity 3. 
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Phenotypic correlations among traits obtained from the ASREML analyses are in 
Table 3.2. Weight gain was negatively correlated with all measures of viremia and VL, with 
phenotypic correlations ranging from -0.13 to -0.36. The phenotypic correlation between VL 
and WG42 was -0.25. Phenotypic correlations between VL and daily measures of viremia 
ranged from 0.01 to 0.60. In general, as the number of days between viremia measures 
increased, the phenotypic correlations between the measures decreased. 
 
Estimates of Genetic Parameters 
 Estimates of heritability and environmental variance components from the single-trait 
animal model analyses are in Table 3.1. Heritability estimates from bivariate animal models 
were similar to estimates from single-trait animal models. Estimates of heritabilities for daily 
viremia ranged from 0.02 to 0.28 (Table 3.1). Viral load, as an overall measure of viremia, 
was moderately heritable at 0.31. Litter explained a substantial proportion (31%) of the 
phenotypic variance at 7 dpi but litter effects decreased with time and disappeared by 21 dpi. 
The high estimate for litter at 7 dpi may, however, be confounded with the small estimate of 
heritability obtained for that day. Litter explained 14% of phenotypic variance for VL. 
Estimates of genetic correlations of viremia at 4 dpi with viremia on later days were low but 
genetic correlations among later days were near perfect. However, all estimates of genetic 
correlations of viremia had high standard errors (Table 3.2). Genetic correlations of VL with 
serum viremia at 11, 14, and 21 dpi were all positive, with estimates near 1. 
Both measures of WG were moderately heritable, with estimates of 0.30 (Table 3.1). 
Litter explained 14% of the phenotypic variance for WG42 but zero for WG21. The two 
measures of WG had a high genetic correlation of 0.99 (Table 3.2). Neither measure of WG 
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had a significant genetic correlation with any of the measures of viremia but all estimates 
were negative (Table 3.2). The estimate of the genetic correlation between WG42 and VL 
was -0.46 but not significantly different from zero. 
 
Genomic Regions 
 Results of the genome wide association study (GWAS) for VL using Bayes-B are in 
Figure 3.2 and Table 3.3. Analyses using the Bayes-C method (results not shown) identified 
the same genomic regions as Bayes-B. The 5-SNP windows on Sus scrofa Chromosome 
(SSC) 4 and X were found to explain substantially more variation in VL than other regions 
for analyses with both Bayes-B (>2.0% of GEBV variance) and Bayes-C (>0.25% of GEBV 
variance) methods (Figure 3.2A). In addition, at least one unmapped SNP showed an 
association with VL, in particular when using method Bayes-B, explaining 1.6% of the 
variance of GEBV. By allowing SNP effects to have different variances, method Bayes-B 
shrunk large effects less than Bayes-C and was therefore more discriminating when the same 
mixture fraction ( =0.99) was assumed for both methods. Accordingly, regions with strong 
effects explained a larger proportion of variance with Bayes-B. The region on SSC4 with the 
largest window GEBV variance consisted of 33-SNPs that were in strong linkage 
disequilibrium (LD) and, together, accounted for 4.3% of the GEBV variance for Bayes-C 
and 15.7% for Bayes-B. The region on SSCX resulted from a single SNP, which explained 
0.2% of the GEBV variance for Bayes-C and 1.8% for Bayes-B. 
 Viral load is a summary statistic quantified as area under the curve of log-transformed 
viremia at 0, 4, 7, 11, 14, and 21 dpi. Therefore, the regions identified for VL must result 
from associations with viremia on individual days. The region on SSC4 for VL was apparent 
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for all days on which viremia was measured. Using Bayes-B, the proportion of the GEBV 
variance explained by the 33-SNP region was greatest at 11 and 14 dpi, with estimates of 9.8 
and 4.5%, respectively (Table 3.4). The correlations among the 33-SNP GEBV for viremia at 
4, 7, 11, 14, 21 dpi, and with the GEBV for VL, were all positive and nearly perfect (r > 0.99, 
results not shown). However, the covariance with the GEBV for VL was greatest for viremia 
at 11 and 14 dpi (Table 3.4), indicating that viremia on these days is primarily responsible for 
the observed effect of this 33-SNP window on VL. The association on SSCX with VL was 
also found for viremia on days 4, 7, 11, 14, and 21 (results not shown) but the proportion of 
the GEBV variance explained by the 5-SNP region was greatest at 14 and 21 dpi, with a 
Bayes-B estimate of 0.02% for both dpi.  
All piglets used in this study were barrows; therefore, effects on the X chromosome 
could only come from the dam. When litter was included as a fixed factor in the GenSel 
analysis, the effects of all regions were reduced for all traits; however, the effect of the region 
on the X chromosome for VL was reduced the greatest (results not shown). For example, the 
peak proportion of GEBV variance for VL was reduced nearly ten-fold when phenotypes 
were pre-adjusted for estimated dam effects from the ASREML analysis and nearly 100-fold 
when dam was fitted as a fixed factor. 
 Results of the genome-wide association analysis for WG42 are in Figure 3.2B and 
Table 3.3. Using both methods Bayes-B and -C, regions on SSC 1, 4, 7, and 17 were found to 
be associated with WG42. These same regions were also associated with WG21, with the 
exception of SSC17 (results not shown). A region on SSC16 was associated with WG21 but 
not with WG42. The region on SSC4 was the same as that identified for VL and the 
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proportion of GEBV variance explained by the 33-SNP window was 11.2% and 1.7% for 
Bayes-B and -C, respectively. 
 
Detailed analysis of the region on SSC4  
The region on SSC4 that was associated with VL and WG42 consisted of 33 
consecutive SNPs that spanned 1 Mb of DNA based on build 10.  The SNP in this region 
were in very strong LD; 6 SNPs (MARC0056249, WUR10000125, ALGA0029524, 
ASGA0023344, ASGA0023349, and ALGA0029538) were in perfect LD (r2 = 1) and each 
of these explained 99.3% of the variance of the GEBV for the 33-SNP region. Figure 3.3 
presents a scatter plot of the 33-SNP window GEBV from Bayes-B for VL against those for 
WG42 (similar results for WG21, data not shown) grouped by genotype for one of these 6 
SNPs, WUR10000125. When fitting all SNPs simultaneously, as in the Bayesian analyses, 
the effects in this region were distributed across all SNPs in the region. The grouping of 
window GEBV by genotype for SNP WUR10000125, however, shows that most of the 
effects from this region were captured by this SNP. To further quantify this, the window 
GEBV were regressed on the genotype covariate for this SNP (0/1/2). Results showed that 
SNP WUR10000125 captured 99.4% of the variation in the window GEBV for VL and 
99.3% of the variation for WG42. Figure 3.3 also shows that the GEBV for VL and WG for 
this region were nearly perfectly correlated (r = -0.9995). Using the Illumina A/B calling 
nomenclature for SNP WUR10000125, the homozygous BB genotype is desirable and the 
homozygous AA genotype is undesirable. The frequencies of the desirable BB genotype and 
of allele B were low, at 2.7 and 16.1%. 
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 To further investigate the effect of this region, SNP WUR10000125 was fitted as a 
fixed factor in the previously described ASREML analyses of phenotype. The allele 
substitution effect was highly significant in these analyses for both VL (P < 0.0001) and 
WG42 (P < 0.0001). For comparison to the estimates from the Bayesian analyses, allele 
substitution effects for this SNP were also estimated by analyzing the whole genome GEBV 
obtained from the Bayes-B and Bayes-C analyses using the same model in ASREML. The 
analysis of GEBV from Bayes-B resulted in a very similar allele substitution effect estimate 
for VL, compared to the analysis of phenotype (-4.12 vs. -4.10), but a slightly smaller 
estimate for WG42 (1.82 vs. 2.00 kg). 
Inclusion of SNP genotype as a fixed class effect resulted in highly significant P-
values of <0.0001 for both VL and WG42. The significant class effect reflected differences 
between genotypes AA and AB, with genotype BB not significantly (p>0.67) different from 
the AB genotype. Results showed some indication of dominance (Figure 3.4) but this needs 
further investigation, as the number of individuals with genotype BB was small. Inclusion of 
the SNP as a fixed factor reduced the estimate of heritability substantially, from 0.31 to 0.24 
for VL and from 0.30 to 0.18 for WG, while the variance component for litter expressed as a 
proportion of phenotypic variance remained at 14% for both traits.  
The effect of SNP genotype was also included as an interaction with trial to 
investigate the consistency of estimates across trials. The interaction was not significant for 
either trait (P > 0.52) and estimates of allele substitution and genotype effects were consistent 
across trials for both VL and WG (Figure 3.4). In all 3 trials, pigs with the AA genotype had 
significantly (P < 0.0001) lower WG and higher VL than pigs of the AB genotype. Least 
square means for the BB genotype were more variable because of small numbers. 
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The effect of SNP WUR10000125 was also quantified for WG21 and for WG from 
21 dpi to 42 dpi to evaluate whether the effect on WG42 originated from growth up to or 
beyond 21 dpi or from both periods. The allele substitution effect was highly significant for 
both traits (P<0.0001), with estimates of 1.0 kg for WG21 and 1.4 kg for WG from 21 dpi to 
42 dpi. 
Daily viremia levels and body weight were analyzed by genotype for SNP 
WUR10000125 to investigate the impact of the 33-SNP region on viremia and growth 
curves. Figure 3.5 shows the resulting LS means by genotype, with their associated P-values. 
The effect of the SNP was significant at P<0.05 for 4, 7, 11, 14, and 21 dpi, with P-values 
<5*10-16 and <4*10-9 at 11 and 14 dpi, respectively. Based on LS means, the AB and BB 
genotypes were more similar at 11 and 14 dpi, with a possible dominance effect. Thus, much 
of the effect of the SNP in VL was driven by viremia at 11 and 14 dpi. Furthermore, SNP 
genotype was not significant (P>0.21) after 21 dpi when rebound was occurring. For WG, 
there was no difference in BW between the 3 genotype classes through 7 dpi (P>0.29). 
Starting at 14 dpi, the SNP was significant (P< 9*10-5) and the AB genotype diverged from 
the AA genotype, with the difference increasing throughout the trial. The P-value of the SNP 
for BW at 42 dpi was highly significant at 2*10-10. Although based on small numbers, pigs 
with the BB genotype had similar weights to the AB genotype at 28 dpi and beyond.  
 Haplotypes for all animals for the 33 SNP region were determined using the software 
program PHASE (Stephens et al., 2001). Using all 33 SNPs as a haplotype block, 34 
different haplotypes were identified in this population. Of the 34 haplotypes, 13 accounted 
for approximately 95% of observations and 12 of the 14 individuals with the BB genotype 
for SNP WUR10000125 were homozygous for the same haplotype. The other 2 individuals 
 44
had heterozygous haplotypes, with 1 individual having 1 copy of the common haplotype and 
1 haplotype that differed from it at 7 SNP. The other individual had 1 haplotype that differed 
from the common haplotype at 7 SNP and the other at 8 SNP.  
 
Detailed analysis of the region on SSCX 
 The single SNP on SSCX (ASGA0081159) that was associated with VL and WG was 
also fitted as a fixed factor in the previously described ASREML analyses of phenotype. 
There were no heterozygous genotypes at this locus because all individuals were barrows. 
Estimates of genotype effects and allele substitution effects for this SNP on VL and WG42 
are in Figure 3.4. Inclusion of the SNP genotype resulted in a P-value <0.0001 for VL. The 
region on SSCX did not show strong associations with WG42 using methods Bayes-B or 
Bayes-C (Figure 3.2B) but the ASREML analysis showed a significant association of the 
SNP with WG42 (P<0.002). These differences between methods may be the result of the low 
minor allele frequency of this SNP (0.13) or partial LD of the QTL with other SNP. 
Estimates of heritability were reduced with the inclusion of SNP ASGA0081159 as a fixed 
factor, from 0.31 to 0.24 for VL and from 0.30 to 0.22 for WG42. The variance component 
for litter was reduced from 0.14 to 0.10 for VL but was unaffected for WG42.  
 Estimates of genotype effects for SNP ASGA0081159 were consistent across trials 
for VL (Figure 3.4B); pigs with the A allele had significantly higher VL than pigs with the B 
allele for each trial, although the numbers of individuals with the favorable B allele were 
very small in trials 1 and 2. SNP genotype effects for WG42 were consistent and favorably 
correlated with the effects on VL in trials 1 and 3. Across the 3 trials, and in trials 1 and 3, 
pigs with the A allele gained significantly less weight than those with the B allele. Least 
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square means of WG42 were not significantly different in trial 2, with an estimated 0.2 kg 
lower weight gain for pigs with the B allele and a standard error of 2.0 kg. The large 
variability seen in this trial is due to very low frequency of the B allele in this trial. 
 
Discussion 
 The analyses of VL and WG revealed promising results for selection to improve host 
disease resistance to PRRS. Both traits were moderately heritable at 30%, which indicates 
that host response to this strain of the PRRSV can be improved through selection. Viral load 
and weight gain were moderately negatively correlated at both the phenotypic and the genetic 
level. On SSC4, a 33-SNP region was identified for both traits with a nearly perfect negative 
correlation between effects on VL and effects on WG21 and WG42. This, along with the 
clustering of the GEBV into 3 groups, suggests that a single bi-allelic QTL is responsible for 
the observed perfect correlation between effects on the 2 traits. Furthermore, over 10% of the 
variance of whole-genome GEBV was accounted for by the effects of these 33 SNP. This 1 
Mb region is in high LD and 6 SNP that are in perfect LD in this population each explained 
nearly all of the variation in the GEBV for the 33 SNP region. 
 
Genetic Parameters 
The traits VL and WG have been shown to be negatively correlated in pigs infected 
with PRRS. Doeschl-Wilson et al. (2009) reported 21-day WG to be negatively correlated 
with virus titer in bronchoalveolar lavage (-0.26) and serum (-0.40) in pigs infected 
intranasally with PRRSV, which is consistent with our results. Furthermore, Petry et al. 
(2005) found that two lines of pigs that were experimentally infected with PRRSV had 
significantly reduced WG compared to their uninfected littermate controls. In the current 
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study, uninfected littermates that were raised at the breeding company farms had greater gain 
and less variation in WG42 compared to their infected counterparts, although direct 
comparison of these results is complicated by the fact that location and infection status were 
confounded. 
 Litter explained 14% of the phenotypic variance for WG42 and VL, but had a zero 
estimate for WG21. Although sows that produced the offspring for this study were PRRS 
negative, the sizeable litter component suggests that the dam provided a maternal component 
that affected the ability of her offspring to respond to the PRRSV. Due to sample size, the 
effects of litter could not be partitioned into genetic and environmental components. 
Both measures of WG and VL showed a significant trial by parity interaction. Lewis 
et al. (2009b) found that, under PRRS infection in the field, sows of later parities had more 
pigs born alive, fewer mummified and stillborn piglets, and an increase in number weaned 
compared to pigs born in early parities. Although not directly comparable, Lewis et al. 
(2009b) and the current study found significant parity effects with respect to PRRS. In the 
current study, first parity pigs had reduced VL compared to pigs of parities 2 and 3 for trials 
1 and 2, but in trial 3, first parity pigs had increased VL compared to pigs of parities 2 and 3. 
This inconsistency of parity effects between trials may be due to farm effects, as trial 3 pigs 
were from a different farm than pigs from trials 1 and 2. 
 In general, heritability of disease resistance in livestock is low, e.g. Salmonella 
resistance as measured by survival time in broilers at 0.06 (Janss and Bolder, 2000), bovine 
respiratory disease in beef cattle at 0.08 (Snowder et al., 2006), and PRRS resistance in swine 
at 0.10 (Lewis et al., 2009a; Lunney and Chen, 2010). However, in a study that evaluated 
performance traits of sows during non-diseased and PRRS diseased states, heritability of total 
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weaned increased from 0.02 during the non-diseased state to 0.15 during the diseased state 
(Lewis et al., 2009a). In the current study, heritability estimates were moderately high (0.3) 
for WG21, WG42, VL, and day specific viremia, with the exception of 7 and 21 dpi, which 
were both lowly heritable (Table 3.1) but standard errors were substantial. 
 Genetic correlations between viremia on specific days revealed at most weak 
correlations (Table 3.2) but the standard errors for most estimates were large. Weak genetic 
correlations suggest that genomic regions associated with different days may change as the 
disease progresses. These results coincide with the genomic analysis of day specific viremia, 
which showed inconsistent genomic regions across time (results not shown). However, 
genetic correlations between VL and viremia at 11, 14, and 21 dpi were nearly 1. 
 
Genomic Regions 
 With the development of high-density SNP chips for numerous species, GWAS has 
increasingly been used to identify genomic regions and QTL associated with quantitative 
traits in livestock. As reviewed by Goddard and Hayes (2009), QTL have been identified 
through the use of GWAS for various traits in many livestock species, such as milk 
production in dairy cattle and mortality and disease resistance in chickens. Only one other 
study has reported associations between SNP and PRRS resistance. Lewis et al. (2009c) 
identified 6 significant SNP from a 7k SNP chip that were associated with the sow 
performance traits of total born alive, total born dead, and total mummies; however, the 
location of these SNP was not reported. Data reported by Lewis et al., (2009c) were from a 
database that contained 5 years of production traits from a multi-line multiplication herd. 
Pigs were naturally exposed to PRRSV in the field and the PRRS diseased and non-diseased 
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states of the herd were determined based on phenotypic records. Our findings are the first 
regarding genomic regions associated with PRRS resistance or susceptibility in growing pigs. 
In the current study, genomic regions for WG42 were identified on SSC 1, 4, 7, and 17. 
Sanchez et al. (2006) identified QTL for average daily gain in uninfected animals on 
chromosomes 1, 2, 4, and 7 using microsatellite markers; however, none of these QTL 
overlapped with the regions on SSC 1, 4, or 7 found in the current study. Nezer et al. (2002) 
used microsatellites and identified a QTL for average daily gain on SSC7 but, again, this was 
not in the region associated with WG in the current study. One explanation for this lack of 
similarity between genomic regions is that previous studies were conducted with healthy 
animals. Other possible explanations include different methods of QTL detection, times 
when growth was quantified, and use of different breeds.  
The GEBV for the 33 SNP region on SSC4 were nearly perfectly correlated for all 
traits. Furthermore, the covariance between the GEBV for daily viremia and VL was highest 
at 11 and 14 dpi, which shows that much of the effect of the 33 SNP region on VL is 
primarily driven by variation on those two days. Therefore, the effect of the QTL or gene 
responsible for the associations observed for the region on SSC4 with viremia and VL does 
not appear to change through 21 dpi. However, the effect of this region disappears after 
21dpi, as seen in Figure 3.5, likely due to the increase in effects associated with the virus 
(rebound) and other environmental factors, rather than host genetics. The QTL responsible 
for VL is also likely the QTL responsible for WG, as the GEBV for WG21 and WG42 were 
perfectly correlated at 1, although the presence of two separate QTL in this high LD region 
cannot be excluded. This region was also significant for the analyses of growth up to 21 
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WG21 and WG from 21 to 42 dpi. Therefore, the effects of this QTL on growth do not 
appear to change over time. 
Maternal effects were identified as an important source of variation in the ASREML 
analyses of VL and WG. Ideally, litter would be fitted as a random effect in the Bayes-B 
model to account for this in the GWAS. However, the 3.04 version of the GenSel software 
does not allow independent random effects such as litter to be fitted. Robustness of the 
Bayes-B results to litter effects was checked by pre-adjusting phenotypes for the effect of 
litter or by fitting litter as a fixed factor in the analysis. Both these approaches reduced the 
variance explained by regions across the genome, in particular on the X chromosome, as 
expected, but did not change the location of the regions showing associations.  
 
A major QTL on SSC4 
 A region with major effects on VL and WG was identified on chromosome 4. The 
effects of SNP WUR10000125 in the 33 SNP region on SSC4 for VL and WG were large 
and consistent across trials (Figure 3.4), with effects of 0.66 and 0.59 phenotypic SD for 
WG42 and VL, respectively. With allele substitution effects over 0.5 phenotypic SD for both 
VL and WG, this places this QTL among the larger effects identified in swine (Hayes and 
Goddard, 2001). The across trial results suggested that the identified QTL may be acting in a 
dominant manner, as the AB and BB genotypes were not significantly different but power to 
detect this latter difference was small because of the low frequency of the BB genotype. 
There was a clear difference between animals with genotype AA and AB for WG and VL. 
Within trial, dominance was less evident because of the small number of animals with the BB 
genotype group. However, in each trial, animals with genotype AA had greater VL and less 
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WG compared to animals with the genotype BB. Therefore, the A allele is undesirable with 
respect to PRRS but further research is required to evaluate its effects on other economically 
important traits, including response to other strains of PRRSV and response to other diseases. 
When SNP WUR10000125 was fitted as a fixed factor in ASREML, heritability decreased 
for VL and WG but variance due to litter remained at 14% for both traits. This indicates that 
the effects of this SNP are associated with a direct genetic effect on the individual and are not 
due to litter effects, which are environmental from the viewpoint of the challenged barrow. 
The presence of the BB genotype also indicates that this SNP segregates in both parental 
breeds but further work is required to determine if the paternal and maternal associations are 
consistent.  
Estimates of the additive effects of SNP WUR10000125 obtained from the ASREML 
analysis of GEBV from Bayes-C were smaller than estimates obtained from analysis of 
GEBV obtained from Bayes-B, which were in turn smaller than estimates obtained from 
ASREML analysis of phenotype, at least for WG42. The Bayesian methods fit SNP effects as 
random, which results in estimates being shrunk towards zero. The extent of the regression 
depends on the amount of data, the variance ratios, and the mixture fraction ( ). The extent 
of regression of large effects is less for Bayes-B because it assumes SNP specific variances, 
which are larger for large effects, in contrast to Bayes-C, which assumes homogeneous 
variance across all SNP included in the model. Shrinkage is dependent upon sample size; 
therefore, as sample size increases, estimates of SNP effects are expected to converge for 
Bayes-B and -C. 
The associations found for the 33 SNP region on SSC4 were re-evaluated using 
several approaches for estimating the variance explained by one of the SNP in this region, 
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WUR10000125, that was in high LD with other SNP in the region and explained the largest 
proportion of variance of window GEBV for this region: 1) the variance of whole-genome 
GEBV explained by the SNP, 2) 2pqα
^ 2, where α
^  is the posterior mean of the estimated 
allele substitution effect for the SNP and 3) the reduction in genetic variance when including 
the SNP as a fixed factor in the ASREML analysis. For VL, the estimates of variance 
explained by this SNP with these 3 approaches were 3.1, 4.5, and 4.3; for WG42, they were 
3.0, 1.1, and 2.4. Thus, within a trait, estimates of the contribution of the region to observed 
variation were fairly similar for the 3 approaches. 
All P-values reported for the SNP effects were obtained by including the SNP as a 
fixed effect in ASREML because significance tests were not readily available for the 
Bayesian model analyses. For the SNP on SSC4, P-values were highly significant (P<1*10-
11). 
 
Candidate Genes for the QTL on SSC4 and SSCX 
 The interferon induced guanylate-binding protein family genes are potential 
candidates within the 33 SNP region on SSC4 based on a mapview of the pig genome 
(http://www.ncbi.nlm.nih.gov/mapview). When an animal is infected with a pathogen, a class 
of cytokines, called interferons, is released as part of an immune response to induce protein 
expression, such as guanylate binding protein. The importance of cytokines in PRRS 
responses has been reported by numerous labs (Miller et al., 2004; Lunney et al., 2010; 
Thanawongnuwech et al., 2010). Human guanylate binding proteins have been reported to 
inhibit replication of both vesicular stomatitis and encephalomyocarditis viruses (Anderson et 
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al., 1999). Furthermore, Itsui et al. (2009) found that guanylate binding protein-1 inhibited 
replication of the hepatitis C virus. 
 Determining the causative mutation solely through the analyses reported here is 
prohibited by the strong LD in the 33 SNP region on SSC4. Sequencing family members 
within each genotype group could possibly reveal new SNP to add to the analyses; however, 
these SNP would more than likely also be in high LD with the current SNP. The LD in this 
region must be broken to discriminate the causative mutation.  
The carbohydrate sulfotransferase gene (CHST7) was identified within 90 kb from 
the significant SNP ASGA0081159 on SSCX, based on the Sus Scrofa genome browser 
(http://useast.ensembl.org/Sus_scrofa/). Sulfated polysaccharides have been shown to exhibit 
antiviral properties, including inhibition of viral particle attachment to target host cells and 
cell-to-cell spread of the virus (Nyberg et al., 2004). Located within 1 Mb from SNP 
ASGA0081159, several additional candidate genes were found, including CFP, TIMP1, and 
ARAF. Complement factor properdin (CFP), has been shown to be involved in initiation of 
the alternative pathway of the immune system (Spitzer et al., 2007). Tissue inhibitor of 
metalloproteinases 1, TIMP1, may impact immune cell activity as an antiapoptotic peptidase 
(Boggio et al., 2010). ARAF, v-raf murine sarcoma 3611 viral oncogene homologue, has also 
been shown to inhibit apoptosis (Rauch et al., 2010).  
 
Conclusions 
 Weight gain and viremia after experimental PRRSV challenge of piglets were 
moderately heritable. Therefore, genetic selection to reduce the impact of infection with this 
specific strain of PRRSV is possible. The two traits had moderately negative phenotypic and 
genetic correlations, although the latter had a high standard error. Regions on SSC4 and 
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SSCX had strong effects on both WG and VL and accounted for a large proportion of the 
variation in whole genome GEBV, indicating that these regions contain major QTL or genes 
affecting response to PRRSV. One possible candidate gene family for the SSC4 region is the 
interferon induced guanylate-binding proteins. On SSCX, the CHST7 gene is within the 
region of interest. Both of these genes have shown to have antiviral properties. These results 
are promising but further research is needed in different populations and with different 
strains of PRRSV. If these regions are validated in other populations and for other strains of 
PRRSV, breeders and producers will be able to genotype their animals for this region and 
implement marker-assisted selection for host response to PRRS infection into their breeding 
program. 
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Table 3.1.  Means and estimates (±SE) of heritability and variance components (proportions of phenotypic variance) for viremia 
and weight gain after infection. 
Trait1 n Mean SD Heritability Litter Pen(trial) Residual 
Viremia 4 dpi2 561 5.9 0.55 0.16 ± 0.13 0.17 ± 0.07 0.03 ± 0.02 0.63 ± 0.10 
Viremia 7 dpi2 554 6.4 0.38 0.02 ± 0.09 0.31 ± 0.06 0.06 ± 0.03 0.61 ± 0.07 
Viremia 11 dpi2 547 6.1 0.45 0.28 ± 0.17 0.23 ± 0.08 0.03 ± 0.02 0.46 ± 0.12 
Viremia 14 dpi2 545 5.5 0.74 0.26 ± 0.16 0.21 ± 0.08 0.02 ± 0.02 0.52 ± 0.12 
Viremia 21 dpi2 494 3.8 1.14 0.09 ± 0.12 0.03 ± 0.06 0.00 ± 0.00 0.88 ± 0.09 
VL 531 103 10 0.31 ± 0.18 0.14 ± 0.08 0.01 ± 0.02 0.54 ± 0.13 
WG21, kg 539 4.6 2.25 0.30 ± 0.11 0.00 ± 0.00 0.05 ± 0.03 0.65 ± 0.11 
WG42, kg 517 13.4 4.48 0.30 ± 0.18 0.14 ± 0.08 0.00 ± 0.00 0.56 ± 0.13 
1 dpi = day post infection, WG21 = weight gain from 0 dpi to 21 dpi, WG42 = weight gain from 0 dpi to 42 dpi, and VL = viral load calculated as area under 
the curve of log-transformed viremia between 0 and 21 dpi. 
2 Log10 Templates/Reaction 
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Table 3.2. Estimates of phenotypic (above diagonal) and genetic (below diagonal) correlations based on bivariate analyses of 
viremia and weight gain following infection. 
Trait1 4 dpi 7 dpi 11 dpi 14 dpi 21 dpi VL WG21, kg WG42, kg 
Viremia 4 dpi2 - 0.43 ± 0.03 0.06 ± 0.04 0.01 ± 0.04 0.02 ± 0.05 0.34 ± 0.04 -0.15 ± 0.04 -0.13 ± 0.04 
Viremia 7 dpi2 -0.58 ± 3.4 - 0.04 ± 0.04 0.19 ± 0.04 0.05 ± 0.05 0.38 ± 0.04 -0.21 ± 0.04 -0.19 ± 0.04 
Viremia 11 dpi2 -0.02 ± 0.52 0.68 ± 1.6 - 0.62 ± 0.03 0.29 ± 0.04 0.59 ± 0.03 -0.09 ± 0.04 -0.17 ± 0.04 
Viremia 14 dpi2 0.10 ± 0.53 0.85 ± 1.4 0.90 ± 1.3 - 0.42 ± 0.04 0.60 ± 0.03 -0.34 ± 0.04 -0.36 ± 0.04 
Viremia 21 dpi2 0.08 ± 0.70 0.81 ± 3.2 0.99 ± 0.35 0.94 ± 0.52 - 0.56 ± 0.03 -0.24 ± 0.04 -0.28 ± 0.04 
VL 0.23 ± 0.47 0.27 ± 1.6 0.98 ± 0.08 0.95 ± 0.08 0.99 ± 0.11 - -0.22 ± 0.04 -0.25 ± 0.04 
WG21, kg -0.99 ± 0.89 -0.22 + 1.1 -0.44 ± 0.38 -0.42 ± 0.37 -0.40 ± 0.64 -0.54 ± 0.32 - 0.78 ± 0.02 
WG42, kg -0.26 ± 0.51 -0.07 ± 1.5 -0.51 ± 0.35 -0.54 ± 0.33 -0.19 ± 0.76 -0.46 ± 0.35 0.99 ± 0.06 - 
1 dpi = day post infection, WG21 = weight gain from 0 to 21 dpi, WG42 = weight gain from 0 to 42 dpi, and VL = viral load calculated as area under the 
curve of log-transformed viremia between 0 and 21 dpi. 
2 Log10 Templates/Reaction 
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Table 3.3. Percentage of genetic variance explained by chromosomal regions that are associated with viral load and weight gain to 
42 days post infection (dpi) based on method Bayes-B.  
Trait SSC3 1st Marker Last Marker Number of Markers % of total genetic variance 
Viral Load1 4 ALGA0029502 MARC0040196 33 15.7 
X ASGA0081159 ASGA0081159 1 1.8 
Weight Gain2 1 ALGA0005548 INRA0003832 18 2.1 
4 ALGA0029502 MARC0040196 33 11.2 
7 MARC0082535 MARC0082535 1 2.6 
17 ALGA0094184 ASGA0076123 8 1.0 
1 viral load calculated as area under the curve of log-transformed viremia between 0 and 21 dpi 
2 Weight gain to 42 dpi 
2 Sus scrofa chromosome 
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Table 3.4. Variance of genomic estimated breeding values (GEBV based on method Bayes-B) for the whole genome (60k SNPs) 
and for the 33-SNP region on chromosome 4 for viremia following infection, along with the percentage of GEBV variance 
accounted for by the 33-SNP region and the covariance between GEBV for viremia on each day with GEBV for viral load for the 
whole genome and the 33-SNP window. 
 
Trait1 
Variance of GEBV for trait 
explained by 33-SNP window 
Covariance of 33-SNP GEBV for 
trait with GEBV for VL 
Variance % of 60k GEBV 
variance  
Covariance % of 60k GEBV 
covariance 
Viremia 4 dpi2 0.00081 1.12 0.05 10.5 
Viremia 7 dpi2 0.00014 0.74 0.02 7.9 
Viremia 11 dpi2 0.00691 9.79 0.15 15.5 
Viremia 14 dpi2 0.00623 4.48 0.13 10.0 
Viremia 21 dpi2 0.00011 0.15 0.02 2.2 
VL 3.12 15.7 -- -- 
     
1 dpi = day post infection and VL = viral load calculated as area under the curve of log-transformed viremia between 0 and 21 dpi. 
2 Log10 Templates/Reaction. 
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A) 
B) 
Figure 3.1. Raw phenotypic data of n~190 pigs infected with porcine 
reproductive and respiratory syndrome virus from trial 2 of body weight (A) and 
log-transformed viremia (B) over 42 days post infection. Graphs for trials 1 and 
3 were similar. 
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 Figure 3.2. Manhattan plot of the genome-wide association analysis of viral load (A) and 
weight gain to 42 days post infection (B) using method Bayes-B with π=0.99, showing the 
proportion of variance in genomic EBV that is explained by each sliding window of 5 
consecutive SNPs, labeled by index number of the first SNP and ordered by chromosome 
(1-18, X, and unknown). Viral road was calculated as area under the curve of log-
transformed viremia from 0 to 21 days post infection. Variances for the unknown region are 
for each individual SNP.  
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Figure 3.3. Scatter plot of genomic estimated breeding values from method Bayes-B for the 
33 SNP window on chromosome 4 for weight gain from 0 to 42 days post infection and viral 
load, calculated as area under the curve of log-transformed viremia from 0 to 21 days post 
infection. Pigs grouped by genotype at SNP WUR10000125. 
 
  
r = -0.9995 n = 14 
n = 136 
n = 357 
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Figure 3.4. Estimates of allele substitution effects (across top) and least square means by 
genotype for SNP WUR10000125 (Panels A and B) and SNP ASGA0081159 (Panels C and 
D) across and within each of three trials for viral load (Panels A and C), calculated as area 
under the curve of log-transformed viremia from 0 to 21 days post infection and weight gain 
from 0 to 42 days post infection (Panels B and D). Within a trial, columns with different 
letters are significantly different at p<0.05.
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Figure 3.5. Least square means of viremia 
values located near points within day post infection.
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and growth curves from an animal model by genotype for SNP WUR10000125. P
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CHAPTER 4. VALIDATION AND FURTHER CHARACTERIZATION OF A 
MAJOR QUANTITATIVE TRAIT LOCUS ASSOCIATED WITH HOST RESPONSE 
TO EXPERIMENTAL INFECTION WITH PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS1 
 
A paper accepted for publication in Animal Genetics 
 
N. J. Boddicker2, D. J. Garrick3, R. R. R. Rowland4, J. K. Lunney5, J. M. Reecy6,  
and J. C. M. Dekkers7 
 
Abstract 
 Infectious diseases are costly to the swine industry; porcine reproductive and 
respiratory syndrome (PRRS) is the most devastating. In earlier work, a quantitative trait 
locus associated with resistance/susceptibility to PRRS virus was identified on Sus scrofa 
chromosome 4 using ~560 experimentally infected animals from a commercial cross. The 
favorable genotype was associated with decreased virus load and increased weight gain. The 
objective here was to validate and further characterize the association of the chromosome 4 
region with PRRS resistance using data from two unrelated commercial  
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crossbred populations. The validation populations consisted of 2 trials each of ~200 pigs 
sourced from different breeding companies that were infected with PRRS virus and followed 
for 42 days post infection. Across all 5 trials, heritability estimates were 0.39 and 0.34 for 
viral load (area under the curve of log-transformed viremia from 0 to 21 days post infection) 
and weight gain to 42 days post infection, respectively. Effect estimates of SNP 
WUR10000125 in the chromosome 4 region were in the same directions and of similar 
magnitudes in the two new trials as had been observed in the first three trials. Across all 5 
trials, the 1 Mb region on chromosome 4 explained 15% of genetic variance for viral load 
and 11% for weight gain. The effect of the favorable minor allele at SNP WUR10000125 
was dominant. Ordered genotypes for SNP WUR10000125 showed that the effect was 
present irrespective of whether the favorable allele was paternally or maternally inherited. 
These results demonstrate that selection for host response to PRRS virus infection could 
reduce the economic impact of PRRS. 
 
Introduction 
 Porcine reproductive and respiratory syndrome (PRRS) causes reproductive failure in 
breeding females, respiratory problems in growing animals, and collectively costs the US 
swine industry approximately $664 million annually, of which $365 million is attributed to 
losses among growing pigs (Holtkamp et al., 2013). The PRRS Host Genetics Consortium 
was established to address this important industry issue by investigating the genetic basis of 
host response to PRRS virus infection in experimentally infected commercial crossbred pigs 
(Lunney et al., 2011; Rowland et al., 2012). Previous work, using data from the first 3 
infection trials of ~560 pigs, all from the same commercial F1 cross, identified a major 
quantitative trait loci (QTL) for PRRS resistance/susceptibility on Sus scrofa chromosome 
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(SSC) 4 (Boddicker et al., 2012). The identified 1 Mb region was associated with viral load 
(VL), a measure of viremia over 21 days post infection (dpi), and weight gain (WG) to 42 dpi 
(WG42). Pigs with the favorable SNP WUR10000125 genotypes in the region had reduced 
viral load and increased weight gain compared to pigs with the unfavorable genotypes. This 
region explained 15% of the variance in genomic estimated breeding values (GEBV) for viral 
load and 11% for weight gain to 42 dpi. The correlation between the GEBV for VL and 
WG42 for the 1 Mb region was perfect at -1, likely reflecting a single QTL in the region that 
controls both traits.  
 The objectives of the current study were to 1) validate the association of the SSC4 
region with PRRS resistance in 2 unrelated commercial crossbred populations; and 2) further 
characterize the effect of the region in terms of gene action, parent- and breed-of-origin 
effects, and genetic variance explained. 
 
Materials and Methods 
 The Kansas State University Institutional Animal Care and Use Committee approved 
all experimental protocols for this study. 
 
Study design 
 A detailed description of the design, data collection, and molecular techniques used in 
PRRS host genetic consortium trials has been previously published (Lunney et al. 2011). A 
total of 5 trials were analyzed here. Trials 1 through 3 were described in Boddicker et al. 
(2012) and included pigs of the same cross from a single breeding company. Trials 4 and 5 
are unique to this paper and were sourced from 2 different breeding companies and each 
represent a different cross. Briefly, each trial of ~200 commercial pigs, involved transporting 
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animals at weaning (11-21 days of age) to Kansas State University, where they were 
subjected to a PRRS challenge. Within a trial, pigs were from the same high health farm, 
except for trial 5, which included pigs from 2 farms. All farms were free of PRRS virus 
(PRRSV), Mycoplasma hyopneumoniae, and swine influenza virus. Upon arrival, pigs were 
randomly placed into pens of 10 to 15 pigs. After a 7-day acclimation period, pigs now 
between 18 and 28 days of age (day 0), were experimentally infected intramuscularly and 
intranasally with 105 (TCID50) of NVSL 97-7985, a highly virulent PRRSV isolate (Fang et 
al., 2007). Blood samples were collected at -6, 0, 4, 7, 11, 14, 21, 28, 35, and 42 days post 
infection (dpi). Body weight was collected at 0, 7, 14, 21, 28, 35, and 42 dpi. Pigs were 
euthanized at 42 dpi. 
 Viremia was measured using a semi-quantitative TaqMan PCR assay for PRRSV 
RNA, as described in Boddicker et al. (2012). The assay results were reported as the log10 of 
PRRSV RNA copies per ml of serum. Ear tissue was collected from all pigs for DNA 
isolation. Tissue or genomic DNA from the sires of pigs in trials 1 through 3 and from sires 
and dams for trials 4 and 5 was supplied by the breeding companies. Tissues or DNA 
samples were sent to GeneSeek Inc. (Lincoln, Nebraska) for genotyping with Illumina’s 
Porcine SNP60 BeadChip (San Diego, California).  
 Data for ~960 pigs infected with PRRSV across the 5 trials were evaluated. Table 4.1 
provides an overview of the population structure by trial. Pigs in trials 1 through 3 were F1 
individuals from a Large White (LW) and Landrace (LR) cross (see Boddicker et al. 2012 for 
further details). Pigs in trial 4 were from Duroc sires crossed with a LW/LR/Yorkshire 
composite line, and trial 5 pigs were a cross between Duroc sires and an F1 LR/Yorkshire 
dams. A total of 64 pigs died before 42 dpi, including 2 from trial 4 and 14 from trial 5. Dead 
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pigs were necropsied; subsequent gross and microscopic pathology by a board-certified 
pathologist identified PRRS associated disease as the major source of mortality. 
 
Pedigree  
 Pedigree information was provided by the breeding companies and spanned 3 
generations for the first 3 trials and 1 generation for trials 4 and 5. Genotypes on parents and 
offspring were used to validate and correct pedigrees, where possible. Monomorphic SNPs 
were removed, leaving ~ 55,000 informative markers for each trial. Parent-offspring 
mismatch frequencies were calculated as the number of SNPs for which the parent and 
offspring had opposing homozygous genotypes divided by the total number of polymorphic 
SNPs for which the parent and offspring were both homozygous. If a parent-offspring pair 
had a mismatch frequency less than 2%, then the named parent was accepted. Otherwise, 
offspring genotypes were compared to all possible parents and the most likely parent was 
chosen, provided the mismatch frequency was less than 10%. Otherwise, the parent was set 
to missing. Dam genotypes were not provided for the first 3 trials and, therefore, the dams 
provided by the breeding company were assumed correct. For trial 4, not all parent genotypes 
were provided and the pedigree provided by the company was not reliable. Therefore, full- 
and half-sib families were identified based on genomic relationships computed following 
VanRaden (2008). Thresholds for assigning full and half-sib relationships were determined 
based on frequency distributions of genomic relationships, which clearly showed full- and 
half-sib groupings. Based on this, pairs of piglets were identified to be full-sibs if their 
genomic relationship was greater than 0.35 and as half-sibs if their relationship was between 
0.10 and 0.35.  
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Phenotypic traits 
 Details on the phenotypic traits analyzed are in Boddicker et al. (2012). Briefly, VL 
was quantified as area under the curve for log-transformed viremia for 0, 4, 7, 11, 14, and 21 
dpi. Weight gain to 21 or 42 dpi (WG21, WG42) was calculated as body weight (BW) at day 
21 or 42 minus BW at day 0. Edits for trials 1-3 are in Boddicker et al. (2012). Edits removed 
15 individuals from trials 4 and 5 for the analysis of VL, with 13 due to death prior to 21 dpi, 
1 with missing parentage information, and 1 with missing viremia information. For WG42, 
18 individuals were removed from trials 4 and 5, with 17 due to death prior to 42 dpi and 1 
with missing parentage information. The number of individuals available after edits is listed 
in Table 4.2. 
 
Statistical analyses 
 Heritabilities and variances due to litter were estimated based on pedigree 
relationships with a single-trait animal model using the software ASREML (Gilmour et al., 
2006). Sex and the interaction of trial and parity of the sow were included as fixed factors 
and pen within trial, animal, and litter as random effects. Piglets were born from parities 
ranging from 1-7. Parities 3 through 7 were combined into one parity class. The effect of 
farm of origin, which was relevant only for trial 5, since piglets came from a single farm for 
each of the other trials, was not significant (P > 0.65) and therefore not included in the 
analyses. Genetic correlations between traits were estimated using bivariate animal models 
with the same fixed and random factors as used in the single-trait models. 
 
 
 
Genome-wide association analyses
 Associations of SNP genotypes with phenotypes were analyzed by 
simultaneously using Bayesian genomic selection methods (Habier et al., 2011), as 
implemented in the software GenSel (Fernando and Garrick, 2009), using the following 
mixed model: 
 
where y = vector of phenotypic observations, X = incidenc
phenotypes, b = vector of fixed factors of sex, pen within trial, and the interaction of trial and 
parity class, zi = vector of the genotype covariate for SNP i based on the number of B alleles 
using Illumina’s (San Diego, California) genotype calling (coded 0, 1, 2, or equal to the trial 
average for missing genotypes), 
whether SNP i was included (
the Monte Carlo Markov Chain (MCMC). Pen within trial was included as a fixed factor, as 
opposed to a random effect in ASREML, because the current version of GenSel does not 
allow additional random effects. A total of 50,000 iterations were run for each 
analysis, with the first 5,000 iterations discarded as burn
equal to π=0.99. The Bayesian model was implemented using method Bayes
2011).  Genomic regions associated with traits were identifi
windows using build 10.2 of the swine genome (
199 Sus%20scrofa%2C%20whole%20genome%20shotgun%20sequence, accessed 
November 1, 2011). 
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Validation of the effect of the SSC4 region 
 Validation of the effect of the 1 Mb region on SSC4, as identified by Boddicker et al. 
(2012), was carried out using SNP effect estimates obtained from the first 3 trials to predict 
GEBV of animals in trials 4 and 5: 
 
where GEBVi = genomic estimated breeding value for the ith animal of trial 4 or 5, n = 
number of SNPs included in the prediction, zij = genotype covariate of SNP j for animal i 
(coded 0, 1, 2, or trial average for missing genotypes) and   = allele substitution effect 
estimate for SNP j based on analysis of trials 1 through 3. Genomic estimated breeding 
values from the whole genome analysis were computed either based on SNPs across the 
entire genome (n = 58,277 SNPs after removing SNPs that were monomorphic across all 5 
trials) or based on only the 38 SNPs in the 1 Mb region on SSC4. Accuracy of the resulting 
GEBV was evaluated by correlating the GEBV with phenotypes in trials 4 and 5 adjusted for 
fixed effects estimated from the ASREML analyses of phenotypes. 
 
Further characterization of the QTL on SSC4 
Estimation of SNP effects 
 Details on single marker analysis of SNP WUR10000125 identified in the genome-
wide analyses for trials 1-3 are in Boddicker et al. (2012) and were repeated here for trials 1-
5. Briefly, SNP WUR10000125 was included as an additional class variable in the ASREML 
analysis of trials 4, 5, and all 5 trials jointly, because that SNP contributed over 99% of the 
variance explained by the region on SSC4.  Non-additive gene action was investigated by 
fitting contrasts between genotypic effects.  Dominance was investigated by testing if the AB 
GEBVi = (zij α
^
j )
j=1
n
∑
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genotype was significantly different from the average of the AA and BB genotypes (allele 
names, A versus B, were based on Illumina’s (San Diego, California) A/B genotype calling). 
The B allele was favorable (Boddicker et al., 2012), so the contrast between genotypes AB 
and BB was used to test for complete dominance. Dominance was investigated using all 5 
trials jointly. Cause and effect relationships of the effects of SNP WUR10000125 on VL and 
WG42 were investigated by including VL as a fixed linear covariate in the analysis of WG42 
and WG42 as a fixed linear covariate in the analysis of VL. 
 
Breed and parental origin effects 
 The effect of SNP WUR10000125 was evaluated for parent- and breed-of-origin 
effects. Available genotypes of offspring and their parents for the 38 SNPs in the 1 Mb 
region on SSC4 were phased using PHASE software (Stephens et al., 2001), separately for 
trials 1-3, 4, and 5. Based on the identified haplotypes, parental origins were determined for 
SNP WUR10000125 alleles of heterozygous animals. Parental origin could not be 
determined for 12 animals in the first 3 trials because their genotype for SNP WUR10000125 
was missing. Ordered genotypes (AA, AB, BA, BB) were fitted as a class variable in the 
previously described ASREML univariate animal model and significance of parent- or breed-
of-origin effects were determined based on the contrast between the AB and BA genotypes. 
Results 
Phenotypic parameters 
 Raw phenotypic means for viremia and WG are in Table 4.2. Viremia peaked, on 
average, at 7 dpi and thereafter decreased through 21 dpi. The variation in viremia was 
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lowest at 7 dpi and increased thereafter through 21 dpi. The mean WG to 21 dpi was 5.6 kg 
and 15.1 kg to 42 dpi, with an increase in variation from 21 and 42 dpi. 
 Phenotypic correlations among traits obtained from the ASREML analyses are in 
Table 4.3. Both measures of WG were negatively correlated with all measures of viremia. 
The phenotypic correlation between WG42 and VL was moderate. Phenotypic correlations 
between VL and daily measures of viremia were all positive, with the highest correlation at 
14 dpi. 
 
Estimates of genetic parameters 
 Estimates of heritability and litter components from the single-trait animal model 
analyses for all 5 trials jointly, and by trial, are in Table 4.2. Trials 1, 2 and 3 were analyzed 
together. Heritability estimates for trials 1-3 were greater than reported for the same data by 
Boddicker et al. (2012) and litter variances were smaller, likely due to the pedigree 
corrections that were made. Heritability estimates for trials 4 and 5 were low to moderate but 
had large SE due to small sample sizes. The estimate of litter variance of VL for trial 5 was 
0. These results must be interpreted with caution because estimates have large SE and litter 
and genetic effects are confounded. For trials 1 through 5 combined, heritability estimates 
were all moderate, with the exception of viremia at 7 dpi, which had an estimate of 0. 
Heritability estimates for VL and WG42 across the 5 trials were 0.39 and 0.34, respectively. 
The proportion of phenotypic variance explained by litter was 0.11 for VL and 0.09 for 
WG42.  
 Estimates of genetic correlations among traits based on joint analysis of all 5 trials are 
in Table 4.3. Estimates of the genetic correlations of WG with each measure of viremia were 
 76
negative but had large SE. The genetic correlation between WG42 and VL was -0.31±0.26. 
Viremia at 11 and 14 dpi were highly positively correlated (0.94±0.08). Viral load was also 
highly positively correlated (>0.9) with viremia at 7, 11 and 14 dpi. The estimate of the 
genetic correlation between WG21 and WG42 was perfect at 1. 
 
Validation of the effects of the SSC4 region 
 Correlations between GEBV and phenotypes adjusted for fixed effects for individuals 
from trials 4 and 5, where GEBV were predicted based on estimates of SNP effects obtained 
from trials 1-3, are in Table 4.4. When dividing by the square root of heritability, these 
correlations can be interpreted as estimates of the accuracy of the GEBV. All correlations 
were positive and, on average, the GEBV predicted WG marginally better than VL, and 
predictions based solely on the SSC4 region were marginally better than the whole genome 
predictions.  
 Results of single marker analyses for the most significant SNP in the SSC4 region 
(WUR10000125) that was identified by Boddicker et al. (2012) for VL and WG42 are in 
Figure 4.1. This SNP was significant for WG42 for trial 4 (p < 0.0004); AA animals gained 
3.2 kg less BW over the 42-day test period compared to AB animals. Individuals with 
genotype BB were not significantly different from the other two genotypes, but the number 
of BB animals was small (Figure 4.1). The SNP was also significant (p < 0.03) for VL in trial 
4; AA individuals had higher VL compared to AB individuals. For trial 5, the SNP was 
significant for both WG42 (p < 0.03) and VL (p < 0.001). Individuals with AA genotype had, 
on average, lower WG and higher VL compared to AB individuals. Individuals with 
 77
genotype BB were not significantly different from the other two genotypes because of small 
numbers (Figure 4.1). 
 
Joint analysis of all 5 trials 
 The posterior mean of the percentage of genetic variance explained by the 1 Mb 
region on SSC4 for viremia on individual days ranged from 0.77 to 10.9% (Table 4.5), with 
21 dpi having the lowest and 11 dpi the highest percentage. If all 2,592 of the 1 Mb windows 
across the genome contributed equally to the genetic variance, each window would 
contribute 0.039%. Thus, the SSC4 region was estimated to contribute a substantially greater 
percentage of genetic variance than expected under an infinitesimal model for each dpi (= 
0.039% based on 2,592 1 Mb windows evaluated). Table 4.5 also shows a significance test 
for the hypothesis that the SSC4 region contributes more variance than expected (Wolc et al., 
2012) based on the percentage of samples from the posterior distribution for which the 1 Mb 
window on SSC4 contributed more then 0.039% of the genetic variance. This percentage was 
as high as 99.8, for viremia at 11 dpi, and not lower than 39.6, for 21 dpi. Table 4.5 also 
shows the marker-based heritability estimates obtained from GenSel; estimates were 
moderate to high and generally higher than pedigree-based estimates (Table 4.2), likely 
because litter effects were not included in the GenSel analyses. 
The 1 Mb region on SSC4 was estimated to explain 15, 5 and 11.3% of the genetic 
variance for VL, WG21, and WG42, respectively, and every sample showed greater variance 
than expected for the 1 Mb region (Table 4.5). Supplementary Figure 4.1 shows the posterior 
distribution of the percentage of genetic variance explained by the 1 Mb region on SSC4 for 
every 100th iteration of the MCMC for WG42 (Suppl. 2A) and VL (Suppl 2B). For VL, 
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genetic variance explained by the region was at least 5% for all MCMC samples. For WG42, 
94% of samples had variance greater than 5%. 
 Single marker analysis results for SNP WUR10000125 across all trials are presented 
in Figure 4.1. The SNP was highly significant for WG42 (p < 1.5x10-12, Figure 4.1A) and VL 
(p < 1.6*10-14, Figure 4.1B). The LS means for the three genotypes showed evidence of 
dominance of the favorable B allele. The difference between the LS means for the AB 
genotype and the average of the AA and BB genotypes was -2.8 ± 1.0 units (p < 0.007) for 
VL and 1.5 ± 0.6 kg (p < 0.015) for WG42; therefore, dominance effects were significant for 
both traits. The BB genotype was not well represented but was not significantly different 
from the AB genotype (p > 0.48) for either trait.  
 The contrast between AA and AB genotypes for SNP WUR10000125 were still 
significant (p<0.001) when VL was included as a covariate in the analysis of WG42 and of a 
similar magnitude (-1.8 vs -2.3 kg with or without VL included as a covariate). Assuming a 
linear effect of VL on WG, this indicates that the effect of the SSC4 region on WG42 was 
not completely caused by the effect of the SSC4 region on VL. Similarly, the contrast 
between the AA and AB genotypes for VL was still significant (3.7 vs. 4.7 units with or 
without WG42 as a covariate, p<0.001) when including WG as a covariate in the analysis of 
VL, suggesting the effect of the SSC4 region on VL is not through its effect on WG.  
 
Parent- or breed-of-origin effects 
 The effect of SNP WUR10000125 was tested by trial to determine parent- and breed-
of-origin effects for the SSC4 region. Haplotype probabilities were high, with an average of 
0.997 and SD of 0.03 across all 5 trials, which indicates that sufficient information was 
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available to phase genotypes for most individuals. Across all 5 trials, 60 unique haplotypes 
were present. Estimates of the frequency of the B allele for each parental line by trial are 
shown in Table 4.1. 
Figure 4.2 shows the LS means for the ordered genotypes for WG42 (Figure 4.2A) 
and VL (Figure 4.2B). Effects of the heterozygotes ordered by parental origin (AB versus 
BA) were not significantly different (p > 0.30) from each other for VL or WG42 and at least 
one of the ordered heterozygotes was significantly different from the AA genotype (p < 0.02) 
within each trial. Analyzed jointly, the AB and BA genotypes were not significantly different 
from each other (p > 0.99) but the AA genotype was significantly different from both AB and 
BA genotypes (p < 0.01) for both VL and WG42 (Figure 4.2). Therefore, there is no 
statistical evidence for parent of origin or breed of origin effects. 
 
Discussion 
 Boddicker et al. (2012) identified a region on SSC4 that was associated with VL and 
WG using pigs from a single commercial cross between a LW and a LR line that were 
experimentally infected with PRRSV. In this study, the effects of that region were validated 
in 2 additional, unrelated populations and the favorable allele was shown to have a dominant 
mode of inheritance. Furthermore, the effect of the region on SSC4 was shown to be present 
in, and expressed by both paternal and maternal chromosomes from the Landrace, Large 
White, Yorkshire, and Duroc lines that were involved in the crosses. In the following, these 
results will be discussed in further detail and compared to literature. It must be emphasized 
that comparisons to Boddicker et al. (2012) are confounded because the current analyses 
included the data used in that study (trials 1-3). 
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Genetic Parameters 
 Decreased WG is reportedly associated with the onset of PRRSV infection (Doeschl-
Wilson et al., 2009; Greiner et al., 2000; Boddicker et al., 2012). Greiner et al. (2000) 
reported decreased weight gain at 8 dpi with PRRSV, relative to weight gain 8 days pre-
infection. Boddicker et al. (2012) reported negative phenotypic correlations between VL and 
WG to 21 dpi and WG to 42 dpi. In the current study, WG21 and WG42 were also found to 
be phenotypically negatively correlated with all measures of viremia and VL, consistent with 
previously published results of decreased WG when pigs are infected with PRRSV. 
 Compared to results of Boddicker et al. (2012), correction of pedigree errors resulted 
in substantial increases in heritabilities for trials 1-3 and in a reduction of the proportion of 
variance due to litter (Table 4.2). Both measures of WG were moderately heritable in trials 4 
and 5, which is consistent with results from the first 3 trials. When all 5 trials were analyzed 
together, heritability of VL increased from 0.31 for trials 1-3 in Boddicker et al. (2012) to 
0.39 for joint analysis of all 5 trials in the current study. Heritability estimates for viremia 
over time for trials 4 and 5 ranged from 0 to 0.38 but had large SE due to small sample sizes 
within trial. These estimates may still be underestimates as a result of additional pedigree 
errors that could not be corrected because of missing parental SNP genotypes. 
Marker-based heritability estimates were generally substantially higher than the 
estimates obtained from pedigree information (Table 4.5). This is likely because litter was 
not included in the GenSel analysis, as the current version of GenSel does not allow 
additional random effects to be included. However, for VL, the two estimates of heritability 
were in agreement with each other (pedigree = 0.39, marker = 0.49). Viral load is a summary 
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statistic for viremia, which reduces some of the measurement and sampling errors that are 
present in measures of viremia on individual days. 
 Within trial, estimates of variance due to litter were not reliable due to small sample 
sizes and confounding between genetic and litter effects. Joint analysis of all trials revealed 
that the dam provided a maternal component in addition to her direct genetic contribution 
that aided her offspring to respond to the virus, despite the dams being from PRRS-free 
herds. Litter explained a substantial proportion of the phenotypic variance for viremia at 7, 
11, and 14 dpi across trials (0.31, 0.16, and 0.18, respectively, i.e. greater for dpi closer to the 
day of infection). This maternal component could be due to maternal genetics or due to 
maternal environmental effects. Sows that provide a better maternal environment up to 
weaning result in stronger piglets that may be able to cope better with challenges, such as 
PRRS. Boddicker et al. (2012) reported a larger litter effect for VL and WG42 for the first 3 
trials likely due to pedigree errors that were corrected in the current analyses.  
 Estimates of genetic correlations were generally positive among measures of viremia 
and among measures of WG, and negative between measures of viremia and WG (Table 4.3). 
However, most of these estimates were not significantly different from zero (p > 0.10). 
Similar to what was observed by Boddicker et al. (2012), viremia at 11 and 14 dpi were 
highly and positively genetically correlated with each other and with VL. Viremia on these 
two days heavily influenced the results observed for VL.  
 
Validation 
Boddicker et al. (2012) used Build 10 of the swine genome. The 1 Mb region on 
SSC4 that was identified by Boddicker et al. (2012) included 37 SNPs in build 10, of which 4 
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were monomorphic. Two of these SNPs were located upstream (~469 kb) from the region in 
build 10.2 and 3 SNP that were unmapped in build 10 were placed into the region on SSC4 in 
build 10.2. Thus, in build 10.2, the SSC4 region included 38 SNPs, including 4 monomorphic 
SNPs.   
At the whole genome level, validation correlations between GEBV and adjusted 
phenotypes were low to moderate (Table 4.4). The correlation estimates can be converted to 
estimates of the accuracy of GEBV (i.e. the correlation between true and estimated breeding 
values) by dividing by the square root of heritability of the trait. Using heritabilities of 0.4, 
this results in estimates of accuracy ranging from 0.11 to 0.32 at the whole genome level and 
0.19 to 0.38 for the 1 Mb region on SSC4. These accuracies are high, especially considering 
the limited size of the training data and the fact that prediction was across breeds. Across-
breed predictions are typically not accurate due to dominance, epistasis and differences in 
linkage disequilibrium between breeds (Garrick, 2010). Accuracies of GEBV computed 
based on the 1 Mb region on SSC4 were on average of similar magnitude as accuracies of 
whole genome GEBV. This suggests that the rest of the genome added as much noise as true 
effects to the GEBV predictions. The SSC4 region had very similar linkage disequilibrium 
patterns in all five trials, which may explain the predictive power of effects estimated for this 
region across breeds (Supplementary Figure 4.2). 
 The effects of SNP WUR10000125 in trials 4 and 5 were similar to those previously 
found for the first 3 trials (Boddicker et al. 2012), where AA animals had increased VL and 
decreased WG42 compared to the AB animals for both traits. Therefore, the effect of this 
region has now been identified in 3 unrelated populations, suggesting the genetic variant 
likely existed before the divergence of the breeds represented in this study. Furthermore, the 
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low frequency of the B allele may indicate that, historically, the B allele has not had an 
advantage for natural or artificial selection.  
 When the SNP was fitted as a fixed factor in the joint analysis of all 5 trials, the effect 
of the favorable allele was shown to be dominant. Expressed in terms of phenotypic SD, the 
effects were 0.54 and 0.53 for VL and WG42. The minor allele (frequency = 0.15) was 
associated with the desired phenotype of reduced VL and increased WG. The SSC4 region 
explained a large percentage of the genetic variance for VL and WG42 (15.1 and 11.3%). 
These percentages are similar to those reported for the first 3 trials by Boddicker et al. (2012) 
but were calculated in a different manner; percentages in Boddicker et al. (2012) were 
calculated based on variances of GEBV; here, estimates were based on the posterior 
distribution of the variances of true breeding values. Nevertheless, all these results provide 
convincing evidence that the previously identified QTL on SSC4 is present in two additional, 
unrelated commercial populations and has large effects on host response to experimental 
PRRSV infection. 
Potential candidate genes for the QTL identified in the region were discussed in 
Boddicker et al. (2012). Fine-mapping this QTL and future identification of the causative 
mutation is clearly hampered by the extensive LD that exists in the region across breeds. 
Therefore, functional analyses will be required to provide any convincing evidence of 
causality among candidate mutations. 
 The frequency of the favorable B allele is low, which begs the question, why? 
Interestingly, the frequency is low in both maternal and terminal lines, which are selected for 
reproductive and production traits, respectively. Thus, it is unlikely that the QTL on SSC4 
associated with PRRS is in LD with QTL for reproduction or production traits. Based on the 
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results available from PigQTLdb (http://animalgenome.org/cgi-bin/QTLdb/SS/index), no 
QTL for production traits, such as growth or feed efficiency, have been reported within 2 Mb 
of the PRRS QTL on SSC4. However, QTL have been reported for meat quality traits, such 
as intramuscular fat content, shear force, and carcass weight within 9 Mb of the SSC4 region. 
Nonfunctional nipples is the only reproduction-related QTL that has been reported within 2 
Mb of the PRRS QTL. Selection for performance in the presence of PRRS infection is 
expected to favor the B allele. The low frequency of that favorable allele is likely due to a 
combination of the following: 1) PRRSV is a relatively new disease and 2) selection typically 
occurs in high-health nucleus farms, which tend to be fee of PRRS. 
 
Origin of SSC4 effects 
 Parent-of-origin effects are commonly the result of imprinting and, as reviewed by 
Guilmatre and Sharp (2012), there is evidence that imprinting contributes to a number of 
human disorders such as Alzheimer’s disease, autism, breast cancer, and both type 1 and 2 
diabetes. However, to our knowledge, there is no previous evidence of imprinting effects for 
response to infectious diseases. The parent-of-origin analysis performed here not only tested 
if the effect was specific to paternally or maternally inherited alleles but also whether effects 
were breed specific. These effects were, however, partially confounded because some breeds 
were only used as paternal or maternal breeds in the crosses analyzed. The first 3 trials were 
based on a cross between two white breeds (Yorkshire and LR cross) and trials 4 and 5 
encompassed the Yorkshire, LR, LW, and Duroc breeds. Duroc pigs are typically used as 
terminal sires in the commercial sector and Yorkshire and LR are typically used as maternal 
breeds. The Yorkshire and LR lines used in trials 4 and 5 are, however, expected to be 
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distinct from each other and from the Yorkshire and LR lines used in trials 1 to 3 because of 
the separate populations and selection strategies used by each breeding company. When SNP 
WUR10000125 was fitted as an ordered genotype, the effect was present irrespective of 
whether the allele was paternally or maternally inherited. Additionally, the effect of the 
favorable allele was present for each of the parental breeds and lines represented in the 
crosses.  
 
Conclusions 
A large QTL was previously identified on SSC4 using ~560 pigs from a single 
commercial cross. The effects of this region have now been validated in two unrelated 
crosses from two additional breeding companies. The effects were of similar magnitude and 
in the same direction as previously identified. The QTL acts in a dominant matter, where pigs 
with the favorable allele have reduced viremia and increased weight gain. The effect is 
present is lines from the major breeds involved in commercial pork production, and there is 
no indication of parent-of-origin or breed-of-origin effects, as this study included Landrace, 
Yorkshire, Large White, and Duroc breeds. Frequencies of the favorable allele were less than 
17% in each parental line, suggesting ample room for marker-assisted selection on this 
region. These results are promising for the swine industry and for swine health with respect 
to PRRS. However, they are based on infection with a specific strain of the PRRSV under 
experimental conditions. Additional research, such as challenges with other PRRSV isolates 
and field trials, is required to better understand the effects of this genomic region on pig 
production in the field. Nevertheless, if the effect of this region is common across breeds and 
populations, the favorable allele has a low frequency, and the effects observed here replicate 
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in the field, selection for the favorable allele could lead to substantial reductions in economic 
losses due to PRRS. 
 
Supporting information 
 
Figure 4.S1 Posterior distribution for the percentage of genetic variance explained by the 1 
Mb region on Sus scrofa chromosome 4 for weight gain and viral load. 
 
Figure 4.S2 Linkage disequilibrium of the 1 Mb region on Sus scrofa chromosome 4. 
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Table 4.1. Population structure of trials 1 through 5.  
1 LR = Landrace, LW = Large White, Y = Yorkshire 
2 Trials 1 through 3 consisted of the same cross from one breeding company 
3 Trials 1 and 2 were Landrace by Large White crosses. For trial 3, 121 piglets were from Landrace sires by Large White dams crosses and 63 piglets were 
from  
   the reciprocal cross of Large White sires by Landrace dams. 
4 Frequency of the favorable allele (B) at SNP WUR10000125. For trials 1-3, dam genotypes were not provided, so frequencies were determined using   
   ordered genotypes of the offspring. 
    WUR10000125 
allele Number offspring per family Total number of offspring 
Trial  Breed1 N frequency4 Minimum Mean Maximum Barrows Gilts Total 
1-32,3 Sires LR 33 0.22 1 17.1 114 565 0 565 Dams LW 204 0.08 1 2.8 6 
4 Sires Duroc 6 0.08 8 32.5 50 109 86 195 Dams LW/LR/Y 33 0.10 1 5.9 13 
5 Sires Duroc 10 0.12 2 19.9 42 109 90 199 Dams LR/Y 38 0.22 2 5.2 10 
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Table 4.2. Trait means and estimates (±SE) of heritability and litter effects (proportions of phenotypic variance) for viremia and 
weight gain after infection obtained from single trait pedigree-based ASREML analyses. 
1 dpi = day post infection, WG21 = weight gain from 0 dpi to 21 dpi, WG42 = weight gain from 0 dpi to 42 dpi, and VL = viral load calculated as area under 
the curve of log-transformed viremia between 0 and 21 dpi. 
2 Log10 Templates/ml (qPCR). 3 Standard deviation calculated as the square root of the sum of animal, litter, and residual variances from the joint ASREML analysis of all 5 trials. 
 
 Trials 1-5 Trials 1-3 Trial 4 Trial 5 
Trait1 n Mean SD3 Heritability Litter Heritability Litter Heritability Litter Heritability Litter 
Viremia  
  4 dpi2 927 5.9 0.54 
0.22 
(0.11) 
0.09 
(0.05) 
0.39 
(0.18) 
0.10 
(0.07) 
0.09 
(0.16) 
0.04 
(0.07) 0 
0.16 
(0.06) 
Viremia  
  7 dpi2 928 6.3 0.31 0 
0.30 
(0.04) 0 
0.33 
(0.05) 
0.11 
(0.17) 
0.08 
(0.08) 0 
0.24 
(0.08) 
Viremia    
 11 dpi2 906 6.1 0.41 
0.33 
(0.14) 
0.16 
(0.06) 
0.39 
(0.18) 
0.17 
(0.08) 
0.26 
(0.24) 
0.04 
(0.09) 
0.27 
(0.34) 
0.12 
(0.15) 
Viremia  
 14 dpi2 897 5.6 0.64 
0.20 
(0.11) 
0.20 
(0.06) 
0.21 
(0.14) 
0.23 
(0.07) 
0.04 
(0.17) 
0.15 
(0.10) 
0.38 
(0.18) 0 
Viremia  
 21 dpi2 859 3.8 1.0 
0.22 
(0.08) 0 
0.24 
(0.12) 0 
0.08 
(0.16) 
0.08 
(0.09) 
0.14 
(0.13) 0 
VL 909 107 7.6 0.39 (0.15) 
0.11 
(0.06) 
0.49 
(0.19) 
0.06 
(0.08) 
0.03 
(0.19) 
0.38 
(0.12) 
0.34 
(0.17) 0 
WG21, kg 909 5.6 2.0 0.41 (0.09) 0 
0.42 
(0.12) 0 
0.48 
(0.18) 0 
0.22 
(0.13) 0 
WG42, kg 889 15.1 4.0 0.34 (0.14) 
0.09 
(0.06) 
0.37 
(0.18) 
0.12 
(0.08) 
0.40 
(0.17) 0 
0.20 
(0.13) 0 
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Table 4.3. Estimates of phenotypic (above diagonal) and genetic (below diagonal) correlations based on bivariate analyses of 
viremia and weight gain following infection for trials 1 through 5. 
 
Trait1 4 dpi 7 dpi 11 dpi 14 dpi 21 dpi VL WG21, kg WG42, kg 
Viremia 4 dpi - 0.38 ± 0.03 0.09 ± 0.04 0.06 ± 0.04 0.03 ± 0.04 0.34 ± 0.04 -0.16 ± 0.04 -0.14 ± 0.04 
Viremia 7 dpi -0.01 ± 3.7 - 0.13 ± 0.04 0.09 ± 0.04 0.09 ± 0.04 0.34 ± 0.04 -0.16 ± 0.04 -0.13 ± 0.04 
Viremia 11 dpi 0.28 ± 0.34 0.79 ± 1.0 - 0.68 ± 0.02 0.30 ± 0.04 0.71 ± 0.02 -0.05 ± 0.04 -0.14 ± 0.04 
Viremia 14 dpi 0.42 ± 0.38 0.96 ± 1.6 0.94 ± 0.08 - 0.39 ± 0.03 0.78 ± 0.02 -0.20 ± 0.04 -0.24 ± 0.04 
Viremia 21 dpi 0.11 ± 0.44 0.99 ± 0.45 0.78 ± 0.20 0.81 ± 0.18 - 0.75 ± 0.02 -0.17 ± 0.04 -0.20 ± 0.04 
VL 0.40 ± 0.29 0.98 ± 0.71 0.92 ± 0.07 0.96 ± 0.04 0.86 ± 0.10 - -0.23 ± 0.04 -0.28 ± 0.04 
WG21, kg -0.63 ± 0.62 -0.73 ± 0.56 -0.16 ± 0.28 -0.15 ± 0.30 -0.04 ± 0.34 -0.27 ± 0.24 - 0.78 ± 0.02 
WG42, kg -0.47 ± 0.32 -0.61 ± 0.45 -0.16 ± 0.30 -0.32 ± 0.31 -0.21 ± 0.34 -0.31 ± 0.26 1.00 ± 0.02 - 
1 dpi = day post infection, WG21 = weight gain from 0 to 21 dpi, WG42 = weight gain from 0 to 42 dpi, and VL = viral load calculated as area under the 
curve of log-transformed viremia between 0 and 21 dpi. 
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Table 4.4. Correlations between phenotypes for trials 4 and 5 and genomic estimated breeding values at the whole genome level 
and for the 1-Mb region on Sus scrofa chromosome 4 (SSC4), using allele substitution effect estimates obtained from trials 1 
through 3. 
 
Trait1 
Trial 4 Trial 5 
Genome SSC4 Region Genome SSC4 Region 
Viral Load 0.07 0.14 0.20 0.18 
Weight Gain, kg 0.19 0.12 0.15 0.24 
1 Viral load was calculated as area under the curve of log-transformed viremia between 0 and 21 days post infection (dpi). Weight gain is from 0 to 42 dpi. 
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Table 4.5. Percentage of genetic variance explained by the 1-Mb region on Sus scrofa 
chromosome 4 for the joint analysis of trials 1 to 5 using Bayes B and its significance based 
on the proportion of posterior samples that had variance greater than expected. 
 
Trait1 
% of total 
genetic variance 
Proportion 
> expected3 
Marker-based 
Heritability4 
Viremia 4 dpi2 2.2 0.860 0.43 
Viremia 7 dpi2 1.3 0.699 0.43 
Viremia 11 dpi2 10.9 0.998 0.58 
Viremia 14 dpi2 6.5 0.984 0.49 
Viremia 21 dpi2 0.77 0.396 0.19 
VL 15.1 1.00 0.49 
WG21, kg 5.0 1.00 0.70 
WG42, kg 11.3 1.00 0.44 
1 dpi = day post infection, WG21 = weight gain from 0 dpi to 21 dpi, WG42 = weight gain from 0 dpi to 42 dpi, 
and VL = viral load calculated as area under the curve of log-transformed viremia between 0 and 21 dpi. 
2 Log10 Templates/ml (qPCR) 3 Proportion of posterior samples from the MCMC chain for which the 1 Mb region on chromosome 4 explained 
a greater percentage of the genetic variance than expected if all 1-Mb regions across the genome explained an 
equal percentage of the genetic variance, i.e. 0.039%. 
4 Heritability estimates obtained from GenSel software using method Bayes-B with π=0.99. 
 
 Figure 4.1. Least squares means by genotype for SNP WUR10000125 across all trials 1 
through 5 and within trials 4 and 5 for weight gain from 0 to 42 days post infection (A) and 
viral load (B), calculated as area under the curve of log
days post infection. Within a trial, columns with a different letter are significantly different at 
p<0.05. Numbers of individuals within genotype are listed in the bars.
A) 
B) 
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-transformed viremia from 0 to 21
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) 
B) 
Figure 4.2. Least squares means by ordered genotype for SNP WUR10000125 across all trials 1 through 5 and within trial for weight gain from 0 to 42 days post infection (A) and viral load (B), calculated as area under the curve of log-transformed viremia from 0 to 21 Trials 1 through 3 were grouped as animals were of the same cross from the same genetics company. Within a trial, columns with a different letter are significantly different at p<0.05. In the genotype notation, the first allele is of paternal origin and the second allele is of maternal origin. 
94
days post infection. 
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A)  
Figure 4.S1. Posterior distributions for the percentage of genetic variance explained by the 1 Mb region on Sus scrofa chromosome 4 for weight gain from 0 to 42 days post infection (A) and viral load (B), calculated as area under the curve of log-transformed viremia from 0 to 21 days post infection. Results are based on every 100th iteration from the Monte Carlo Markov Chain of the Bayes B model used in the analysis 
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Figure 4.S2.  Linkage disequilibrium plots from Haploview for trials 4 (A), 5 (B), and 1 
through 5 (C), for the 1 Mb region on Sus scrofa chromosome 4. 
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CHAPTER 5. ADDITIONAL VALIDATION OF A QTL ASSOCIATED WITH HOST 
RESPONSE TO EXPERIMENTAL INFECTION WITH PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS ON SSC4 
 
A paper to be submitted to Genetic Selection and Evolution 
 
Nicholas Boddicker and Jack C. M. Dekkers 
 
Introduction 
The swine industry has been battling the economically important disease of porcine 
reproductive and respiratory syndrome (PRRS), caused by the PRRS virus (PRRSV), for 
decades with limited success. Complete understanding of the virus is lacking, making 
vaccine development a challenge (Kimman et al., 2009). Breed differences in swine were 
identified as early as 1998 (Halbur et al., 1998). Maternal lines (Large White and Landrace) 
appeared to be less susceptible to the virus compared to breeds or lines selected for lean 
growth and efficiency (Pietrain, Duroc, and Hampshire) (Halbur et al., 1998; Petry et al., 
2005; Ait-Ali et al., 2007; Doeschl-Wilson et al., 2009). Genetic selection for resistance or 
tolerance has been absent due to the lack of a good DNA marker for marker-assisted 
selection, lack of a good indicator trait for indirect selection, and breeders do not want to 
infect the herd with PRRSV for direct selection. 
Recently, a quantitative trait locus (QTL) was identified on Sus scrofa (SSC) 4 that 
explains a considerable amount of the total genetic variance for weight gain to 42 days post 
infection and virus load (Boddicker et al., 2012). The effect of this ~1 Mb region has been 
identified in 3 unrelated populations, encompassing 5 different experimental challenge trials 
of 200 weaner pigs (Boddicker et al., 2013). Many of the single nucleotide polymorphisms 
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(SNPs) in the ~1 Mb region are in very high linkage disequilibrium, which makes 
determining the causative mutation difficult. The objectives of this chapter are: 
1) Further characterization and validation of a QTL on SSC4 associated with host 
response to PRRSV infection in 3 unrelated populations 
2) Determine if there is a smaller informative haplotype block within the ~1 Mb 
region on SSC4 associated with host response to PRRSV infection 
3) Determine which haplotypes within the SSC4 region are associated with the 
favorable effects of the QTL for virus load and weight gain 
 
Materials and Methods 
 The Kansas State University Institutional Animal Care and Use Committee approved 
all experimental protocols for this study. 
 
Study Design 
A detailed description of the design, data collection, and molecular techniques used in 
PRRS host genetic consortium trials has been previously published (Lunney et al., 2011). A 
total of 8 trials of approximately 200 pigs were analyzed here. Trials 1 through 3 were 
described in Boddicker et al. (2012) and included pigs of the same cross from a single 
breeding company. Trials 4 and 5 were described in Boddicker et al. (2013) and included 2 
unrelated populations from different breeding companies. Trials 6 through 8 are unique to 
this paper and were sourced from 3 additional breeding companies; therefore, the pigs in 
these trials are unrelated to those in Boddicker et al. (2012; 2013). Pigs in trial 7 were 
sourced from the same breeding company as those in trial 4 but different sire and dam lines 
were used in the two trials. Briefly, each trial of ~200 commercial pigs, involved transporting 
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animals at weaning (18-28 days of age) to Kansas State University, where they were 
subjected to a PRRS challenge. Within a trial, pigs were from the same high health farm, 
except for trials 5 and 8, which each included pigs from 2 farms. All farms were free of 
PRRSV, Mycoplasma hyopneumoniae, and swine influenza virus. Upon arrival, pigs were 
randomly placed into pens of 10 to 15 pigs. After a 7-day acclimation period, pigs now 
between 25 and 35 days of age (day 0), were experimentally infected intramuscularly and 
intranasally with 105 (TCID50) of NVSL 97-7985, a highly virulent PRRSV isolate (Fang et 
al., 2007). Blood samples were collected at -6, 0, 4, 7, 11, 14, 21, 28, 35, and 42 days post 
infection (dpi). Body weight was measured at 0, 7, 14, 21, 28, 35, and 42 dpi. Pigs were 
euthanized at 42 dpi. 
 Viremia was measured using a semi-quantitative TaqMan PCR assay for PRRSV 
RNA, as described in Boddicker et al. (2012). The assay results were reported as the log10 of 
PRRSV RNA copies per ml of serum. Ear tissue was collected from all pigs for DNA 
isolation. Tissue or genomic DNA from the sires of pigs in trials 1 through 3 and from sires 
and dams for trials 4 through 8 was supplied by the breeding companies. Tissues or DNA 
samples were sent to GeneSeek Inc. (Lincoln, Nebraska) for genotyping with Illumina’s 
Porcine SNP60 BeadChip (San Diego, California).  
Data from ~1,550 pigs infected with PRRSV across the 8 trials were evaluated. Table 
5.1 provides an overview of the population structure by trial. For further detail on population 
structure for trials 1 through 3, see Boddicker et al. (2012); for further detail on trials 4 and 5, 
see Boddicker et al. (2013). Pigs in trial 6 were purebred Landrace (LR). Pigs in trial 7 were 
from Pietrain sires and LW/LR/Yorkshire dams. Trial 8 pigs were from Duroc sires and 
Yorkshire/LR dams. In trials 6 to 8, a total of 175 pigs died before 42 dpi, comprising 92 
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from trial 6, 3 from trial 7, and 16 from trial 8. Dead pigs were necropsied and subsequent 
gross and microscopic pathology by a board-certified pathologist identified PRRS associated 
disease as the major source of mortality, except within trial 6. Death loss was high in trial 6, 
at 46% by the end of the trial, due to secondary bacterial infection, as identified by 
pathologist. The bacteria involved in the secondary infection included Escherichia coli, 
Streptococcus suis, Staphylococcus aureus, and Mycoplasma pneumonia. 
 
Phenotypic traits 
 Details on the phenotypic traits analyzed are in Boddicker et al. (2012). Briefly, viral 
load (VL) was quantified as area under the curve for log-transformed viremia in serum at 0, 
4, 7, 11, 14, and 21 dpi. Weight gain to 21 or 42 dpi (WG21, WG42) was calculated as body 
weight (BW) at day 21 or 42 minus BW at day 0. Edits for trials 1-3 are in Boddicker et al. 
(2012) and in Boddicker et al (2013) for trials 4 and 5. Edits removed 88 individuals from 
trials 6 through 8, with 86 due to death prior to 21 dpi and 2 with missing viremia data. For 
WG42, 111 individuals were removed from trials 6 through 8, all due to death prior to 42 dpi. 
The number of individuals available after edits is listed in Table 5.2. 
 
Statistical analyses 
 Heritabilities and variances due to litter were estimated based on corrected pedigree 
relationships (see Boddicker et al., 2013 for details) with a single-trait animal model using 
the software ASREML (Gilmour et al., 2006). Sex and the interaction of trial and parity of 
the sow were included as fixed factors and pen within trial, animal, and litter as random 
effects. Piglets were born from parities ranging from 1-7. Parities 3 through 7 were combined 
 
into one parity class. Farm of origin for trial 8 was not significant (p > 0.43) and was 
excluded from the analyses. Genetic correlati
bivariate animal models with the same fixed and random factors as used in the single
models. 
 
Genome-wide association analyses
 Associations of SNP genotypes with phenotypes were analyzed by fitting all SNPs 
simultaneously using Bayesian genomic selection methods 
implemented in the software GenSel (Fernando and Garrick, 2009), using the following 
mixed model: 
 
where y = vector of phenotypic observations, X = incidence matrix relating fixed factors to 
phenotypes, b = vector of fixed factors of se
parity class, zi = vector of the genotype covariate for SNP i based on the number of B alleles 
using Illumina’s (San Diego, California) genotype calling (coded 0, 1, 2, or equal to the trial 
average for missing genotypes), 
whether SNP i was included (
the Markov chain Monte Carlo (MCMC). Pen within trial was included as a fixed factor, as 
opposed to a random effect in ASREML, because the current version of GenSel does not 
allow additional random effects. A total of 50,000 iterations were run for each analysis, with 
the first 5,000 iterations discarded as burn
π=0.99. The Bayesian model was implemented using method Bayes
Genomic regions associated with traits were identified using 1 Mb, non
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ons between traits were estimated using 
 
(Habier et
x, pen within trial, and the interaction of trial and 
αi = allele substitution effect for SNP i, and δ
δi=1) or excluded (δi=0) in the model for a given iteration of 
-in. The probability of δi=0 was set equal to 
-B (Habier et al., 2011).  
-trait 
 al., 2011), as 
i = indicator for 
-overlapping 
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windows using build 10.2 of the swine genome (http://www.ncbi.nlm.nih.gov/nuccore?term= 
199 Sus%20scrofa%2C%20whole%20genome%20shotgun%20sequence, accessed 
November 1, 2011). 
  
Validation of the effect of the SSC4 region 
 Validation of the effect of the ~1 Mb region on SSC4, as identified by Boddicker et 
al. (2012), was carried out using SNP effect estimates obtained from the first 3 trials to 
predict GEBV of animals in trials 6 through 8: 
 
where GEBVi = genomic estimated breeding value for the ith animal of trial 6, 7, or 8, n = 
number of SNPs included in the prediction, zij = genotype covariate of SNP j for animal i 
(coded 0, 1, 2, or trial average for missing genotypes) and   = allele substitution effect 
estimate for SNP j based on analysis of trials 1 through 3. Genomic estimated breeding 
values were computed either based on SNPs across the entire genome (n = 58,277 SNPs after 
removing SNPs that were monomorphic across all 5 trials) or based on only the 38 SNPs in 
the 1 Mb region on SSC4. Accuracy of the resulting GEBV was evaluated by correlating the 
GEBV with phenotypes in trials 6, 7, and 8, after adjustment for fixed effects estimated from 
the ASREML analyses of phenotypes. 
 
Further characterization of the QTL on SSC4 
Estimation of SNP effects 
 Details on single marker analysis of SNP WUR10000125 identified in the genome-
wide analyses or trials 1 through 3 are in Boddicker et al. (2012) and were repeated here for 
GEBVi = (zij α
^
j )
j=1
n
∑
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trials 6 through 8. Briefly, genotypes for SNP WUR10000125 were included as a fixed class 
variable in the ASREML analysis of trials 6, 7, and 8, and all 8 trials jointly, thereby making 
no assumptions about additivity. The SNP WUR10000125 treated as a random additive 
effect contributed over 99% of the variance explained by the region on SSC4 in the Gensel 
analysis.  
 
Breed and parental origin effects 
 Details on the analysis of parent- and breed-of-origin effects are in Boddicker et al. 
(2013). Briefly, parental and offspring genotypes for the 38 SNPs in the ~1 Mb region on 
SSC4 were phased using PHASE software (Stephens et al., 2001), separately for all 8 trials. 
Parental origins were determined for SNP WUR10000125 alleles of heterozygous animals. 
Ordered genotypes (AA, AB, BA, BB) were fitted as a class variable in the previously 
described ASREML univariate animal model. Ordered genotypes could not be determined 
for 5 of the heterozygous animals due to missing parental genotype information and these 
were removed from the analysis. 
 
Haplotype Analyses 
 The 38 SNPs in the ~1 Mb region on SSC4 were analyzed to remove uninformative 
groups of SNPs, with the goal of reducing the size of the ~1 Mb region. Linkage 
disequilibrium (LD) between SNPs in the ~1 Mb region was determined using Haploview 
(Barrett et al., 2005). Using a univariate animal model that included sex, the interaction of 
trial and parity of the sow, and SNP WUR10000125 as fixed factors and pen within trial, 
animal, and litter as random effects, each of the remaining 37 SNPs were fitted as an 
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additional covariate, one at a time, to determine if the additional SNP accounted for effects 
not captured by SNP WUR10000125. The threshold for discarding a SNP from the region 
was p < 0.05. 
Haplotypes, as determined by PHASE software, were analyzed with MEGA5 
software (Tamura et al., 2011) to establish a phylogenetic tree. The neighbor-joining method, 
with the p-distance option, was used to create the tree. Haplotypes identified for the ~1 Mb 
region and for the reduced region were analyzed. Using the results from the phylogenetic tree 
for the reduced region, haplotypes were allocated to two or three groups based on 
phylogenetic distance from one another to determine which haplotypes were associated with 
the desirable phenotypes of VL and WG. The main effect of Group was fitted as a fixed class 
factor with the interaction of experiment and parity of the sow, and sex as additional fixed 
factors, and animals, pen within experiment, and dam as random effects in an animal models 
using. If the two B haplotypes groups were not significantly different from each other, but 
were significantly different from the A haplotype group, both B haplotypes groups were 
assumed to carry the favorable allele of the causative mutation. 
 
Results and Discussion 
Phenotypic parameters 
 Raw phenotypic means for viremia and WG across all trials are in Table 5.2. On 
average, viremia peaked at 7 dpi and subsequently decreased to 21 dpi. The variation in 
viremia was lowest at 7 dpi and increased through 21 dpi. On average, WG from 21 dpi to 42 
dpi was 8.7 kg; the variation in WG also increased with dpi. 
 Phenotypic correlations among traits and across all trials are in Table 5.3. Both 
measures of WG were negatively correlated with all measures of viremia. As expected, the 
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two measures of WG were positively correlated with each other. Phenotypic correlations 
between VL and measures of viremia were all positive. The highest correlation between VL 
and viremia was at 14 dpi (r = 0.76), and the lowest at 4 dpi (r = 0.32). 
 
Estimates of genetic parameters 
 Estimates of heritability and litter components from the single-trait animal model 
analyses for all 8 trials jointly, and by trial, are in Table 5.2. Heritability estimates for VL 
ranged from 0 to 0.69 amongst trials 6 through 8. Most of these estimates had large SE due to 
small sample sizes; however, trials 6 and 8 had heritability estimates of 0.69 for VL, with 
relatively small SEs. Both of these heritability estimates were associated with litter 
components equal to 0. Because each dam contributed only 1 litter, estimates of genetic 
variance and litter variance are partially confounded and must be interpreted with caution. 
Many of the traits within a trial had estimates of heritability or variance explained by litter 
equal to 0. For joint analysis of all trials, heritability estimates of viremia on individual days 
ranged from 0.06 to 0.47 and heritability estimates for VL and WG42 were 0.44 and 0.29, 
respectively. The updated estimates of heritability reported here were of similar magnitude as 
those reported in Boddicker et al. (2013); however there is partial confounding between the 
estimates obtained from trials 1 through 5 in Boddicker et al. (2013) and results presented 
here from analysis of trials 1 through 8. Furthermore, in comparison to the estimates from the 
first 5 trials, the proportion of variance explained by litter effects decreased for VL (0.11 to 
0.09) and increased for WG42 (0.09 to 0.12). These estimates of heritability provide solid 
evidence that genetic improvement of host response to PRRSV infection is possible. 
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 Estimates of genetic correlations amongst the traits are in Table 5.3. In general, 
measures of viremia were positively correlated with each other and negatively correlated 
with measures of WG. Many of the correlation estimates had large SE. As previously 
published (Boddicker et al., 2013), viremia at 14 dpi and VL are highly positively correlated 
(r = 0.96), indicating that most of the variation observed for VL (which is a summary statistic 
viremia over time) can be explained by the variation in viremia at 14 dpi. 
 
Validation 
 Table 5.4 shows the correlations between GEBV based on allele substitution effect 
estimates obtained from trials 1 through 3 and phenotypes adjusted for fixed effects for 
individuals from trials 6 through 8. On average, the GEBV for the SSC4 region predicted 
phenotype slightly better than the GEBV for the entire genome did. Using a heritability of 
0.40, accuracies of GEBV, computed as the correlation with phenotype divided by the square 
root of heritability, ranged from 0.11 to 0.40 for the SSC4 region and from 0.02 to 0.38 for 
the entire genome. These estimates are of similar magnitude as the accuracies from trials 4 
and 5 (Boddicker et al., 2013), strengthening the validity of effects of this region across 
unrelated populations. As reported by Boddicker et al., (2013), the SSC4 region accounted 
for ~15% of the genetic variance for VL. Therefore, the remaining 85% of variance is spread 
across the genome, yet the rest of the genome does not do any better than the region on SSC4 
with respect to prediction of phenotype. One hypothesis is that the rest of the genome has 
little, or no, predictive ability. 
 Results of single marker analysis of the effects of SNP WUR10000125 (Boddicker et 
al., 2012) are in Figure 5.1. The SNP was significant for WG42 (Figure 5.1A) for trials 6 (p < 
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0.01) and 8 (p < 0.004), where AA animals gained 4.8 kg and 3.5 kg less, respectively, than 
AB animals. Although the effect was in the same direction for trial 7 for WG42, there was no 
statistical significance between the genotypes for this trial (p > 0.57). For VL (Figure 5.1B), 
the SNP was significant for trials 6 (p < 0.005) and 7 (p < 0.001) but not for 8 (p > 0.56). For 
trial 8, the effects of the SNP on VL were, however, in the same direction as for the other 
trials (i.e. increased VL for AA animals compared to AB animals). The non-significant 
effects of the WUR SNP on WG in trial 7 and on VL in trial 8 are likely false negatives 
because the effect of the SNP is significant for the other trait in each of these trials. It is also 
possible that the significant effects in trials 7 and 8 are false positives but this is less likely 
because the effect is present in the other trials for both traits (Boddicker et al., 2013). These 
results show that the effect of this region is present in 6 unrelated populations from 5 
different breeding companies. 
 
Joint analysis of all 8 trials 
 The posterior means of the percentage of genetic variance explained by the ~1 Mb 
region on SSC4 are in Table 5.5. The percentages ranged from 0.90 to 6.98 for viremia on 
individual days, with 4 dpi having the lowest percentage and 11 dpi having the highest. 
Under the infinitesimal model, each 1 Mb region across the genome is expected to account 
for 0.039% of the genetic variance. Table 5.5 shows the proportion of MCMC samples for 
which the SSC4 region explained a greater percentage of genetic variance than expected. 
This proportion ranged from 0.72 for viremia at 21 dpi to 1 for viremia at 11 dpi. Compared 
to the analysis of the first 5 trials, viremia at 11 dpi still explained the greatest amount of 
genetic variance but the percentage of variance explained by the SSC4 region for viremia at 
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11 dpi decreased from 10.9% to 7.0%. The SSC4 region explained the smallest percentage of 
genetic variance for viremia at 21 dpi in trials 1 through 5, but the least for viremia at 4 dpi in 
trials 1 through 8. 
The ~1 Mb region was estimated to explain 13.2, 1.8, and 9.1% of the genetic 
variance for VL, WG21, and WG42, respectively. Each of these estimates was lower than the 
corresponding estimates from analysis of trials 1 through 5 (Boddicker et al. 2013). One 
explanation is that some of the additional trials had a weak association between the WUR 
SNP and the phenotype for one or more of these traits, i.e. trial 7 for WG42 and trial 8 for 
VL.  
Single marker analysis results for SNP WUR10000125 across all trials are in Figure 
5.1. The SNP was highly significant for WG42 (p < 1.8x1013, Figure 5.1A) and VL (p < 
1x10-16, Figure 5.1B). On average, animals with the AB genotype had lower VL (-4.5 units) 
and greater WG42 (2 kg) compared to animals with genotype AA. In phenotypic SD, the 
estimates of the effects are 0.50 for WG42 and 0.49 for VL. These effects are of the same 
magnitude as those estimated based on data from trials 1 through 5, i.e. the effect of this 
region for both traits is approximately half of a phenotypic SD. Across all populations, the 
favorable B allele had a frequency equal to 0.16. 
 
Origin of SNP WUR10000125 
 The LS means for the ordered genotypes at the WUR SNP (AA, AB, BA, BB) are 
presented in Figure 5.2 for trials 6 through 8. Corresponding results for the first 5 trials are in 
Boddicker et al. (2013). There was no significant difference between any of ordered 
genotypes in trials 6 or 7 for WG42 (Figure 5.2A). However, only 6 animals were 
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heterozygous for the WUR SNP and had ordered genotypes for trial 6 and the effects were in 
the expected direction given the results from Boddicker et al. (2013), i.e. both ordered 
heterozygotes had greater WG42 compared to AA animals. The main effect of the ordered 
heterozygous genotype was significant (p < 0.02) for trial 8, with no significant difference 
between the two alternate heterozygotes (p > 0.75). The main effect of ordered genotype was 
also significant for VL (Figure 5.2B) in trials 6 and 7 (p < 0.01), with no significant 
difference between the alternate heterozygotes within a trial (p > 0.07). Across trials, the 
main effect of ordered genotype was highly significant for WG42 (p < 5.9x10-11) and VL (p 
< 2.9 x10-17). The two alternate heterozygotes were not significantly different from each 
other (p > 0.90) and both were significantly different from AA animals (p < 0.001) for both 
WG42 and VL. Although partially confounded, these analyses test for both parent-of-origin 
and breed-of-origin. The breeds represented in trials 6 through 8 included LW, LR, 
Yorkshire, Pietrain, and Duroc (Table 5.1). Trials 6 and 8 validated the results from the first 
5 trials, i.e. there was no statistical evidence of a parent- or breed-of-origin effect in unrelated 
animals of the same breeds. Trial 7 added the Pietrain breed and, similar to the other trials, 
there was no statistical evidence of a parent- or breed-of-origin effect. The frequency of the B 
allele in the parental lines by trial is in Table 5.1. 
 
Reducing the 1 Mb region on SSC4 
 The region on SSC4 spans 1,284,081 base pairs and includes a total of 38 SNPs that 
are on the 60k SNP panel, 2 of which are fixed and 2 for which no genotypes were called. 
Figure 5.3 is a LD plot of the of the 34 polymorphic SNPs. Haploview identified 5 haplotype 
blocks, including a block (Block 2) of 15 SNPs that spans 487 kb that has very high LD 
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amongst most SNPs. This block harbors SNP WUR10000125, which captures over 99% of 
the effects of the SSC4 region on VL and WG (Boddicker et al. 2012). In general, LD is not 
expected to the same between breeds and unrelated populations. As an example, one study 
found very different LD patterns between a LW population, Ningxiang (a Chinese breed), 
and the European wild boar, across 3 different genomic regions (Amaral et al., 2008). 
Differences in LD can result from selection, mutation, recombination, and drift. Block 2 is 
unique in the sense that LD is very high across 6 unrelated populations that consist of 
different breeds (Figure 5.3) Therefore, the causative mutation is likely within Block 2. 
 Table 5.6 shows the p-value for the effects of each SNP on VL and WG42, when SNP 
WUR10000125 is also included in the model. The region highlighted in grey is Block 2 from 
the Haploview analysis. The SNPs located before and after Block 2 all had p-values greater 
than 0.05 for both VL and WG42, indicating that these SNPs do not capture a significant 
amount of additional variation in VL or WG42 that is not already accounted for by SNP 
WUR10000125. Therefore, these SNPs are likely not in high LD with the causative mutation, 
and were excluded from the candidate region. Many of the SNPs within Block 2 also had p-
values greater than 0.05; however, with the high LD present and confounding amongst SNPs, 
Block 2 was not reduced in size. Given these results, the ~1 Mb candidate region was 
reduced to a 487 kb region that likely harbors the causative mutation. 
 
Haplotype analysis 
 A total of 77 unique haplotypes were identified in the original ~1 Mb region across 
all 8 trials, 11 of which carried the B allele at SNP WUR10000125 (B haplotypes). Table 5.7 
contains the list of B haplotype numbers for the 1 Mb region and for the 487 kb region, and 
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the number of copies of each haplotype across all populations. For the ~1 Mb region, 
haplotype 16 had the greatest number of copies and was the only haplotype that was present 
in every population. Of the 11 B haplotypes, 6 had less than 20 copies across all trials. After 
reducing the region to 487 kb, 19 unique haplotypes were present, of which 4 carried the B 
allele. Eight of the original 11 B haplotypes were combined into one haplotype after the 
region was reduced (Table 5.7), and this was the haplotype present across all trials. 
Furthermore, the common B haplotype (number 17) was present in every parental breed and 
across all trials. 
 Figure 5.4 contains 2 phylogenetic trees, generated using Mega 5 software, one for 
the haplotypes in the original ~1 Mb region (Figure 5.4A) and one for the haplotypes in the 
487 kb region (Figure 5.4B). Using only the unique haplotypes, the tree clearly grouped the 
haplotypes based on the allele present at SNP WUR10000125, with the B haplotypes 
grouped at the bottom of the tree in Figures 5.4A and 5.4B. B haplotype 17 in Figure 5.4B 
had the most copies (n = 423) and was present across all populations and is, therefore, likely 
the haplotype present in the ancestral population that all breeds in the present study 
originated from, with the remaining B haplotypes originating from recombination or 
mutation since the establishment of the breeds. 
 Starting with haplotype 17 in Figure 5.4B, the phylogenetic tree was cut to determine 
whether all B haplotypes carried the causative variant. The contrasts tested with each cut 
were as follows: Group 1) haplotype 17 vs. haplotypes 15 and18 vs. A haplotypes; Group 2) 
17, 15 vs. 18 vs. A; Group 3) 17, 15, 18 vs. A; Group 4) 17, 15, 18, vs. 14, vs. A; and Group 
5) 17, 15, 18, vs. 14, 13, 11, vs. A. Moving up the tree, if an individual had at least one of the 
haplotypes to the right of the cut, the individual was placed in the group to the right of the 
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cut, because of the identified dominance mode of action of the QTL (Boddicker et al., 2013). 
Only one copy of haplotype 19 was present across trials and that animal’s other haplotype 
was haplotype 17, so the effect of haplotype 19 was confounded with haplotype 17.  
Least squares means of haplotypes within group are in Figure 5.5. Results showed 
that all B haplotypes were associated with the favorable phenotype, and were significantly 
different from haplotypes that carried the A allele (p < 0.001) for both VL and WG42, except 
for Group 2. For group 2, haplotype 18 had significantly lower VL than the other B 
haplotypes but was not significantly different from B or A haplotypes for WG. Haplotypes 
18 had a total of 21 copies (20 individuals) and was specific to trial 5; therefore, the results 
for group 2 may represent effects specific to this trial and this may confound the estimates of 
the effect of this haplotype. Haplotype 14, which was at the base of the A haplotypes (Figure 
5.4), was not significantly different from the other A haplotypes (p > 0.83) and tended 
towards significance from the B haplotypes (Group 4, p < 0.09) for VL. For WG42, B 
haplotype 14 was not significantly different from the other B and from the A haplotypes. 
Haplotype 14 only had a total of 11 copies and the SEs associated with the effect of 
haplotype 14 were large. Moving further up the tree, A haplotypes 14, 13, and 11, together, 
were not significantly different from the other A haplotypes but were significantly different 
from the B haplotypes for both VL and WG. In summary, the phylogenetic analysis 
segregated the different haplotypes primarily by the allele at SNP WUR10000125, and there 
was a significant difference between the haplotypes A and B haplotype groups. Due to the 
high LD present in the 487 kb region, there were relatively few haplotypes across the 
different populations for this region. This may indicate that there is little recombination in 
this region. In fact, across all ~1,600 animals in this experiment, only one recombination 
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could be identified within the ~1 Mb region on SSC4. However, this recombination event did 
not occur within the 487 kb region, but between SNPs 31 and 32 in Figure 5.3. Therefore, 
this may be a region with very little recombination given, explaining the relatively few 
haplotypes that were present across all trials. 
 
Conclusions and implications 
 A QTL on SSC4 was previously identified using animals from one breeding company 
and validated in animals from 2 additional breeding companies. This region has now been 
validated in the genetic lines of 3 additional breeding companies. The effects are in the same 
direction and of similar magnitude as in previous populations. Animals with the favorable 
allele have reduced VL and increased WG. The effect was previously identified in lines from 
the LR, LW, Yorkshire and Duroc breeds, and now also in the Pietrain breed. Combining all 
8 trials broke some of the LD in the ~1 Mb region, resulting in a haplotype block of 487 kb. 
A total of 19 unique haplotypes were identified in the 487 kb region. A phylogenetic analysis 
separated the haplotypes by the allele at the SNP that explains nearly all genetic variance for 
VL and WG that is contributed by the region, providing additional evidence that SNP 
WUR10000125 is the most informative SNP in the region and is likely in very high LD with 
the causative mutation. Furthermore, it has been shown that all haplotypes that contain the B 
allele at the WUR SNP are associated with the favorable phenotypes. One B haplotype was 
present across all populations represented in this study; therefore, this haplotype was likely 
present before the segregation of the breeds. With only 19 unique haplotypes from 15 SNPs 
across the populations, there has likely been very little recombination even after the breeds 
were established, which was confirmed by the absence of observed recombination events in 
the data at hand. These results are promising to the swine industry. With the effect present in 
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the 5 breeds analyzed here, there is a good possibility that the effect is present in many more 
populations and that genetic progress for PRRS tolerance or resistance can be made. 
However, additional work is needed to verify the effects of this region with different PRRSV 
strains and in the field.  
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Table 5.1. Population structure of trials 1 through 8. 
1 LR = Landrace, LW = Large White, Y = Yorkshire 
2 Trials 1 through 3 consisted of the same cross from one breeding company 
3 Trials 1 and 2 were Landrace by Large White crosses. For trial 3, 121 piglets were from Landrace sires by Large White dams crosses and 63 piglets were 
from the reciprocal cross of Large White sires by Landrace dams. 
4 Frequency of the favorable allele (B) at SNP WUR10000125. For trials 1-3, dam genotypes were not provided, so frequencies were determined using   
   ordered genotypes of the offspring. 
 
 
    WUR Number offspring per family Total number of offspring 
Trial  Breed1 N frequency4 Minimum Mean Maximum Barrows Gilts Total 
1-32,3 Sires LR 33 0.22 1 17.1 114 565 0 565 Dams LW 204 0.08 1 2.8 6 
4 Sires Duroc 6 0.08 8 32.5 50 109 86 195 Dams LW/LR/Y 33 0.10 1 5.9 13 
5 Sires Duroc 10 0.12 2 19.9 42 109 90 199 Dams LR/Y 38 0.22 2 5.2 10 
6 Sires LR 31 0.02 1 6.2 24 198 0 198 Dams LR 72 0.03 1 2.8 5 
7 Sires Pietrain 6 0.42 20 32.8 40 109 88 197 Dams LW/LR/Y 28 0.20 1 7 13 
8 Sires Duroc 14 0.11 2 12.4 34 97 101 198 Dams Y/LR 34 0.07 1 4.5 17 
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Table 5.2. Trait means and estimates (±SE) of heritability and litter effects (proportions of phenotypic variance) for viremia and 
weight gain after infection obtained from single trait pedigree-based ASREML analyses. 
1 dpi = day post infection, WG21 = weight gain from 0 dpi to 21 dpi, WG42 = weight gain from 0 dpi to 42 dpi, and VL = viral load calculated as area under 
the curve of log-transformed viremia between 0 and 21 dpi. 
2 Log10 Templates/ml (qPCR). 3 Standard deviation calculated as the square root of the sum of animal, litter, and residual variances from the joint ASREML analysis of all 8 trials. 
 
 
 Trials 1-8 Trial 6 Trial 7 Trial 8 
Trait1 n Mean SD3 Heritability Litter Heritability Litter Heritability Litter Heritability Litter 
Viremia  
  4 dpi2 1440 5.89 0.54 
0.28 
(0.10) 
0.10 
(0.04) 
0.59 
(0.43) 0 
0.53 
(0.45) 
0.07 
(0.17) 
0.15 
(0.27) 
0.18 
(0.13) 
Viremia  
  7 dpi2 1435 6.28 0.32 
0.06 
(0.07) 
0.16 
(0.04) 
0.11 
(0.11) 0 
0.12 
(0.27) 
0.19 
(0.14) 
0.01 
(0.07) 0 
Viremia    
 11 dpi2 1419 6.11 0.40 
0.32 
(0.11) 
0.13 
(0.05) 
0.28 
(0.20) 0 0 
0.06 
(0.05) 
0.37 
(0.33) 
0.10 
(0.15) 
Viremia  
 14 dpi2 1402 5.57 0.61 
0.19 
(0.09) 
0.16 
(0.05) 
0.43 
(0.21) 0 0 
0.11 
(0.06) 
0.35 
(0.16) 0 
Viremia  
 21 dpi2 1350 3.91 1.01 
0.27 
(0.07) 0 
0.59 
(0.25) 0 0 
0.09 
(0.06) 
0.48 
(0.19) 0 
VL 1416 106.9 7.34 0.44 (0.13) 
0.09 
(0.05) 
0.69 
(0.22) 0 0 
0.19 
(0.08) 
0.69 
(0.19) 0 
WG21, 
kg 1416 5.68 2.19 
0.47 
(0.07) 0 
0.24 
(0.21) 0 
0.30 
(0.32) 
0.05 
(0.12) 
0.56 
(0.38) 
0.08 
(0.17) 
WG42, 
kg 1373 14.4 4.03 
0.29 
(0.11) 
0.12 
(0.05) 0 
0.14 
(0.13) 
0.11 
(0.24) 
0.15 
(0.12) 
0.35 
(0.17) 0 
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Table 5.3. Estimates of phenotypic (above diagonal) and genetic (below diagonal) correlations based on bivariate analyses of 
viremia and weight gain following infection using data from trials 1 through 8. 
Trait1 4 dpi 7 dpi 11 dpi 14 dpi 21 dpi VL WG21, kg WG42, kg 
Viremia 4 dpi - 0.33 ± 0.03 0.12 ± 0.03 0.05 ± 0.03 -0.01 ± 0.03 0.32 ± 0.03 -0.13 ± 0.03 -0.12 ± 0.03 
Viremia 7 dpi 0.31 ± 0.44 - 0.17 ± 0.03 0.11 ± 0.03 0.11 ± 0.03 0.40 ± 0.03 -0.13 ± 0.03 -0.11 ± 0.03 
Viremia 11 dpi 0.26 ± 0.25 0.36 ± 0.44 - 0.63 ± 0.02 0.27 ± 0.03 0.68 ± 0.02 -0.11 ± 0.03 -0.16 ± 0.03 
Viremia 14 dpi 0.30 ± 0.30 0.70 ± 0.35 0.80 ± 0.13 - 0.38 ± 0.03 0.76 ± 0.01 -0.22 ± 0.04 -0.23 ± 0.03 
Viremia 21 dpi -0.18 ± 0.18 1.00 ± 0.35 0.59 ± 0.19 0.88 ± 0.10 - 0.74 ± 0.01 -0.22 ± 0.03 -0.23 ± 0.03 
VL 0.25 ± 0.23 0.88 ± 0.24 0.79 ± 0.09 0.96 ± 0.04 0.90 ± 0.06 - -0.27 ± 0.03 -0.29 ± 0.03 
WG21, kg -0.58 ± 0.21 -0.73 ± 0.22 -0.42 ± 0.20 -0.20 ± 0.26 -0.51 ± 0.19 -0.54 ± 0.16 - 0.78 ± 0.01 
WG42, kg -0.41 ± 0.27 -0.57 ± 0.29 -0.28 ± 0.25 -0.38 ± 0.28 -0.53 ± 0.20 -0.46 ± 0.20 1.00 ± 0.02 - 
1 dpi = day post infection, WG21 = weight gain from 0 to 21 dpi, WG42 = weight gain from 0 to 42 dpi, and VL = viral load calculated as area under the 
curve of log-transformed viremia between 0 and 21 dpi. 
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Table 5.4. Correlations between phenotypes adjusted for fixed effects for trials 6, 7 and 8 and genomic estimated breeding values 
based on all SNPs across the genome and only SNPs in the 1-Mb region on Sus scrofa chromosome 4 (SSC4), using allele 
substitution effect estimates obtained from trials 1 through 3. 
 
Trait1 
Trial 6 Trial 7 Trial 8 
Genome SSC4 Region Genome SSC4 Region Genome SSC4 Region 
Viral Load 0.14 0.24 0.20 0.23 0.13 0.08 
Weight Gain, kg 0.08 0.25 0.01 0.07 0.24 0.25 
1 Viral load was calculated as area under the curve of log-transformed viremia between 0 and 21 days post infection (dpi). Weight gain is from 0 to 42 dpi. 
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Table 5.5. Percentage of genetic variance explained by the 1-Mb region on Sus scrofa 
chromosome 4 in the joint analysis of trials 1 to 8 using Bayes B and its significance based 
on the proportion of posterior samples that had variance greater than expected. 
 
Trait1 
% of total 
genetic variance 
Proportion 
> expected3 
Marker-based 
Heritability4 
Viremia 4 dpi2 0.90 0.73 0.40 
Viremia 7 dpi2 2.72 0.90 0.32 
Viremia 11 dpi2 6.98 1.00 0.52 
Viremia 14 dpi2 4.65 0.91 0.44 
Viremia 21 dpi2 2.42 0.72 0.20 
VL 13.2 1.00 0.43 
WG21, kg 1.78 1.00 0.83 
WG42, kg 9.14 1.00 0.40 
1 dpi = day post infection, WG21 = weight gain from 0 dpi to 21 dpi, WG42 = weight gain from 0 dpi to 42 dpi, 
and VL = viral load calculated as area under the curve of log-transformed viremia between 0 and 21 dpi. 
2 Log10 Templates/ml (qPCR) 3 Proportion of posterior samples from the MCMC chain for which the 1 Mb region on chromosome 4 explained 
a greater percentage of the genetic variance than expected if all 1-Mb regions across the genome explained an 
equal percentage of the genetic variance, i.e. 0.039%. 
4 Heritability estimates obtained from GenSel software using method Bayes-B with π=0.99. 
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Table 5.6. Statistical significance (p-values) of associations of single nucleotide 
polymorphisms within the 1 Mb region on Sus scrofa chromosome 4 after accounting for the 
effects of SNP WUR10000125. 
  LD (r2) with P-values 
Number SNP Name Position WUR10000125 VL1 WG2 
1 MARC0005129 139136697 0.28 0.75 0.94 
2 MARC0072497 139169386 0.27 0.68 0.7 
3 ALGA0029505 139182285 0.27 0.52 0.95 
4 ASGA0023314 139260674 0.79 0.62 0.10 
5 MARC0027457 139409628 - Fixed 
6 MARC0095662 139440014 - Fixed 
7 ALGA0029510 139460508 0.35 0.18 0.76 
8 INRA0017729 139501559 0.96 0.52 < 0.01 
9 ASGA0023322 139599067 0.75 0.65 0.7 
10 MARC0056249 139642883 1.00 LD = 1 
11 WUR10000125 139666759 - Used in model 
12 ALGA0029524 139694323 0.95 0.91 0.163 
13 H3GA0014860 139717541 0.11 0.41 0.64 
14 ASGA0023335 139739837 0.94 0.08 0.11 
15 ASGA0023344 139772783 1.00 LD = 1 
16 MARC0014819 139800473 1.00 LD = 1 
17 ALGA0029534 139823807 0.94 0.08 0.11 
18 M1GA0006779 139861417 0.17 0.39 0.92 
19 ASGA0023349 139875297 0.94 0.03 0.39 
20 ALGA0029538 139943624 0.94 0.03 0.37 
21 ASGA0023354 139973857 0.90 0.41 0.81 
22 ASGA0023355 139989537 0.19 0.17 0.57 
23 DRGA0005385 140011063 0.90 0.41 0.81 
24 MARC0045227 140028977 0.16 0.97 0.91 
25 ASGA0023369 140054732 0.04 0.62 0.72 
26 M1GA0006784 140077330 0.72 0.61 0.79 
27 M1GA0006785 140099804 0.04 0.97 0.96 
28 M1GA0006789 140161976 0.12 0.71 0.73 
29 ALGA0029567 140216349 0.08 0.07 0.82 
30 MARC0000425 140220490 0.71 0.93 0.83 
31 MARC0071762 140288666 0.19 0.06 0.4 
32 H3GA0014885 140337996 0.15 0.98 0.96 
33 ALGA0029569 140352057 0.30 0.64 0.74 
34 ASGA0023397 140379843 0.64 0.81 0.94 
35 ALGA0029576 140394822 0.34 0.89 0.29 
36 MARC0040196 140420778 0.64 0.81 0.95 
1 VL = viral load calculated as area under the curve of log-transformed viremia between 0 and 21 days post  
infection. 
2 WG = weight gain from 0 dpi to 42 dpi 
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Table 5.7. Haplotypes (with arbitrary numbers corresponding to the phylogenetic trees in Figures 5.4A and 5.4B) that contain the B 
allele for SNP WUR10000125 on Sus scrofa chromosome 4, along with SNP sequence and the number of copies present in trials 1 
through 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Letter in bold is SNP WUR10000125 
 
 
 
1 Mb Haplotype 
Number 
Reduced Haplotype 
Number 
Reduced Haplotype 
SNP sequence1 
Number of 
Copies 
Trials for which Reduced 
Haplotype was Present 
16 17 
GAGGCGAGGGCCCAG 
285 All 
17 17 89 All 
18 17 1 All 
20 17 1 All 
26 17 2 All 
59 17 1 All 
60 17 22 All 
77 17 22 All 
12 18 GAGGCGCGGACAACG 21 5 
21 19 GAGGCGCGGACCCCG 1 1 
76 15 AGGGCGAGGGCCCAG 8 6 
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 Figure 5.1. Least squares means by genotype for SNP WUR10000125 across all trials 1 
through 8 and within trials 6, 7, and 8 for weight gain from 0 to 42 days post infection (A) 
and viral load (B), calculated as area under the curve of log
days post infection. Within a trial, columns with a different letter are significantly different at 
p < 0.05. Numbers of individuals within genotype are listed in the bars.
A) 
B) 
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-transformed viremia from 0 to
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 Figure 5.2. Least squares means by ordered genotype for SNP WUR10000125 across all 
trials 1 through 8 and within trial for weight gain from 0 to 42 days post infection (A) and 
viral load (B), calculated as area under the curve of log
days post infection. Within a trial, columns with a different letter are significantly different at 
p < 0.05. In the genotype notation, the first allele is of paternal origin and the second allele is 
of maternal origin. 
A) 
B) 
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Figure 5.3. Linkage disequilibrium (r2) plot of the 1 Mb region on Sus scrofa chromosome 4 across trials 1 through 8. Black 
squares signify r2 = 1 and white squares signify r2 = 0. 
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Figure 5.4. Phylogenetic trees of the haplotypes present across trials 1 through 8 
for the 1 Mb region (A) and the 487 kb region (B) on Sus scrofa chromosome 4. 
The trees were created using the neighbor-joining, p-distance method in the 
Mega 5 software. Haplotypes with the B allele for SNP WUR10000125 are 
labeled with a B following the haplotype number. 
A) 
B) 
  
Figure 5.5. Least squares means by haplotype class within a group based on the phylogenetic 
analysis for virus load (A), calculated as area under the curve of log
from 0 to 21 days post infection, and weight gain from 0 to 42 days post infection (
Within a group, columns with a different letter are significantly different at p < 0.05. 
Numbers of individuals within a haplotype group are listed in the bars. Black bars represent 
haplotypes with B alleles for SNP WUR10000125 and white bars represent
A alleles for SNP WUR10000125.
 
A) 
B) 
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CHAPTER 6. EXPLORING DIFFERENT MODELS FOR QTL DISCOVERY AND 
GENOMIC REGIONS ASSOCIATED WITH PRRS VIRUS INFECTION 
 
A paper to be submitted to Genetic Selection and Evolution 
 
Nicholas Boddicker and Jack C. M. Dekkers 
 
Introduction 
 Porcine reproductive and respiratory syndrome (PRRS) is a complex disease that has 
had a large economic impact on the swine industry (Holtkamp et al., 2013). Complex 
diseases are difficult to understand if host phenotypes are a challenge to quantify or if they 
are not practical to collect outside of normal operating procedures within the production 
system, both of which are true for PRRS. Making selection decisions for host response to 
PRRS is difficult under a PRRS free herd status, and breeders are understandably not willing 
to subject their breeding herds to a PRRS virus (PRRSV) challenge. Therefore, breeders need 
alternative information to base selection decisions on with respect to PRRS. 
With the onset of single nucleotide polymorphism (SNP) chips, genome-wide 
association analyses have allowed for the identification of SNP associations with phenotypic 
traits, such as virus load and weight gain under PRRSV challenge (Boddicker et al., 2012). 
Once identified, these SNPs can be used in place of phenotypic selection for complex disease 
traits. Boddicker et al. (2012) identified a QTL on Sus scrofa chromosome (SSC) 4 that 
explained 13% of the genetic variance for virus load and 9% for weight gain to 42 days post 
infection (dpi). This region has been thoroughly characterized and validated in a number of 
populations (Boddicker et al., 2012; Boddicker et al., 2013; Chapter 5). However, those 
studies did not thoroughly investigate the rest of the genome, which may contain pertinent 
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information for host response to PRRSV infection. In addition, mortality following PRRS 
challenge has not yet been investigated. Thus, the objectives of this chapter are: 
1) Compare the percentage of genetic variance explained by genomic regions identified 
to be associated with virus load and weight gain to 42 dpi using an additive and an 
additive plus dominance model. 
2) Investigate accuracies of genomic estimated breeding values, after accounting for the 
QTL on SSC4, using cross validation. 
3) Investigate additional genomic regions associated with weight gain and virus load in 
response to PRRSV challenge  
4) Investigate genomic regions associated with mortality following PRRSV challenge 
 
Materials and Methods 
 The Kansas State University Institutional Animal Care and Use Committee approved 
all experimental protocols for this study. 
 
Study design 
 A detailed description of the design, data collection, and molecular techniques used in 
PRRS host genetic consortium trials has been previously published (Lunney et al., 2011). 
Briefly, the data analyzed here consisted of 8 trials of ~200 animals from 6 unrelated 
populations from 5 different breeding companies. Population structures of the 8 trials were 
provided in Chapter 6. Breeds used in the crosses included Large White (LW), Landrace 
(LR), Yorkshire, Duroc, and Pietrain. For each trial, pigs were weaned (18-28 days of age) 
and transported to Kansas State University, where they were subjected to a PRRS challenge. 
Pigs were sourced from high health farms that were free of PRRS virus (PRRSV), 
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Mycoplasma hyopneumoniae, and swine influenza virus. Upon arrival, pigs were randomly 
placed into pens of 10 to 15 pigs. After a 7-day acclimation period, pigs now between 25 and 
35 days of age (day 0), were experimentally infected intramuscularly and intranasally with 
105 (TCID50) of NVSL 97-7985, a highly virulent PRRSV isolate (Fang et al., 2007). Blood 
samples were collected at -6, 0, 4, 7, 11, 14, 21, 28, 35, and 42 days post infection (dpi). 
Body weight was collected at 0, 7, 14, 21, 28, 35, and 42 dpi. Pigs were euthanized at 42 dpi. 
Viremia was measured using a semi-quantitative TaqMan PCR assay for PRRSV 
RNA, as described in Boddicker et al. (2012). The assay results were reported as the log10 of 
PRRSV RNA copies per ml of serum. Ear tissue was collected from all pigs for DNA 
isolation. Tissue or genomic DNA from the sires of pigs in trials 1 through 3 and from sires 
and dams for trials 4 through 8 was supplied by the breeding companies and sent to 
GeneSeek Inc. (Lincoln, Nebraska) for genotyping with Illumina’s Porcine SNP60 BeadChip 
(San Diego, California). 
 
Phenotypic traits 
Details on the phenotypic traits analyzed are in Boddicker et al. (2012, 2013). Briefly, 
VL was quantified as area under the curve for log-transformed viremia for 0, 4, 7, 11, 14, and 
21 dpi. Weight gain to 42 dpi (WG) was calculated as body weight (BW) at 42 dpi minus 
BW at day 0 dpi. Mortality was defined as death prior to the end of the experiment due to 
PRRSV or PRRSV and secondary infection, as determined by a board-certified pathologist. 
All mortalities were classified into the PRRSV only category, except for trial 6, where a 
secondary infection was present (Chapter 5) and for that trial all mortalities were classified as 
such. 
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Genome-wide association analyses 
 Associations of SNP genotypes with phenotypes were analyzed by fitting all SNPs 
simultaneously using Bayesian genomic selection methods (Habier et al., 2011), as 
implemented in the software GenSel (Fernando and Garrick, 2009). Two genetic models 
were used: an additive model and an additive plus dominance model. A total of 50,000 
iterations were run for each phenotypic analysis, with the first 5,000 iterations discarded as 
burn-in. Genomic regions associated with traits were identified based on the percentage of 
genetic variance explained by 1 Mb, non-overlapping windows using build 10.2 of the swine 
genome (http://www.ncbi.nlm.nih.gov/nuccore?term= 199 
Sus%20scrofa%2C%20whole%20genome%20shotgun%20sequence, accessed November 1, 
2011). 
 
Additive model 
 The following additive model was used to identify genomic regions: 
y = Xb+ z jα jδ j +ε
j
k
∑  
where y = vector of phenotypic observations, X = incidence matrix relating fixed factors to 
phenotypes, b = vector of fixed factors of sex, pen within trial, and the interaction of trial and 
parity class, zj = vector of the genotype covariate for SNP j based on the number of B alleles 
using Illumina’s (San Diego, California) genotype calling (coded 0, 1, 2, or equal to the trial 
average for missing genotypes), αj = allele substitution effect for SNP j, and δj = indicator for 
whether SNP j was included (δj=1) or excluded (δj=0) in the model for a given iteration of 
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the Monte Carlo Markov Chain (MCMC). Pen within trial was included as a fixed factor 
because the current version of GenSel does not allow additional random effects. The 
probability of δi=0 was set equal to π=0.99. The Bayesian model was implemented using 
method Bayes-B (Habier et al., 2011).  
Genomic estimated breeding values (GEBV) were predicted using the following 
model: 
    
where GEBVi = genomic estimated breeding value for the ith animal, k = number of SNPs 
included in the prediction, zij = genotype covariate of SNP j for animal i (coded 0, 1, 2, or 
trial average for missing genotypes) and   = allele substitution effect estimate for SNP j 
based on analyses of the training populations. 
 
Additive and Dominance model 
 The following additive plus dominance model was used to identify genomic regions: 
            
where y = vector of phenotypic observations, X = incidence matrix relating fixed factors to 
phenotypes, b = vector of fixed factors of sex, pen within trial, and the interaction of trial and 
parity class,  = vector of the additive genotype covariate for SNP j based on the number of 
B alleles using Illumina’s (San Diego, California) genotype calling (coded 0, 1, 2, or equal to 
trial average for missing genotypes),   = additive effect for SNP j,   = indicator for 
whether the additive effect of SNP j was included ( = 1) or excluded ( = 0) in the model 
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for a given iteration of the MCMC,  = vector of the dominance genotype covariate for SNP 
j based on whether the genotype was homozygous or heterozygous (coded 0 and 1 for 
homozygous and heterozygous, respectively, or equal to trial average for missing genotypes),  = dominance effect for SNP j,  = indicator for whether the dominance effect of SNP j 
was included ( = 1) or excluded ( = 0) in the model for a given iteration of the MCMC. 
The probability of δja = 0 and δjd = 0 was set equal to π=0.99. The Bayesian model was 
implemented using method Bayes-B (Habier et al., 2011). 
 Genomic estimated genetic values were predicted using the following model: 
          
where GEGVi = genomic estimated breeding value for the ith animal,   = additive genotype 
covariate of SNP j for animal i (coded 0, 1, 2, or trial average for missing genotypes),   = 
additive effect estimate for SNP j based on analyses of the training populations,   = 
dominance genotype covariate of SNP j for animal i (coded 0 for homozygous, 1 for 
heterozygous, or trial average for missing), and   = dominance effect estimate for SNP j 
based on the analyses of the training populations.  
 
Cross-validation 
 Accuracy of genomic predictions across populations was evaluated by cross-
validation, which involved training on one population and validating on another population. 
Populations were defined by trial, except for trials 1 through 3, which was considered as 1 
population, as pigs included in those three trials were crossbreds from the same lines and 
breeding company. Each population was validated twice using two different training 
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populations, a ‘reduced’ and a ‘full’ training population. Table 6.1 shows the reduced and 
full training populations for each population that was validated. For the reduced training 
populations, only 1 of the first 3 trials was used. Trial 3 was used for this purpose because it 
had the highest estimates of heritability for both VL and WG (0.45 and 0.50, respectively), 
among trials 1, 2, and 3. For the full training populations, trials 1 through 3 were included 
when validating on trials 4 through 8. When validating on trials 1 and 2, trial 3 was included 
in the training population, which resulted in some of the animals in the validation population 
to be related to animals in the training population. 
 Estimates of allele substitution effects for the training population were acquired using 
the additive Bayesian model described above. The SNP WUR10000125 genotypes on Sus 
scrofa chromosome (SSC) 4 were included as an additional fixed class effect to account for 
nonadditive effects of the QTL in this region on VL and WG (Boddicker et al., 2012) and 
allow predictive ability of the rest of the genome to be assessed. Bayesian method Bayes-CPi 
and BayesC0 was used rather than Bayes-B. Method Bayes-CPi assumes a homogenous 
variance across all SNPs and estimates parameter π from the data, whereas Bayes-C0 uses a 
fixed value of π=0 (Habier et al., 2011). The starting value of π was set to 0.99 for the Bayes-
CPi analysis. 
 Accuracies, defined as the correlation between the GEBV and the true BV, from 
Bayes-CPi cross-validation were estimated by a bivariate analysis, separately for each trial, 
using ASREML (Gilmour et al., 2006). Through the validation process, each individual in 
each trial received a validation GEBV. Phenotype and GEBV were used as phenotypes for 
two correlated traits in a model that fitted an overall mean and a random polygenic animal 
effect for both traits. In this analysis, the model for phenotype included parity, pen, sex and 
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genotype for SNP WUR10000125 as fixed class effects, along with litter as an additional 
random effect. Furthermore, a joint bivariate analysis (joint analysis) of the GEBVs across all 
trials was performed to estimate accuracy across all populations. The model for GEBV 
included trial as a fixed factor with a random polygenic animal effect. For phenotype, fixed 
factors included the interaction between trial and parity, pen within trial, sex, and genotype 
for SNP WUR10000125 and random effects of animal and litter. Accuracies using the joint 
analysis were estimated using GEBV obtained from Bayes-CPi and Bayes-C0 cross-
validation analyses. Pen (or pen within trial) has typically been fitted as random (Boddicker 
et al., 2012); however, pen was included as a fixed factor in the GenSel analysis because 
GenSel does not currently allow additional random effects to be included. Therefore, pen was 
fitted as fixed in the ASREML analysis here for phenotype to correlate responses that 
accounted for the same fixed effects. Accuracy was also calculated as the correlation between 
GEBVs and phenotypes, adjusted for estimates of fixed factors within a given trial, divided 
by the square root of heritability (Boddicker et al., 2013; Chapter 5). A heritability of 0.44 
was used for VL and 0.29 for WG (Chapter 5).  
 
Estimates of SNP effects using ASREML 
Additive and dominance effects of SNP WUR10000125 were estimated as fixed 
effects using an animal model in ASREML (Gilmour et al., 2006) that included the fixed 
factors of trial by parity of the sow, sex, and additive and dominance covariates for SNP 
WUR10000125. Random effects included animal, litter, and pen within trial. 
Effects of SNPs that were associated with VL or WG, aside from the SSC4 region, 
were estimated using an animal model in ASREML. Fixed factors included the interaction of 
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trial and parity of the sow, sex, and SNP; random effects included animal, litter, and pen 
within trial. The effects of a SNP were fitted as either a class variable to allow for 
dominance, or as a covariate. 
 
Genetic parameters and estimates of SNP effects for mortality 
Heritability of mortality was estimated using a threshold animal model in ASREML, 
with the interaction of trial and parity of the sow and sex as fixed factors and random effects 
of animal, litter, and dam. Associations between SNPs and mortality were analyzed using the 
same model, but with SNP included as a fixed linear covariate. For the analysis of mortality 
in trial 6, parity was the only fixed factor included in the model. 
 
Results and Discussion 
Additive vs. additive plus dominance models 
 Model comparisons were carried out to investigate whether allowing for dominance 
in the genome wide association analysis would capture additional genetic variance for a 
given 1 Mb window or identify new genomic regions not captured using an additive model. 
The percentage of genetic variance explained by each non-overlapping window of 1 Mb 
across the genome for VL is presented in Figure 6.1A for the additive model and in Figure 
6.1B for additive plus dominance model. There was little difference in the results from the 
two models. The posterior mean of the total genetic variance was 22.2 for the additive model 
and 21.7 for the additive plus dominance model. The lower genetic variance from the 
additive plus dominance model is opposite to expectations but could be the result of MCMC 
sampling or the specifics of the sample of data that were analyzed. Both models identified the 
region on SSC4, with any one of the remaining windows explaining little genetic variance. 
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The peak at the end of each graph encompasses 4,547 markers with unknown positions, 
which generally had low model frequencies (frequency of which a SNP was included in the 
45,000 MCMC iterations), ranging from 0.006 to 0.13 for the additive model and from 0.007 
to 0.22 for the additive plus dominance model. Comparatively, the SNP with the highest 
model frequency across the whole genome for the additive model was a SNP in the SSC4 
region, which had a model frequency of 0.50. For the additive plus dominance model, the 
dominance effect of SNP WUR10000125 had the highest model frequency at 0.35.  
Individual SNPs with unknown positions were not further investigated. When SNP 
WUR10000125 was fitted as an additional fixed factor in the additive and the additive plus 
dominance models, the percentage of genetic variance explained by the SSC4 region was 
diminished to less than 0.06%. The total genetic variance after fitting SNP WUR10000125 
dropped to 19.7 for the additive model and 18.7 for the additive plus dominance model. 
Furthermore, accounting for the effects of SNP WUR10000125 did not change the results of 
the rest of the genome using either the additive or the additive plus dominance model.   
 The results of the genome wide association analysis for WG using the two models are 
presented in Figure 6.2. As with VL, there was very little difference in the results between 
the two models. The posterior mean of the total genetic variance was 6.5 for the additive 
model and 6.1 for the additive plus dominance model. No additional regions were identified 
using the additive plus dominance model that were not captured using the additive model. 
When genotypes for SNP WUR10000125 were fitted as an additional fixed class in the 
models, the percentage of genetic variance explained by the remaining markers in the SSC4 
region dropped to less than 0.05%. The total genetic variance after fitting SNP 
WUR10000125 dropped to 5.9 for the additive model and to 5.4 for the additive plus 
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dominance model. Furthermore, accounting for the effects of SNP WUR10000125 did not 
change the results of the rest of the genome using either model. 
 Table 6.2 shows the top ten 1 Mb windows that accounted for the greatest percentage 
of genetic variance using the additive model, along with the percentage of genetic variance 
and rank of those 1 Mb regions based on the additive plus dominance model for VL and WG. 
For both traits, the top 3 windows were of the same rank for the 2 models. Rank 
discrepancies between the two models were present beyond the top 3 windows for both traits; 
however, these differences were not drastic. For VL, the top 10 windows identified using the 
additive model were amongst the top 14 for the additive plus dominance model. Similarly for 
WG, the top 10 windows identified using the additive model were amongst the top 26 for the 
additive plus dominance model. 
 The total genetic variance estimated from the genome wide association analyses was 
similar between the two models for both VL and WG. Therefore, it is valid to directly 
compare the percentage of genetic variance between the two models for a given 1 Mb 
window. In general, the top 10 windows explained a greater percentage of genetic variance in 
the additive model than those same windows did for the additive plus dominance model, with 
some exceptions. For VL, the additive plus dominance model explained more of the genetic 
variance than the additive model for two windows, one of which was the region on SSC4 
identified previously (Boddicker et al., 2012). This region was shown to have a dominant 
mode of action by Boddicker et al., (2013). This region explained 13.2% of the genetic 
variance using the additive model and this increased to 14.5% using the additive plus 
dominance model. However, the increase of 1.3% observed here was not as high as the 
expected: using the equation (2pqd)2 (Falconer and Mackay, 1996) to estimate the dominance 
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variance, dominance variance for the SSC4 region was expected to be 0.82 or 3.5% of 
genetic variance, given the additive (a = 1.3) and dominance (d = -3.2) effects of SNP 
WUR10000125 on VL and a minor allele frequency of 0.17 (Chapter 5). Similarly for WG, 
this region explained 9.14% of the genetic variance using the additive model and this 
increased to 9.99% using the additive and dominance model. Again, the increase of 0.85% 
was lower than the expected 1.2% given the dominance effect of SNP WUR10000125 (d = 1 
kg). Overall, including dominant SNP covariates did not explain additional genetic variance 
within windows and did not change the overall conclusions compared to the additive model. 
This does not imply that dominance should not be considered in other genome-wide 
association analyses. 
 The genomic predictions for the 1 Mb region on SSC4 obtained from estimates of the 
additive plus dominance model were plotted against estimates of additive and dominance 
effects of SNP WUR10000125 when fitted as a fixed effect in the ASREML analysis (Figure 
6.3). Marks on the x and y axes represent the estimates for the effect of SNP WUR10000125 
based on the ASREML analyses and genomic predictions from the genomic selection 
analyses, respectively. For VL (Figure 6.3A), the effect estimates (a, d, and –a) of SNP 
WUR10000125 for AA, AB, and BB animals from the ASREML analysis were 1.3, -3.2, and 
-1.3 units, respectively. The corresponding average genomic predictions for AA, AB, and BB 
animals were 1.0, -3.0, and 0.4 units, respectively. Interestingly, both models indicated 
overdominance as a mode of action of the QTL on VL, as the AB genotype had a lower VL 
compared to both the AA and BB genotypes. However, the contrast between the LS means of 
the AB and BB genotypes were not significant, as reported in Chapter 5. 
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 For WG (Figure 6.3B), the effect estimates from the ASREML analyses for SNP 
WUR10000125 for AA, AB, and BB animals were -0.9, 1.1, and 0.9 kg, respectively. The 
average genomic predictions for AA, AB, and BB animals were -0.4, 1.0, and 2.1 kg, 
respectively. The two models did not agree on the mode of action of the QTL on WG. The 
fixed effect estimates of SNP WUR10000125 indicated overdominance but could represent 
complete dominance, as the number of BB individuals was low at 43. Conversely, the 
average genomic predictions by genotype indicated an additive mode of action. 
 
Cross-validation 
Accuracies of genomic predictions for the SSC4 region and for the whole genome 
including the SSC4 region, were previously reported (Boddicker et al., 2013; Chapter 5). 
There, trials 1 through 3 were used as training populations to validate on trials 4 through 8. 
On average, accuracies for the SSC4 region were higher for VL (r = 0.28) and WG (r = 0.35) 
compared to the whole genome (0.23 and 0.25, respectively). Given those results, the 
hypothesis was that the rest of the genome has less predictive ability than the region on 
SSC4. The results presented here provide sufficient evidence that the rest of the genome, 
excluding the SSC4 region, has lower accuracies compared to the SSC4 region. 
 Cross-validation was carried out to determine the predictive ability of the genome, 
excluding the large QTL on SSC4 and results are presented in Table 6.3. Accuracies were 
determined by bivariate analysis of GEBV and phenotype. The heritability of GEBV is 
expected to be 1, but ranged from 0.42 to 1 across trials (Table 6.3). 
The reduced training population resulted in genomic prediction accuracy estimates 
ranging from -0.32 to 0.52 for VL, with an average of -0.03 amongst the individual 
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validation populations. Using the full training population, the accuracies ranged from -0.18 to 
0.50, with an average of 0.24. Large SE accompanied these accuracies. When the GEBVs, 
estimated using either Bayes-Cpi or Bayes-C0, were analyzed jointly across all 8 trials using 
the bivariate animal model, accuracies were low (ranging from -0.06 to 0.11) with large SE 
(0.05). For WG, accuracies ranged from 0 to 0.67, with an average of 0.12 when training 
using the reduced population. Accuracies ranged from -0.11 to 0.82 when using the full 
training population, with an average of 0.25. When the GEBVs were analyzed jointly, 
accuracies ranged from 0.04±0.06 to 0.18±0.08.  
Accuracies obtained from the bivariate analyses by trial were plotted against the 
accuracies calculated as the correlation between GEBV and adjusted phenotype divided by 
the square root of heritability (Figure 6.4). Estimates of accuracy differed substantially 
between the two methods of calculation for both VL (Figure 6.4A) and WG (Figure 6.4B), 
although the average accuracies across trials for the two methods were similar: for VL, the 
mean accuracy using adjusted phenotype was 0 and 0.24 for the reduced and full training 
populations, respectively, compared to -0.03 and 0.16 when based on genetic correlations; for 
WG, the mean accuracy based on adjusted phenotype was 0.12 and 0.39 for the reduced and 
full training populations, respectively, compared to 0.21 and 0.25 when based on genetic 
correlations. For VL, the correlation between the two estimates of accuracy across trials was 
0.64 and 0.66 for the reduced and full training populations, respectively. For WG, the 
correlations were 0.64 and 0.95 for the reduced and full training populations, respectively.  
 The full training population resulted in higher accuracies than the reduced training 
population, on average. These results agree with several other studies that have shown that 
accuracies increase with the increase in size of the training population (Meuwissen et al., 
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2001; Goddard, 2009; Saatchi et al., 2011). However, whether analysis was by trial or jointly, 
none of the accuracies were significantly different from 0 (p > 0.10). Therefore, aside from 
the QTL on SSC4, the rest of the genome had little to no predictive ability across populations 
for both VL and WG under PRRSV challenge. 
On average, accuracies of genomic predictions were higher for WG than for VL, 
which is opposite to expectations because VL was more heritable than WG. In general, traits 
that are more heritable have higher accuracies of genomic predictions (Luan et al., 2009). 
One explanation is that LD between markers and QTL may be more similar across 
populations for associations with WG under challenge than for VL. Another explanation 
could be differences in the consistency of QTL effects across populations for VL versus WG. 
Reasons for poor predictive performance across populations can be attributed to 
dominance, epistatis, and differences in linkage disequilibrium (Garrick, 2010). Accuracies 
of GEBV are generally lower when training and validation populations are unrelated. For 
example, Saatchi et al. (2011) partitioned data from Angus bulls into 5 groups using two 
different methods; random allocation and k-means clustering, with the latter aiming to 
increase relationships within groups and decrease relationships between groups. On average, 
accuracies of GEBV when crossvalidating in groups created by random allocation were 
higher than when groups were created by k-means clustering (0.65 vs 0.44). They concluded 
that closer relationships between training and validation populations when using random 
allocation was the reason for the higher estimates of accuracy with random allocation. In the 
current study, the reduced training populations were not related to the validation populations. 
However, when validating on trials 1 and 2, trial 3 was included in the full training 
population, which resulted in some relatedness between training and validation populations. 
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Inclusion of trial 3 in the training population resulted in increased accuracies for trials 1 and 
2 compared to the absence of trial 3 in the reduced training population, which agrees with the 
results of Saatchi et al. (2011). However, SEs were large for all estimates of accuracy. 
Furthermore, increased relationships between training and validation populations and 
increased size of the training population were confounded. 
 
Additional 1 Mb windows associated with WG 
 A region on SSC5 was found to be associated with WG using the additive Bayes-B 
model with π=0.99 (Figure 6.2A, Table 6.2). That region accounted for 2.6% of the genetic 
variance across all trials. This window does not appear to have an association with VL, as the 
percentage of genetic variance of this region was 0.06 for VL. Reports of QTL in this region 
associated with health in the pig include QTL for cholesterol level, haptoglobin 
concentration, alkaline phosphatase activity, interleukin-2 level, and interferon-gamma level 
(http://www.animalgenome.org/cgi-bin/QTLdb/SS/index). Interleukin-2 and interferon-
gamma are both cytokines that respond to pathogen invasion of host cells. Interferon-gamma 
has been shown to inhibit PRRSV replication in macrophages (Bautista and Molitor, 1999; 
Rowland et al., 2001). There were 2 reports of QTL associated with average daily gain of 
healthy pigs spanning the SSC5 region identified here (http://www.animalgenome.org/cgi-
bin/QTLdb/SS/index). 
A 1 Mb window on SSC7 was also found to be associated with WG using the additive 
Bayes-B model with π=0.99 (Figure 6.2A, Table 6.2). This region accounted for 1.45% of 
the genetic variance in WG across all trials. This region explained only 0.06% of the genetic 
variance for VL. This region (Mb 27) is within a ~5 Mb region (Mb 24 – 29) that contains 
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several Swine Leukocyte Antigen genes, suggesting this 1 Mb region is within the swine 
Major Histocompatibility Complex (www.ensembl.org, accessed March, 2013). To date, 
there have been 19 reports of QTL associated with production traits, 18 of which were 
associated with BW or average daily gain (ADG) from birth to market weight (pig genome 
assembly 10.2, animalgenome.org, accessed March, 2013). However, these QTL were 
identified using healthy, non-challenged pigs. The QTL identified here is for WG under 
PRRS challenge and could be a new QTL or one of the previously reported QTL could also 
be associated with WG under PRRS challenge. Additional work is required to understand the 
underlying mechanism.  
 
Additional regions associated with VL  
 A region on SSCX was found to be associated with VL using the additive Bayes-B 
model with π=0.99 (Figure 6.1A, Table 6.2). This region accounted for 1.24% of the genetic 
variance across all trials for VL but only 0.02% of the genetic variance for WG. There have 
been no reports of QTL associated with WG within 3 Mb up or down stream of the 1 Mb 
region here (http://www.animalgenome.org/cgi-bin/QTLdb/SS/index). The region does 
include one reported QTL for blood pH in Meishan and Pietrain pigs infected with 
Sarcocystis miescheriana (Reiner et al., 2009).  
A region on SSC1 was associated with VL using the additive Bayes-B model with 
π=0.99 (Figure 6.1A, Table 6.2). This region accounted for 0.70% of the genetic variance 
across all trials and was the 3rd highest region for VL. This region explained a small 
percentage of genetic for WG (0.03%). Based on the genome-wide association analysis, SNP 
H3GA0004624 had the highest model frequency of all SNPs in the region (0.32), and was 
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further investigated using the ASREML animal model. Analyzing all trials jointly, this SNP 
was significant when fitted as a fixed class effect, allowing for dominance (p < 0.0.1), and 
also when fitted as a linear covariate (p < 0.01). The LS means for SNP H3GA0004624 are 
in Figure 6.5. Animals with genotype BB at this SNP had significantly higher VL compared 
to AA and AB animals. Three QTL associated with health traits have been reported for this 
region, including C3c concentration, alkaline phosphatase activity, and white blood cell 
counts (http://www.animalgenome.org/cgi-bin/QTLdb/SS/index). However, none of these 
QTL were identified under a PRRS challenge. Interesting candidate genes within 2 Mb on 
either side of the 1 Mb window identified through the genome wide association analysis 
include DBC1 (deleted in bladder cancer 1) and tumor necrosis factor (TNF) receptor-
associated factor 1-like (www.animalgenome.org). The DBC1 gene is a tumor suppressor 
gene that is associated with apoptosis, or programmed cell death (Nishiyama et al., 1999). 
The TNF receptor-associated factor 1-like gene is associated with antiviral activity (Su et al., 
2006).  
Given the interesting candidate genes in the SSC1 region, namely that of TNF 
receptor-associated factor 1-like gene (TNF) located 1 Mb downstream of the 1 Mb window, 
SNPs within 2 Mb of either side of the SSC1 region were investigated. Approximately 1 Mb 
downstream of TNF, SNP MARC0056777 had a significant effect on VL when fitted as a 
linear covariate (p < 0.03), but not when fitted as a fixed class factor (p > 0.15), in the joint 
analysis of all trials. In general, the B allele for this SNP was associated with increased VL 
(Figure 6.6). Interestingly, the effect of this SNP was only significant for trial 6 (p < 0.01), 
which had the highest death loss, as a result of secondary infections, and the smallest number 
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of animals with VL data. Estimates of LS means for this SNP across all trials, and by trial, 
are in Figure 6.6. 
 
Genetic parameters of mortality 
The number of pigs that died prior to 21 dpi and 42 dpi within each trial is presented 
in Table 6.4. Across all trials, 11.1% of the animals died prior to 42 dpi. Over 50% of the 
total death loss occurred in trial 6, where 87 pigs died before 42 dpi due to secondary 
bacterial infections (Chapter 5). When using data from all trials, heritability was estimated to 
be 0.15 ± 0.1 for mortality prior to 21 dpi and 0.07 ± 0.13 for mortality prior to 42 dpi. When 
trial 6 was removed, corresponding estimates of heritabilities were 0.19 ± 0.10 and 0.18 ± 
0.09 for mortality prior to 21 and 42 dpi, respectively. The estimates of heritability for 
mortality in trial 6 alone were 0. Therefore, heritability for mortality during PRRSV infection 
was low to moderate, but all estimates were associated with large SEs. 
 
Genomic regions associated with mortality 
A genome-wide association analysis was performed for mortality as a binomial trait 
(0 for survival and 1 for death) jointly across all trials using a threshold model in GenSel 
software. Both probit and logit models were used in a Bayes-B analysis with π=0.99, 0.995, 
or 0.999. However, the proportion of the total variance explained by the markers was over 
99% for all priors for π, which is not expected. Therefore, the QTL identified for VL on 
SSC4 and SSC1 were investigated for an association with mortality using a single SNP 
analysis in ASREML. 
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The effect of SNP WUR10000125 on SSC4 was investigated for an association with 
mortality in trial 6 and across trials by including SNP genotype as a fixed effect in the 
threshold animal model using ASREML. The effect of SNP WUR10000125 was not 
significant for either death prior to 21 dpi (p > 0.51) or 42 dpi (p > 0.86) when using data 
from all 8 trials. The effect of SNP WUR10000125 was also not significant for either death 
prior to 21 dpi (p > 0.50) or 42 dpi (p > 0.98) when analyzing data from just trial 6. Therefore 
SNP WUR10000125 does not appear to be associated with mortality following experimental 
infection with PRRS virus.  
SNP MARC0056777 that was associated with VL in trial 6 on SSC1 was also found 
to be associated with mortality in trial 6. This SNP was significant for death prior to 21 and 
42 dpi in a threshold animal model analysis (p < 0.001). By 21 dpi, ~ 40% of the animals 
with genotypes AB and BB had died, whereas no animals with AA genotype had died (Table 
6.5). By 42 dpi, over 50% of the animals with AB and BB genotypes had died. Animals with 
genotype AA had less than 10% death. However, this SNP was not significantly associated 
with death in the other 7 trials (p > 0.27). 
Collectively, given the effects of SNP MARC0056777 on VL, animals that died in 
trial 6 likely had higher VL due to PRRS while they were battling secondary infections. More 
research is needed to validate these findings, but this region could be of particular importance 
for mortality in the field when a herd is infected with PRRS and hit with a secondary 
infection. In the field, pigs do not typically die from PRRS, but PRRSV suppresses the 
immune system, allowing for secondary infections to easily invade, which ultimately results 
in increased death rates (Chung et al., 1997; Johnson et al., 2004). 
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Conclusions and Implications 
The investigation of host response to PRRSV infection has revealed a large QTL 
located on SSC4. This QTL has a dominant mode of action; however, accounting for 
dominance in the genome-wide association analysis only captured a fraction of the 
dominance variance that was expected. Accounting for dominance in the genome-wide 
association analyses did not reveal additional regions that were not already detected using an 
additive model. Using cross-validation, after accounting for the SSC4 QTL, the rest of the 
genome had little predictive ability for VL and WG across unrelated populations. Additional 
work is required to determine predictive ability within a population. A region on SSC7 was 
associated with WG, and this region is within the SLA. It accounts for a small percentage of 
genetic variance (~1.5%), but was the third largest QTL. A number of QTL have previously 
been identified in this region to be associated with WG under non-challenge environments. 
Another region on SSC1 was associated with VL. Interestingly, that region was also 
associated with death for one trial where a secondary infection resulted in over 50% death 
loss. The region could be of particular importance, as secondary infection is common in the 
field after a barn has been hit with PRRS. The genomic regions identified in this study can be 
used for marker-assisted selection for response to PRRS. The implementation of selection for 
these markers will not make pigs completely resistant to PRRS but will increase the well-
being of the animals and reduce the financial impact as a result of PRRSV infection from the 
studied strain. Further work is required to investigate the effects of these QTL against 
different PRRSV strains and in the field where pigs are subjected to many additional 
environmental stressors. 
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Table 6.1. Training and validation populations used for cross-validation of genomic prediction for virus load (VL) and  
weight gain (WG). 
Validation Population Reduced Training Population Full Training Population 
Trial N for 
VL1 
N for 
WG2 
Trials N for 
VL1 
N for 
WG2 
Trials N for 
VL1 
N for 
WG2 
1 185 177 3, 4, 5, 6, 7 871 843 3, 4, 5, 6, 7, 8 1,059 1,025 
2 178 169 3, 4, 5, 6, 8 865 831 3, 4, 5, 6, 7, 8 1,059 1,025 
3 176 168 3, 4, 5, 7, 8 936 919 - - - 
4 195 193 3, 4, 6, 7, 8 875 842 1, 2, 3, 5, 6, 7, 8 1,218 1,178 
5 184 183 3, 5, 6, 7, 8 864 832 1, 2, 3, 4, 6, 7, 8 1,229 1,188 
6 123 106 4, 5, 6, 7, 8 884 858 1, 2, 3, 4, 5, 7, 8 1,290 1,265 
7 194 194 4, 5, 6, 7, 8 884 858 1, 2, 3, 4, 5, 6, 8 1,219 1,177 
8 188 182 4, 5, 6, 7, 8 884 858 1, 2, 3, 4, 5, 6, 7 1,225 1,189 
1 VL = virus load calculated as area under the curve of log-transformed viremia between 0 and 21 days post infection (dpi) 
2 WG = weigh gain from 0 dpi to 42 dpi 
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Table 6.2. Top 10, 1 Mb windows that explained the greatest percentage of genetic variance 
when using an additive model or an additive plus dominance model, for virus load (VL) and 
weight gain (WG). 
 
1 VL = virus load calculated as area under the curve of log-transformed viremia between 0 and 21 days post 
infection (dpi) 
2 WG = weigh gain from 0 dpi to 42 dpi 
3 Mega base position within a Sus scrofa chromosome 
4 SNP covariates coded as 0, 1, or 2 based on the number of B alleles, or trial average for missing 
5 SNP covariates coded as 0, 1, or 0 for AA, AB or BB individuals, or trial average for missing 
6 Posterior mean of the total genetic variance from the genome-wide association analyses 
 
 
 
 
 
  Additive model4 Additive and Dominance 
model5 
Chromosome Position3 Rank % Rank % 
Virus Load1 
4 139 1 13.2 1 14.5 
19 113 2 1.24 2 0.73 
1 292 3 0.70 3 0.63 
9 13 4 0.64 5 0.57 
19 112 5 0.49 7 0.47 
9 47 6 0.48 4 0.61 
9 29 7 0.46 14 0.19 
4 99 8 0.43 13 0.21 
7 13 9 0.40 12 0.22 
16 74 10 0.39 10 0.23 
Genetic Variance6 22.2 21.7 
Weight Gain2 
4 139 1 9.14 1 9.99 
5 72 2 2.61 2 1.68 
7 27 3 1.45 3 1.22 
10 67 4 0.94 6 0.43 
4 7 5 0.84 11 0.28 
11 1 6 0.71 10 0.31 
3 138 7 0.56 9 0.33 
6 18 8 0.52 8 0.34 
1 123 9 0.48 26 0.16 
17 22 10 0.43 4 0.99 
Genetic Variance6 6.50 6.13 
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Table 6.3. Estimates of accuracy1 and heritability of genomic estimated breeding values in the validation population based on 
bivariate ASREML analyses for genomic predictions obtained using reduced or full training populations (see Table 6.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Accuracy estimated as the genetic correlation between the phenotype and genomic estimated breeding value in the validation population 
2 VL = virus load calculated as area under the curve of log-transformed viremia between 0 and 21 days post infection (dpi) 
3 WG = weigh gain from 0 dpi to 42 dpi 
4 Average across individual validation populations 
5 The starting value of π, defined as the proportion of markers expected to have no effect on the trait of interest, was set to 0.99 
6 By definition, pi was set to 0 
 
Validation 
Population 
Reduced Training 
 Population 
Full Training  
Population 
Trial Virus Load2 h2 Weight Gain3 h2 Virus Load2 h2 Weight Gain3 h2 
1 0.02 ± 0.34 0.87 0.07 ± 0.18 0.77 0.50 ± 0.33 1 0.11 ± 0.17 0.79 
2 -0.08 ± 0.13 1 0 ± 0.18 1 0.31 ± 0.24 1 0.72 ± 1.48 1 
3 -0.21 ± 0.15 1 0.21 ± 0.16 0.73 - - - 0.73 
4 0.52 ± 0.79 1 0.07 ± 0.11 1 0.43 ± 0.78 1 0.09 ± 0.11 1 
5 0 ± 0.15 0.96 0.09 ± 0.24 0.66 0.11 ± 0.16 0.91 -0.11 ± 0.31 0.66 
6 -0.31 ± 0.21 0.42 0.67 ± 0.56 1 -0.18 ± 0.18 0.56 0.82 ± 0.66 1 
7 0.11 ± 0.17 1 0.24 ± 0.48 1 0.07 ± 0.18 1 0.19 ± 0.38 1 
8 -0.32 ± 0.55 0.59 0.34 ± 0.47 0.99 -0.12 ± 0.29 0.74 -0.05 ± 0.19 0.99 
Mean accuracy4 -0.03 - 0.12 - 0.24 - 0.25 - 
Joint Bayes CPi5 -0.06 ± 0.05 0.95 0.18 ± 0.08 0.94 0.11 ± 0.06 1 0.15 ± 0.08 1 
Joint Bayes C06 0.02 ± 0.05 0.96 0.04 ± 0.06 0.97 - - - - 
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Table 6.4. Total number of pigs within each trial and the total number of pigs that died by 21 
or 42 days post infection (dpi). 
 
 
 
Trial 
Total number 
of animals 
21 days 
post infection 
42 days 
post infection 
1 188 11 11 
2 190 12 17 
3 184 9 16 
4 195 0 2 
5 198 14 15 
6 192 68 87 
7 197 3 3 
8 198 11 16 
 155
Table 6.5. Number (and percentage) of pigs that survived or died by 21 or 42 days post 
infection (dpi) by genotype for SNP MARC0056777 on chromosome 1 in trial 6. 
 
21 days post 
infection 
42 days post 
infection 
SNP Genotypes Survived Dead Survived Dead 
AA 31 (100%) 
0 
(0%) 
28 
(90%) 
3 
(10%) 
AB 68 (58%) 
49 
(42%) 
56 
(48%) 
61 
(52%) 
BB 25 (57%) 
19 
(43%) 
21 
(48%) 
23 
(52%) 
Total 124 (65%) 
68 
(35%) 
105 
(55%) 
87 
(45%) 
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Figure 6.1. Manhattan plot of the genome-wide association analysis of virus load using an 
additive model (A) and an additive plus dominance model (B) with method Bayes-B with 
 =0.99, showing the proportion of genetic variance that is explained by each non-
overlapping 1 Mb window, labeled by index number of the first 1 Mb window and ordered 
by chromosome (1-18, X, Y, and unknown). Virus load was calculated as area under the 
curve of log-transformed viremia from 0 to 21 days post infection. 
1-Mb windows ordered by chromosome 
1-Mb windows ordered by chromosome 
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Figure 6.2. Manhattan plot of the genome-wide association analysis of weight gain from 0 to 
42 days post infection using an additive model (A) and an additive plus dominance model 
(B) with method Bayes-B with  =0.99, showing the proportion of genetic variance that is 
explained by each non-overlapping 1 Mb window, labeled by index number of the first 1 Mb 
window and ordered by chromosome (1-18, X, Y, and unknown).  
1-Mb windows ordered by chromosome 
1-Mb windows ordered by chromosome 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3. Genomic predictions
using additive and dominance SNP covariates in method Bayes
against estimates of the genotype effect of SNP WUR10000125 based on an ASREML 
analysis with genotype as fixed effect fo
axes represent the estimates of the effects of SNP WUR10000125 genotypes (
the ASREML analysis. Marks on the Y axes represent the mean 
genotype at SNP WUR10000125. V
transformed viremia from 0 to 21 days post infection.
 
A) 
B) 
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Figure 6.4. Accuracies of genomic predictions estimated using a bivariate animal model 
plotted against accuracies calculated as the correlation between 
adjusted phenotypes divided by the square root of heritability for virus load (A), calculate
area under the curve of log-transformed viremia from 0 to 21 days post infection and weight 
gain to 42 days post infection (B). See Table 
validation populations. 
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Figure 6.5. Least squares means of the effects of genotype for SNP H3GA0004624 on SSC1 
across trials 1 through 8 for virus load, calculated as area under the curve of log
viremia from 0 to 21 days post infection. Columns with a different letter, within tr
significantly different at p < 0.05. Numbers of individuals within genotype are listed in the 
bars.  
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Figure 6.6. Least squares means of the effects of genotype for SNP MARC0056777 on SSC1 
across trials 1 through 8, and by trial, for virus load, calculated as area under the curve of 
log-transformed viremia from 0 to 21 days post infection. Columns with a different let
within trial, are significantly different at p < 0.05. Numbers of individuals within genotype 
are listed in the bars.  
8 
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CHAPTER 7. GENERAL DISCUSSION 
 
Host genetics in response to porcine reproductive and respiratory syndrome virus challenge 
 Herd health is critical to the profitability of swine production systems. Vaccines are 
routinely used to maintain herd health against diseases such as porcine circovirus type 2 and 
swine influenza virus. However, vaccines against porcine reproductive and respiratory 
syndrome (PRRS) virus (PRRSV) have had limited success. The PRRS Host Genetics 
Consortium was established to investigate the role of host genetics in response to PRRSV 
infection with the goal of developing additional tools that can be used to combat PRRS. The 
material in this thesis provides insight as to whether host genetics can be used to improve 
herd health if a population becomes infected with PRRSV. 
The first step to making genetic improvement is the characterization of traits and 
determining if they are heritable. Characterization of traits associated with PRRS is 
challenging for breeding companies because of the high-health status that must be maintained 
in their herds. However, these traits have been characterized under experimental conditions 
and in the field when herds become naturally infected and include survival of nursery pigs 
(Vukasinovic and Clutter, 2010), viremia in weaned piglets (Biffani et al., 2010), and sow 
reproductive performance, including total born alive, total born dead, total mummified, total 
stillborn, and gestation length (Lewis et al., 2009a). Heritability estimates were generally low 
to moderate in those studies, ranging from 0.01 to 0.27. In the results presented here, viremia 
over time, virus load (VL, quantified as area under the curve of log-transformed viremia from 
0 to 21 days post infection), and weight gain (WG) were characterized in 25-35 day old 
commercial crossbred pigs under experimental infection with a single PRRSV isolate. Under 
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those conditions, these traits were generally found to be moderately heritable, ranging from 
0.06 to 0.47 (Chapter 5). Therefore, these results, along with those published by others, 
provide evidence that genetic improvement in response to PRRSV infection is possible. 
Regardless, breeding companies will not subject their nucleus breeding populations to a 
PRRSV challenge to collect phenotypes on these heritable traits. 
Genetic markers associated with phenotypes can be used in place of direct selection 
on own phenotype. This is particularly useful for traits that are difficult to measure, measured 
late in production, or traits that are associated with disease. Few studies have performed 
genome-wide association analyses on pigs infected with PRRS. One study identified 6 
single-nucleotide polymorphisms (SNP) that were associated with reproductive performance 
in sows naturally infected with PRRSV (Lewis et al., 2009b) The locations of these SNPs 
were not disclosed. Collectively, in the current experiment, several genomic regions were 
identified as having associations with the two primary traits of interest, VL and WG (Chapter 
5). One region was associated with both traits and explained a substantial proportion of 
genetic variance. The QTL on Sus scrofa chromosome (SSC) 4 was identified using ~550 
animals of a single cross from the same breeding company (Chapter 3) and this QTL was 
subsequently validated in 5 unrelated populations (Chapter 4, 5). A high degree of linkage 
disequilibrium (LD) is present in the ~488 kb region on SSC4 that likely contains this QTL. 
There are 9 candidate genes within this region that are associated with immune response, 5 of 
which are within the same gene family, which makes determining the causative mutation 
difficult.  
Four SNPs within the SSC4 region that were in complete LD with each other, each 
explained over 99% of the genetic variance for VL and WG that was captured by this region, 
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which likely means these SNPs are in very high, if not perfect, LD with the causative 
mutation (Chapter 3). The frequency of the favorable allele at these SNPs was 0.17 across all 
8 trials (Chapter 5). The effects of the favorable allele for this QTL, characterized using one 
of the 4 SNPs that were in perfect LD with each other (SNP WUR10000125), resulted in 
decreased VL and increased WG. In phenotypic standard deviations (SD), the estimates of 
the effects were 0.49 SD for VL and 0.50 SD for WG between AA and AB/BB genotypes, 
assuming dominance. Furthermore, this QTL explained 13% of the genetic variance for VL 
and 9% for WG (Chapter 5). Comparatively, melanocortin receptor 4 (MC4R) gene has been 
well established to have effects on backfat depth, feed intake, and growth rate in swine (Kim 
et al., 2000; Houston et al., 2004). In phenotypic standard deviations, the allele substitution 
effects of MC4R are reported to be 0.50 SD for BW at 140 days of age and 0.20 SD for 
carcass backfat (Ovilo et al., 2006). Another large QTL is DGAT in cattle, with an additive 
effect of 0.20 SD for fat yield (Boysen et al., 2013). Thus, the effects of the SSC4 QTL 
identified here are of similar magnitude as those of known genes with recognized large 
effects. 
With the high degree of LD present in the SSC4 region, only 19 unique haplotypes 
were identified from 15 SNPs across all populations studied, involving 5 different parental 
breeds and 11 different parental lines (Chapter 5). Furthermore, all haplotypes that carried 
the favorable allele of SNP WUR10000125 were found to be associated with the favorable 
phenotypes. Therefore, this is likely an old QTL that was present before the establishment of 
the breeds that contributed to the populations studied here, and is likely present in other 
breeds and populations. 
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Most of this thesis focused on the SSC4 QTL because of the large amount of genetic 
variation it explained and its favorable effects on both VL and WG. However, the rest of the 
genome accounts for a large percentage of the genetic variance. But the contributions by the 
rest of the genome were primarily made up of QTL with small effects, with a few exceptions. 
A 1 Mb region on SSCX explained 1.2% of the genetic variance for VL and regions on SSC5 
and SSC7 explained 2.6% and 1.5% of the genetic variance for WG, respectively. Accuracies 
of genomic estimated breeding values (GEBV) across breeds for the region on SSC4 were all 
positive and relatively high (0.11 < r < 0.46); however, this did not hold for the whole 
genome. Averaging the accuracies across trials and traits, accuracies of GEBV based on the 
whole genome (r = 0.24) were less than accuracies of GEBV based only on the SSC4 region 
(r = 0.32), and accuracies of GEBV for the whole genome after accounting for the SSC4 
region (r = 0.08) were lower than GEBV for the whole genome including the SSC4 region. 
Therefore, except for the region on SSC4, across-breed prediction of response to PRRSV 
infection does not appear very informative. Dominance, epistasis, and differences in LD can 
all contribute to poor predictive performance across breeds (Garrick 2010). Additional QTL 
within breed or population are present, but breeding companies will need to subject a large 
number of their animals to a PRRSV challenge in order to identify these. Furthermore, 
increasing the density of the marker panel may identify additional QTL that are not in LD 
with markers on the current 60k chip. These challenge experiments are expensive and labor 
intensive and each company will need to decide if the benefits (potential profits) outweigh 
the costs. Nonetheless, a large QTL has been identified here that all breeding companies 
represented in this study can consider using in their breeding programs. 
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Unanswered questions 
 The work presented here has provided a great deal of insight into the genetic basis of 
host response to PRRSV infection. Furthermore, this work has satisfied the primary objective 
of identifying QTL or genomic regions associated with response to PRRSV infection by 
identifying a major QTL on SSC4. However, there are many unanswered questions that must 
be addressed before implementing these results, primarily related to the use of the SSC4 QTL 
in a breeding program. 
 The experimental design of this study used only one specific strain of PRRSV, 
leading to the question “Will these results hold with other PRRSV strains?" Many different 
strains of PRRSV circulate within the United States and Canada (Halbur et al., 1996; 
Andreyev et al., 1997), and are subject to rapid mutation, and other strains that are present in 
Europe and Asia may also enter North America in the future. If the QTL on SSC4 is specific 
to the strain used here, selection for the favorable allele may have limited impact in the field, 
as it is unlikely that a herd will become infected with the specific strain used in this 
experiment. If this QTL is not strain specific, then selection for the favorable allele could 
have a large impact on herd health in response to PRRSV infection. Preliminary results from 
ongoing studies indicate that this QTL is not strain specific, as the effect of the SSC4 region 
was present and in the same direction when pigs were challenged with a different PRRSV 
strain (data not published). Also, based on the genes that are present in this region, namely 
those of the interferon induced guanylate binding protein (GBP) family, this region may be 
important in host response to other viruses, such as swine influenza virus and porcine 
circovirus. Because the GBP genes are interferon-inducible, they are an important aspect of 
the innate immune response. Furthermore, the GBP genes present in this region have been 
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associated with inhibition of different viruses in humans (Anderson et al., 1999; Itsui et al., 
2009), making these excellent candidate genes. 
 There is clear evidence that the SSC4 QTL contributes to piglet performance under 
PRRSV infection, i.e. increased WG if the animal carries at least one copy of the favorable 
allele. There have been no reports of QTL in this region for economically important 
production traits, such as feed intake, feed efficiency, or growth under either healthy or 
challenged conditions (http://www.animalgenome.org/cgi-bin/gbrowse/pig/). Therefore, there 
is no evidence that this QTL affects other production traits under PRRS-free (i.e. healthy) 
conditions. The experimental challenge studies reported on here did not maintain control pigs 
for the purpose of comparing growth under healthy and challenged conditions. If the 
favorable allele under PRRS challenge is unfavorable for economically important production 
traits under healthy conditions, breeding companies will need to decide if losing some 
genetic progress in production traits is worth the increased performance when infected with 
PRRS.  
The current study used pigs from high-health farms and the pigs were challenged with 
a single PRRSV strain under experimental conditions. In the field, there are many other 
environmental stressors that pigs need to overcome. Secondary infection is usually associated 
with PRRSV infection and increases the likelihood of death (Chung et al., 1997; Johnson et 
al., 2004). Although the SSC4 QTL was not associated with mortality during a secondary 
infection that occurred in trial 6 (Chapter 6), additional work is needed to determine if the 
effects of this QTL are present when pigs are subjected to PRRSV and secondary bacterial 
and/or viral infections. If not, then there may be no benefit for breeding companies to 
increase the frequency of the favorable allele in their populations. Conversely, pigs with the 
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favorable allele could perform just as well, if not better, than reported here under different 
environmental conditions.  
As discussed in Chapter 4, the frequency of the favorable B allele is low across 
populations in both maternal and terminal lines, which have been selected for reproductive 
and production traits, respectively. The low frequency of that favorable allele is likely due to 
a combination of the following: 1) PRRSV is a relatively new disease (~25 years old) and 2) 
selection typically occurs in high-health nucleus farms, which tend to be fee of PRRSV. 
Therefore, there may have been no selection pressure on this region in domestic pig 
populations.  
 The PRRSV not only affects the performance of growing animals but also has 
detrimental effects on pregnant gilts and sows. Therefore, it is important to understand the 
effect, if any, this QTL may have on reproductive performance with or without PRRS 
challenge. This information is needed when deciding how to incorporate these results into a 
breeding program. For example, if the favorable allele in the SSC4 region has negative 
effects on reproductive performance but no effect on healthy growing pigs, then breeding 
companies could select for the favorable allele in their terminal sire lines, resulting in 
increased PRRS tolerance in the growing pig without affecting reproductive performance of 
maternal lines. Conversely, if the favorable allele identified in growing pigs is also favorable 
for reproductive traits under PRRS challenge, breeding companies can select for the 
favorable allele to improve pig performance under PRRS challenge in both lines.  
There has been one report of a QTL within the SSC4 region for reproductive 
performance in healthy breeding females (non-functional nipples) 
(http://www.animalgenome.org/cgi-bin/QTLdb/SS/index). A genome-wide association 
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analysis of reproductive performance of sows following natural exposure to PRRSV in the 
field by Lewis et al. (2009b) revealed 6 SNPs that had associations with total born alive, total 
born dead, and total mummies; however, the location of these SNPs was not disclosed. 
Studies funded under a Genome Canada grant are currently ongoing to determine the effect 
of this QTL on reproductive performance of breeding females following experimental 
PRRSV infection, as well as in the field. 
 Clearly, many additional questions on the effects of the SSC4 QTL remain and 
breeding companies should proceed with caution until these questions are answered. The 
ideal situation would include no detrimental effects of this QTL on other production or 
reproductive traits, and the effects of the QTL holding up under field conditions and against 
other PRRSV strains.  
Another question is whether it is important to identify the causative mutation for the 
SSC4 QTL. The SNP WUR10000125 was used to characterize the effects of the SSC4 QTL 
(Chapter 3) and based on these results, this SNP is expected to be in high, if not perfect, LD 
with the causative mutation. This SNP is included in Illumina’s Porcine 60k SNP chip and 
breeding companies can use this SNP to make selection decisions without knowing the 
causative mutation. However, the extent of LD between SNP WUR10000125 and the 
causative mutation is unknown. If LD is not perfect, then maximum genetic gain with respect 
to host response to PRRSV infection may not be achieved. Furthermore, LD between the 
SNP and the causative mutation may break down over time by recombination, resulting in 
animals that carry the favorable allele, but not the causative mutation. Based on the results 
presented in this thesis, this however appears to be a region with very little recombination, as 
only 1 recombination event was identified and this was outside the haplotype block that 
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appears to include the causative mutation. Nonetheless, if possible, it would be in the best 
interest of the breeding companies to select directly on the causative mutation, which means 
that the causative will need to be identified. Identification of the causative mutation will also 
provide knowledge on what it does in terms of immune response. If there is a clear link 
between antiviral activity in response to PRRSV and/or other viruses prior to the above 
questions being answered, selecting for this region in terminal sire lines would be 
recommended to reduce the impact of PRRS in the finishing sector of the swine industry.  
Breeding companies aside, it is in the best interest of the swine industry and PRRS 
community to identify the causative mutation. There is still much to learn about the 
interaction between the PRRS virus and the host. Understanding this interaction may bring 
the swine industry closer to controlling the spread of PRRSV. Improvement of host response 
to PRRSV infection can be achieved by selection but this does not mean that pigs that are 
completely resistant to the virus can be developed by genetic improvement. As shown in 
Chapter 3, all animals become sero-positive for PRRSV, even pigs with the favorable allele 
for SNP WUR10000125. Controlling PRRSV will likely require a combination of 
biosecurity, vaccines, and genetics. Once the causative mutation is identified and its mode of 
action is understood, vaccine companies may be able to use that information to develop more 
reliable and effective vaccines. All around, it is best to identify the causative mutation but 
this is not a requirement for making genetic progress against PRRS. 
 
Potential benefits of selection on the SSC4 region 
 The economic impact of PRRS in the United States is estimated to be $664 million 
annually (Holtkamp et al., 2013). The growing pig herd accounts for over 50% of this cost. It 
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is clear that an economic benefit of selecting for the SSC4 QTL identified in the studies 
reported on in this thesis will be obtained only if the herd becomes infected with PRRS. If the 
herd remains free of PRRS, there is no benefit of having one genotype over the other, 
assuming the QTL has no effect on performance without PRRSV challenge. The favorable 
allele at the SSC4 QTL resulted in decreased virus load and increased weight gain following 
PRRSV challenge shortly after weaning, compared to animals with the undesirable genotype. 
At the end of the 42-day challenge, there was a 2.5 kg weight difference between animals 
with the AA versus the AB genotype for SNP WUR10000125. In the following, these results 
will be used to quantify the potential economic benefit if producers have a barn of nursery 
pigs with the favorable AB or BB genotype (AB) vs. pigs with the unfavorable AA genotype 
(AA) and the nursery barn of a grow-finish farm becomes infected with PRRS. Since the 
impact of the SSC4 QTL on post nursery phase growth is unknown, 4 scenarios were 
investigated in terms of growth response in the post-nursery phase following infection with 
PRRSV in the nursery phase: 1) AA animals have compensatory growth after viral clearance 
and reach market weight the same time as the AB animals, 2) AA and AB animals have equal 
growth rate following the nursery phase, 3) the absolute difference in growth rate between 
AA and AB animals following the nursery phase is the same as the difference at the end of 
the nursery phase, and 4) the proportional difference in growth rate between AA and AB 
animals following the nursery phase is the same as the proportional difference at the end of 
the nursery phase. Figure 7.1 shows the growth curve to 114 kg of body weight for AA and 
AB animals for each scenario.  
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Figure 7.1. Days post-nursery to raise a grow-finish pig to market weight (114 kg) by 
genotype for SNP WUR10000125 for four scenarios (see text). 
 
The profit function for a grow-finish unit that was used to quantify the economic benefits and 
associated definitions are in Table 7.1. The general form of the profit function is Profit = 
Returns – Costs. Returns are the amount of money paid to the producer once an animal has 
reached market weight (Table 7.1, Line 1). Costs include cost of feed to get an animal to 
market weight (Table 7.1, Line 2), cost to house an animal (Table 7.1, Line 3), and the cost 
associated with animal health due to PRRSV (Table 7.1, Line 4).  
 
 
 
0 
20 
40 
60 
80 
100 
120 
-45 -20 5 30 55 80 105 130 
Bo
dy
 w
eig
ht
 (k
g) 
Days post nursery 
AB 
Scenario 1 AA 
Scenario 2 AA 
Scenario 3 AA 
Scenario 4 AA 
10
7 d
ay
s 
11
0 d
ay
s 
11
8 d
ay
s 
13
0 d
ay
s 
114 kg 
 173
Table 7.1 Profit function during grow-finish phase of commercial pigs 
(1) 1Profit (P) = slwt x bmp  
(2) -[(slwt-awwi)/ADGi] x cfpw x [(MEm+MEg(ADGi))/MEd]  
(3) -[(slwt-awwi)/ADGi] x ch  
(4) -cv  
slwt Weight at slaughter 114 kg 
2bmp Base market price $0.502/kg 
awwi Average weaning weight for genotype i AA=21.7 kg 
AB=24.2 kg 
ADGi Average daily gain for genotype i  3MEm Metabolizable energy required for maintenance given 
midpoint body weight (MBW = 45 kg) 
197 kcal x 
MBW0.60 
3MEg Metabolizable energy required for growth 6315 kcal/kg 3MEd Metabolizable energy of the diet 3250 kcal/kg 4cfpw Cost of feed post nursery $0.385/kg 1ch Daily cost per head to house $0.17/day 2cv Animal-health-related cost during nursery phase $2.50/pig placed 
1 http://www.extension.purdue.edu/extmedia/NSIF/NSIF-10/NSIF-FS10.html 
2 http://www.ams.usda.gov/AMSv1.0/ 
3 NRC, 2012 
4 http://mydigimag.rrd.com/publication/?i=128849&p=14 (Pork magazine)  
5 Holtkamp et al., 2013 
 
Animal health costs include vaccine and antibiotic costs, and costs associated with increased 
biosecurity. The costs associated with feed and housing for AA versus AB animals will be 
contrasted first, followed by costs associated with animal-health-related issues. 
 Due to the lack of data beyond the nursery phase, some additional assumptions must 
be made regarding performance during the grow-to-finish phase: 1) mortality during the 
nursery and grow-to-finish phases was not different between the two genotypes, 2) the ADG 
of healthy barrows and gilts for the post nursery grow-to-finish phase is 0.84 kg/d (NRC, 
2012), and 3) post nursery, AB animals have the same ADG as a healthy pig, i.e. 0.84 kg/d. 
Therefore, for each scenario, ADG for AA animals is with respect to the ADG of AB 
animals. 
 For each scenario, Returns are the same between AA and AB animals because of the 
fixed market weight of 114 kg. Therefore, the difference between the two genotypes lies 
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within the costs. The difference in costs between the two genotypes was calculated by 
summing the costs associated with each genotype and subtracting the costs associated with 
the AB animals from that of the AA animals. The costs associated with feed, calculated from 
Table 7.1 (Line 2), and housing, calculated from Table 7.1 (Line 3), along with the difference 
in total cost between the two genotypes are summarized in Table 7.2. Animal health-related 
costs will be discussed later. 
 
Table 7.2. Total cost of feed and housing to raise a grow-finish pig to market weight (114 
kg) by genotype for SNP WUR10000125 for four scenarios (see text). 
    Costs ($)  
Scenario Genotype 
ADG1 
(kg) 
Days to 
Market2 Feed3 Housing Total 
Total 
difference 
in costs 
1 AA 0.864 106.9 93.57 18.17 111.74 $1.92 AB 0.84 106.9 91.65 18.17 109.82 
2 
 
AA 0.84 109.9 94.23 18.68 112.91 $3.09 
AB 0.84 106.9 91.65 18.17 109.82 
3 
 
AA 0.78 118.3 96.12 20.11 116.23 $6.41 
AB 0.84 106.9 91.65 18.17 109.82 
4 
 
AA 0.71 130.0 98.82 22.10 120.92 $11.10 
AB 0.84 106.9 91.65 18.17 109.82 
1 ADG = average daily gain (kg) 
2 Calculated as market weight (114kg) minus average weaning weight for a given genotype (AA=21.7 kg,  
    AB=24.2 kg) divided by ADG for a given genotype and scenario 
3 Calculated using line 2 in Table 7.1 
4 Calculated using line 3 in Table 7.1 
5 Sum of feed and housing columns 
 
Scenario 1. Under this scenario, AA genotype animals have compensatory post 
nursery growth, given the 2.50 kg difference in BW by the end of the nursery phase, and 
reach market weight in the same number of days as the AB genotype. Given the AB animals 
have an ADG of 0.84 kg/d, the AA animals would have an ADG of 0.864 kg/d in the post-
nursery phase. Therefore, there is no difference in days to market, resulting in no difference 
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in the cost of housing. However, AA animals consume more feed than AB animals to achieve 
the compensatory growth, resulting in a difference in feed cost of $1.92, between the two 
genotypes, ultimately resulting in a total difference of $1.92 per pig marketed.  
Scenario 2. This scenario assumes that the two genotypes have the same ADG post 
nursery, i.e. both genotypes have an ADG of 0.84 kg/d. The total cost of feed was $94.23 for 
AA animals and $91.65 for AB animals, with a difference of $2.58. The difference in 
housing costs was $0.51 between the two genotypes. Therefore, it will cost a producer an 
additional $2.58 + $0.51 = $3.09 per marketed AA pig compared to a marketed AB pig. 
Scenario 3. The difference in ADG for the nursery phase was 0.06 kg/d and this 
scenario assumes that this difference is the same during the grow-to-finish phase, i.e. ADG 
for AB animals is 0.84 kg/d and 0.78 kg/d for AA animals. The extra costs associated with 
the AA animals include increased days to house and feed the animals. Furthermore, feed 
efficiency (FE) is slightly poorer for the AA animals (0.37 kg of gain/kg of feed consumed) 
compared to the AB animals (0.38 kg of gain/kg of feed consumed). In total, it will cost the 
producer an additional $4.47 in feed and $1.94 to house an AA animal compared to an AB 
animal, totaling $6.41 extra per AA pig. 
Scenario 4. The last scenario assumes the proportional difference in ADG seen in the 
nursery phase between the AA and AB animals following challenge remains constant 
throughout the grow-to-finish phase. During the nursery phase, the AA animals grew at a 
15% lower rate than AB animals; therefore, ADG for the AA animals during the post nursery 
phase was 0.71 kg/d. The reasons for the extra costs for an AA animal are the same as in 
Scenario 3; increased days to house and feed the animal, along with poorer feed efficiency 
compared to an AB animal. Feed efficiency in this scenario is 0.36 kg of gain/kg of feed 
 176
consumed for AA animals. The difference in costs associated with feed and housing between 
the two genotypes is $7.17 and $3.93, totaling $11.10 per pig. 
 The animal health-related costs include costs associated with treatment, increased 
biosecurity, and other outbreak-related costs, such as disposal of dead pigs. Most medications 
given to pigs during a PRRS outbreak are not directly related to PRRS, but rather to reduce 
the chances of a secondary infection, be that viral or bacterial (Holtkamp et al., 2013). 
Additional work is required to determine if AB animals need less medication or less strict 
biosecurity measures. However, boundaries can be set under the assumption of no difference 
in mortality between the two genotypes. Holtkamp et al. (2013) estimated animal health-
related costs associated with a barn that becomes inefected with PRRSV to be $2.50 per 
animal placed at weaning. Thus, the maximum cost difference between the AA and AB 
animals would be $2.50, i.e. AB animals do not need the additional medication or increased 
biosecurty that is maybe necessary for AA animals. Therefore, given these scenarios, the 
greatest difference in cost between the AA and AB animals would be Scenario 4 with 
treatment and increased biosecurity for AA animals but not for AB animals, resulting in a 
difference of $13.60 per pig ($11.10 for feed and housing and $2.50 for health-related costs). 
With the maximum difference for animal health-related costs between the two genotypes (i.e. 
$2.50), the minimum difference in total cost would occur in Scenario 1, where the cost 
difference was $1.92 for feed and housing, with a difference of $4.42 ($1.92 + $2.50) per pig. 
 This economic assessment between a barn of AA animals and a barn of AB animals 
was carried out to achieve a better understanding of the benefits of selection for the favorable 
B allele for SNP WUR10000125. Due to the lack of data, many assumptions had to be made. 
Maximum and minimum boundaries were determined through these analyses, given the data 
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available. A barn fof AB animals does appear to be economically beneficial compared to a 
barn of AA animals; however, the reduction in costs associated with AB animals is likely 
somewhere between $4.42 and $13.60 per pig marketed. Further research is required to truly 
understand the effects that a PRRSV infection during the nursery phase has on the grow-to-
finish phase of production for AA versus AB animals. Ongoing field trials will shed light on 
these questions. 
 Holtkamp et al. (2013) estimated the total cost of PRRSV in the United States to be 
$664 million annually, of which $361.86 million was attributed to the growing-pig 
population. These estimates were based on surveying swine producers and swine 
veterinarians. In order to participate in the survey, each producer provided records for 
average daily gain, feed conversion rate, mortality, and percent of pigs sold in the primary 
market. These variables were used in the economic analyses. Additionally, only production 
systems that operated on an all-in all-out basis were included in the analyses, i.e. fixed time 
to market as opposed to the fixed market weight that was used here. Therefore, extra “costs” 
due to reduced growth rate in pigs infected with PRRS were actually losses in potential 
revenue, as lighter-weight pigs do not bring as much money as a heavier pig. Of the 103.8 
million pigs marketed per year in the US, 40% were estimated to be positive at weaning, 25% 
negative at weaning and market, and 35% negative at weaning but positive at market 
(Holtkamp et al., 2013). Therefore, 103.8 x 0.40 = 41.5 million pigs fall into the category 
described above for infection during the nursery phase. The economic impact of AA vs. AB 
animals for the entire US swine industry will be investigated here for each senario.  
 For scenario 1, without animal-health-related costs, if all pigs marketed were AB, the 
reduction in costs associated with PRRS would be $79.7 million annually (41.5 million pigs 
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x $1.92). Again, without animal health-related costs, the reduction in costs would be $128.2 
million for scenario 2, $266.0 million for scenario 3, and $460.7 million for scenario 4. When 
incorporating the maximum difference in animal-health-related costs, i.e. $2.50 per AA 
animal placed and $0 per AB animal placed, the minimum reduction in costs associated with 
PRRS is $4.42 x 41.5 = $183.4 million annually, with $2.50 per pig for health-related-costs + 
$1.92 per pig from the difference in ADG for scenario 1. Similarly, the maximum occurs 
when AA animals have $2.50 in health-related costs plus the difference in ADG for scenario 
4, which amounts to $11.10 per pig. Therefore, the maximum reduction in costs associated 
with PRRS is $13.60 x 41.5 = $564.4 million annually. Scenario 4 with the maximum 
difference in health-related costs, and without, appears to be rather extreme, as the annual 
reductions in costs are greater than the cost of PRRS attributed to the growing-pig herd 
($361.86 million). Therefore, the true reduction in costs from having AB versus AA pigs is 
likely somewhere between $79.7 million and $564.4 million. Nevertheless, selecting for the 
favorable B allele could have a huge impact on the economic losses due to PRRS nationwide. 
 All economic estimates above were calculated for pigs that become infected with 
PRRSV during the nursery phase. However, PRRS can strike at any time during production 
or age. Therefore, these estimates do not reflect the potenetial benefits of having AB animals 
when growing animals are infected later in the production phase, or when breeding females 
are infected. With respect to the growing-pig herd, pigs that are infected later in production 
are less affected in terms of overall performance than pigs infected at weaning (Holtkamp et 
al., 2013). Therefore, the economic benefits of the B allele when a pig is infected later in 
production are likely less than those estimated here for a pig infected in the nursery but likely 
still beneficial. If the B allele is favorable for reproductive performance in breeding females, 
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then having AB gilts and sows will reduce the economic impact due to PRRS in the breeding 
sector, which accounts for ~45% of the total economic loss due to PRRS (Holtkamp et al., 
2013). Quantifying these economic benefits requires estimates of the effects of the SSC4 
region on reproductive performance, which are currently not available. 
 
Strategies to achieve the potential benefits of the SSC4 region through selection 
 Assuming there is an economic benefit of having AB animals over AA animals, the 
last issue that needs to be considered in the design of a breeding program is how to include 
these results into the selection process so that producers end up with all AB or BB animals in 
their barns. With respect to growing pigs only, the easiest method of dissemination into 
commercial herds is to use BB terminal sires, such that all terminal offspring are either AB or 
BB, regardless of the genotype of the dam. If the B allele is favorable for the reproductive 
phase, then increasing the frequency of the B allele in the reproductive phase would benefit 
both production settings, as reproductive performance would improve under PRRSV 
infection and and the frequency of BB animals would increase in the growing phase. Even if 
the B allele has no benefits during the reproductive phase, then increasing the frequency of 
the B allele would benefit replacement gilts during the growing phase. Only if the B allele is 
unfavorable for reproductive performance would it not be desirable to increase the frequency 
of the B allele. 
 Dekkers (2004) reviewed 3 methods to incorporate molecular information into the 
selection processes: 1) tandem selection, with selection of candidates on a molecular score, 
e.g. the presence or absence of a certain allele or genotype, followed by selection on 
phenotype or estimated breeding value (EBV); 2) index selection on a combination of 
 180
molecular score and phenotype or EBV; and 3) preselection on molecular score at a young 
age, followed by selection on an updated EBV at a later age. The use of tandem and index 
selection at later stages of selection can result in negative consequences for other traits that 
are part of the breeding objective (Dekkers, 2004). Furthermore, these two strategies allow 
for the selection of animals with an undesirable genotype if their polygenic EBV is 
exceptionally good. For the PRRS scenario here, this means AA animals could be selected 
and used as parents and, depending on the genotype of the dam, AA offspring could end up 
in a barn. Preselection is effective when family sizes are large enough such that multiple 
individuals from a given family are selected at a young age based on a molecular score, 
allowing all families to be represented in the routine selection program (Dekkers, 2004). 
Because swine have litters, full-sib family sizes are sizable, and half-sib families are even 
larger, which satisfies the requirements of preselection.  
 Preselection is a suitable technique for incorporating SNP WUR10000125 into the 
selection program. Once a litter is born, breeders can genotype all piglets for SNP 
WUR10000125 or using the SNP panel and select all AB and BB animals prior to weaning, 
which will minimize the risk of losing response to routine selection on phenotypic 
information (Dekkers, 2004). It is best to select on both AB and BB animals so that there are 
enough selection candidates for the economically important traits that are routinely selected 
for, and to maintain genetic variation in the population. Terminal boars with genotype BB, 
selected based on their EBVs for the remaining traits in the breeding goal, should be used to 
produce terminal offspring. However, AA, AB, and BB males and females should be 
maintained in the breeding herd in the event that detrimental effects on other production traits 
occur due to the increase in the favorable PRRS tolerant allele. If the B allele is fixed in the 
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population, it is difficult to bring the A allele back. Furthermore, if only AB and BB animals 
were retained in the nucleus herd, the A allele could be lost through drift. It must be noted 
that this approach reduces the number of selection candidates to use as sires outside the 
nucleus, as AB animals will not be selected. Fixing the B allele would result in the greatest 
number of selection candidates to use outside the nucleus. As an example, if the frequency of 
the B allele was 0.80, then 0.802 x 100 = 64% of the male offspring will be BB when mated 
at random. This is one method for increasing the frequency of the favorable; however, 
breeding companies will need to decide what is best for their breeding program. Furthermore, 
if the favorable B allele for growing pigs is also favorable for reproductive traits, additional 
strategies will need to be investigated but this is beyond the scope of this chapter. 
 
Implications 
 The research reported in this dissertation provides sufficient evidence that 
improvement of host response to PRRSV in pig populations can be achieved through genetic 
selection. The two primary traits investigated were moderately heritable. The most 
significant result from this research was the QTL identified on SSC4 that was favorably 
associated with both these primary traits. The effect of this region was identified in unrelated 
populations made up of different breeds and crosses. Therefore, this QTL is likely present in 
many breeds and lines present in the United States and Canada, and possibly the world. 
Although additional questions must be answered, breeding companies can incorporate this 
information into their breeding programs. If the effects of this region hold up in the field and 
against other PRRSV strains, the economic impact due PRRS could be significantly reduced.  
 
 182
Literature Cited 
Anderson, S.L., J.M. Carton, J. Lou, L. Xing, and B.Y. Rubin. 1999. Interferon-induced 
 guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular 
 stomatitis virus and encephalomyocarditis virus. Virology. 256:8–14. 
Andreyev, V.G., R.D. Wesley, W.L. Mengeling, A.C. Vorwald, and K.M. Lager. 1997. 
 Genetic variation and phylogenetic relationships of 22 porcine reproductive and 
 respiratory syndrome virus (PRRSV) field strains based on sequence analysis of 
 open reading frame 5. Archives of Virology. 142:993–1001. 
Biffani, S., S. Botti, A. Caprera, E. Giuffra, and A. Stella. 2010. Genetic Susceptibility to 
 Porcine Reproductive and Respiratory Syndrome (PRRS) virus in commercial 
 pigs in Italy. In Proceedings of the Ninth World Congress on Genetics Applied to 
 Livestock Production. Leipzig, Germany. 592–595. 
Boysen, T.-J., C. Heuer, J. Tetens, F. Reinhardt, and G. Thaller. 2013. Novel use of 
 derived genotype probabilities to discover significant dominance effects for milk 
 production traits in dairy cattle. Genetics. 193:431–42. 
Chung, W.B., M.W. Lin, W.F. Chang, M. Hsu, and P.C. Yang. 1997. Persistence of 
 porcine reproductive and respiratory syndrome virus in intensive farrow-to-finish pig 
 herds. Canadian journal of veterinary research = Revue canadienne de recherche 
 vétérinaire. 61:292–8. 
Dekkers, J.C.M. 2004. Commercial application of marker- and gene-assisted selection in 
 livestock: strategies and lessons. Journal of animal science. 82 E-Suppl:E313–328. 
Halbur, P.G., P.S. Paul, X.-J. Meng, M.A. Lum, J.J. Andrews, and J.A. Rathje. 1996. 
 Comparative Pathogenicity of Nine US Porcine Reproductive and Respiratory 
 Syndrome Virus (PRRSV) Isolates in a Five-Week-Old Cesarean-Derived, 
 Colostrum-Deprived Pig Model. Journal of Veterinary Diagnostic Investigation. 
 8:11–20. 
Holtkamp, D.J., J.B. Kliebenstein, E.J. Neumann, J.J. Zimmerman, H. Rotto, T.K. Yoder, 
 C. Wang, P. Yeske, C. Mowrer, and C. Haley. 2013. Assessment of the economic 
 impact of porcine reproductive and respiratory syndrome virus on United States 
 pork producers. Journal of Swine Health and Production. In Press. 
Houston, R.D., N.D. Cameron, and K.A. Rance. 2004. A melanocortin-4 receptor 
 (MC4R)polymorphism is associated with performance traits in divergently selected 
 Large White pig populations. Animal genetics. 35:386–90. 
Itsui, Y., N. Sakamoto, S. Kakinuma, M. Nakagawa, Y. Sekine-Osajima, M. Tasaka-
 Fujita, Y. Nishimura-Sakurai, G. Suda, Y. Karakama, K. Mishima, M. Yamamoto, 
 T. Watanabe, M. Ueyama, Y. Funaoka, S. Azuma, and M. Watanabe. 2009. 
 183
 Antiviral effects of the interferon-induced protein guanylate binding protein 1 and 
 its interaction with the hepatitis C virus NS5B protein. Hepatology (Baltimore, 
 Md.). 50:1727–37. 
Johnson, W., M. Roof, E. Vaughn, J. Christopher-Hennings, C.R. Johnson, and M.P. 
 Murtaugh. 2004. Pathogenic and humoral immune responses to porcine 
 reproductive and respiratory syndrome virus (PRRSV) are related to viral load in 
 acute infection. Veterinary immunology and immunopathology. 102:233–47. 
Kim, K.S., N. Larsen, T. Short, G. Plastow, and M.F. Rothschild. 2000. A missense 
 variant of the porcine melanocortin-4 receptor (MC4R) gene is associated with 
 fatness, growth, and feed intake traits. Mammalian genome : official journal of the 
 International Mammalian Genome Society. 11:131–5. 
Lewis, C.R.G., M. Torremorell, L. Galina-Pantoja, and S.C. Bishop. 2009a. Genetic 
 parameters for performance traits in commercial sows estimated before and after an 
 outbreak of porcine reproductive and respiratory syndrome. Journal of animal 
 science. 87:876–84. 
Lewis, C.R.G., M. Torremorell, L. Galina-Pantoja, N. Deeb, M.A. Mellencamp, A.L. 
 Archibald, and S. Bishop. 2009b. A genome-wide association analysis identifying 
 SNPS for PRRS tolerance on a commercial pig farm. In Proc. Assoc. Advmt. 
 Anim. Breed. Genet. 18:187–190. 
NRC. 2012. Nutrient Requirements of Swine. The National Academies Press, 
 Washington, D.C. 
Ovilo, C., A. Fernández, M.C. Rodríguez, M. Nieto, and L. Silió. 2006. Association of 
 MC4R gene variants with growth, fatness, carcass composition and meat and fat 
 quality traits in heavy pigs. Meat science. 73:42–7. 
Vukasinovic, N., and A.C. Clutter. 2010. Analysis of Survival of Pigs Challenged with the 
 Porcine Reproductive and Respiratory (PRRS) Virus. In Proceedings of the Ninth 
 World Congress on Genetics Applied to Livestock Production. Leipzig, Germany. 
 647–650.  
 
 
